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by
Mahmoud Ghanem
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Abstract
Choline oxidase catalyzes the oxidation of choline to glycine betaine. This reaction is of
considerable medical and biotechnological applications, because the accumulation of glycine
betaine in the cytoplasm of many plants and human pathogens enables them to counteract
hyperosmotic environments. In this respect, the study of choline oxidase has potential for the
development of a therapeutic agent that can specifically inhibit the formation of glycine betaine,
and therefore render pathogens more susceptible to conventional treatment. The study of choline
oxidase has also potential for the improvement of the stress resistance of plant by introducing an
efficient biosynthetic pathway for glycine betaine in genetically engineered economically
relevant crop plant. In this study, codA gene encoding for choline oxidase was cloned. The
cloned gene was then used to express and purify the wild-type enzyme as well as to prepare
selected mutant forms of choline oxidase. In all cases, the resulting enzymes were purified to
high levels, allowing for detailed characterizations. The biophysical and biochemical analyses of
choline oxidase variants in which the positively charged residue close to the flavin N(1) locus
(His466) was removed (H466A) or reversed (H466D) suggest that in choline oxidase, His466
modulates the electrophilicity of the bound flavin and the polarity of the active site, and

ii
contributes to the flavinylation process of the covalently bound FAD as well as to the
stabilization of the negative charges in the active site.
Biochemical, structural, and mechanistic relevant properties of selected flavoproteins
with special attention to flavoprotein oxidases, as well as the biotechnological and medical
relevance of choline oxidase, are presented in Chapter I. Chapter II summarizes all the
experimental techniques used in this study. Chapter III-VII illustrate my studies on choline
oxidase, including cloning, expression, purification and preliminary characterizations (Chapter
III), spectroscopic and steady state kinetics (Chapter IV), the catalytic roles of His466 and the
effects of reversing the protein positive charge close to the flavin N(1) locus (Chapter V and VI),
and the roles of His310 with a special attention to its involvement in a proton-transfer network
(Chapter VII). Chapter VIII presents a general discussion of the data presented.

INDEX WORDS: Choline Oxidase, Active Site Base, Flavin N(1) Locus, Proton-Transfer
Network, Chemical Mechanism, Flavoprotein.
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CHAPTER I
Introduction
1.1. Flavoproteins
Since the discovery and the chemical characterizations of flavins (Figure 1.1) in the 1930s,
they have been known of being capable of both one- and two-electron transfer processes, and as
playing a fundamental role in coupling the two-electron oxidation of many organic substrates to
the one-electron transfers of the respiratory chain (1). The mode of interaction of the
isoalloxazine nucleus of the flavin with the protein is the key determinant of the type of function
carried out by a particular enzyme. From a chemical standpoint, the isoalloxazine moiety of the
flavin is amphipathic, i.e., while the xylene moiety is hydrophobic and can interact with
hydrophobic parts of the protein, the pyrimidine ring is hydrophilic and electron-deficient,
enabling the formation of hydrogen bonds and electrostatic interactions with proteins (Figure
1.2) (2).
The flavin can exist in three different redox states, the oxidized, semiquinoid, and the fully
reduced species (Figure 1.3). In addition, the semiquinone can exist in a neutral (blue) or anionic
(red) form, with a pKa of ~8.5 in solution (3, 4). This pKa can be significantly changed upon the
binding of the flavin to a specific protein, i.e., while some enzymes can stabilize the neutral
radical form over the whole pH range at which the enzyme is stable (pKa >> 8.5), others stabilize
the red anionic semiquinone species (pKa << 8.5). In some enzymes, among which glucose
oxidase was the first example (5), the pKa is in the detectable pH range, allowing the spectral
characterizations of these two species (Figure 1.4).

2
At neutral pH, the pyrimidine moiety of the isoalloxazine nucleus is electron rich molecule
in the reduced state with a negative charge at the N(1)-C(2)=O locus (anionic hydroquinone). A
pKa value of ~6.5 was determined for the ionization of the N(1) locus of the reduced flavin (2). A
powerful tool to probe the active center of many flavin enzymes before their crystal structures
become available is the replacement of the native flavin by suitably modified flavins (6). Many
flavoprotein enzymes, in which flavin cofactor is not covalently attached, can accept a
chemically modified flavin ring structure into their active site (7). A large number of chemically
modified flavins with different substituents at various positions around the isoalloxazine nucleus
have become available (Figure 1.5). The use of chemically modified flavin substituents has
proved to be of great value, since they can be used to probe the flavin environment at a specific
position. In this regard, studies on the interactions of the flavin with the enzyme active site were
initiated by the use of naturally occurring 6-OH and 8-OH flavin chromophores (8, 9).
Edmondson et al., were first to probe the importance of the N(5) position in flavin coenzymes
through the use of 5-deaza-FMN (10).
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Figure 1.5. Artificial flavins that have been used as flavin replacements in flavoproteins.
Taken without permission from ref. (1).
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Our understanding of the versatile chemistry of flavins and the mechanisms of action of
flavoprotein enzymes has progressed significantly in the last 20 years, especially since the X-ray
crystallographic structures of many flavoprotein enzymes have become available. Flavoenzymes
can be grouped into relatively small number of classes, where members within the same class
share several common properties, including the type of reactions that they catalyze, the nature of
the auxiliary redox centers, and their ability to use molecular oxygen as electron acceptor (11).
Simple flavoproteins have been classified on the basis of the reactivity of the reduced enzyme
with molecular oxygen. This classification, as well as the common properties of each class, have
been reviewed previously by Massey and Hemmerich (6), but for convenience they will be
summarized here.
Flavoprotein Monooxygenases. In flavoprotein monooxygenases, such as phydroxybenzoate hydroxylase (PHBH) and bacterial luciferase, the reduced enzyme reacts with
molecular oxygen with the formation of an observable C(4a)-hydroperoxide intermediate (11). In
this class of enzymes, the physiological reductant for the reaction is either NADH or NADPH
(11). The flavin hydroperoxide intermediate then transfers an oxygen atom to the substrate with
the formation of a C(4a)-hydroxyflavin, which returns to its oxidized state upon dehydration.
However, in the absence of the organic substrate, the flavin hydroperoxide can convert slowly to
H2O2 and oxidized flavin (11).
Electron Transferases. The flavoprotein electron transferases, such as flavodoxin,
NADPH-cytochrome P-450 reductase, and ferrodoxin-NADP+ reductase, react slowly with
oxygen with the production of flavin semiquinone and O2-. Enzymes from this class are
physiologically involved in single-electron transfer reactions. In addition, they all
thermodynamically stabilize the blue neutral form of the flavin semiquinone species (11). The
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use of chemically reactive flavins, such as 8-Cl-, 8-SCN-, or 8-SH, showed that the benzene ring
of the flavin is the only solvent accessible part of the cofactor in that class of enzymes (2). The
X-ray crystallographic data of flavodoxin and ferrodoxin-NADP+ reductase have strengthened
that conclusion (12). In contrast to oxidases, enzymes from this group cannot stabilize either a
flavin-N(5)-sulfite adduct or the benzoquinoid forms of 6- and 8-sustituted flavins (2).
Flavoprotein Oxidases. In flavoprotein oxidases such as choline oxidase, glucose
oxidase, cholesterol oxidase, pyranose 2-oxidase, glycolate oxidase, sarcosine oxidase,
monoamine oxidase, and D-amino acid oxidase, to cite a few examples, the reduced enzyme
reacts rapidly with molecular oxygen with the production of H2O2 and the oxidized flavin,
without the formation of any observable flavin intermediate (13).
Flavoprotein oxidases have been found to share many common properties (Table 1.1)
including: 1) they all stabilize a flavin N(5)-sulfite adduct (14-22); 2) they all stabilize the red
anionic semiquinone flavin radical on the one-electron reduction (16, 17, 22-25); and 3) they all
stabilize the benzoquinoid anion forms of 6- and 8-substituted hydroxy- and mercaptoflavins (2,
9, 14, 18, 26, 27). In all the studied to date cases, the negative charge of the anionic flavin is
localized at the N(1)-C(2)=O region of the isoalloxazine moiety (Figure 1.1) (2). These
conclusions have led to the further interpretation that a positively charged locus of the protein
electrostatically interacts with the pyrimidine ring of the flavin to stabilize the negative charge at
the N(1)-C(2)=O locus of the anionic one- or two-electron reduced flavin (6, 14, 18-20). The
mechanistic implications for a protein positive charge stabilizing a negative charge on the N(1)
locus of the flavin are: to render flavin reduction thermodynamically favorable by elevating the
midpoint reduction-oxidation potential of the bound flavin (18, 20, 26-29); to preferentially
stabilize the anionic form of the reduced flavin that readily reacts with molecular oxygen (18, 20,

7
28, 29); and to facilitate the flavinylation process for those enzymes in which the flavin is
covalently linked to the protein moiety (30). In the last few years, the X-ray crystal structures of
many flavoprotein oxidases have been solved, clearly establishing that a positively charged
amino acid residue or a dipole of an α-helix is commonly oriented toward the N(1)-C(2)=O locus
of the enzyme-bound flavin (31-40).
1.1.1. The Reactivity of Flavoproteins with Sulfite
One of the most notable features of flavoproteins is that while the free reduced flavin
undergoes reaction readily with molecular oxygen, this property is retained only by some
flavoproteins including, flavoprotein oxidases and flavoproteins monooxygenases. Until the
discovery of the reactivity of sulfite with flavoproteins, no correlations have been found between
oxygen reactivity and different properties of flavoenzymes, such as spectral properties,
fluorescence, or nature of the flavin prosthetic group (FMN or FAD). The ability of sulfite ions
to react with flavoproteins and to form a reversible flavin-N(5)-sulfite adduct has been examined
in a large number of flavoenzymes (Figure 1.6) (19). This reaction was found to occur with a
number of flavoprotein oxidases such as glucose oxidase (Kd = 0.72 mM) (41), lactate oxidase
(Kd = 28 nM) (14), glycolate oxidase (Kd = 0.27 µM) (42), D- and L-amino acid oxidase (Kd =
3.4 mM) (19, 43), cholesterol oxidase (Kd ~ 0.14 and 24 mM for Brevibacterium sterolicum and
Streptomyces hygroscopicus cholesterol oxidase, respectively) (16), monomeric sarcosine
oxidase (Kd not determined due to the extremely slow complex formation) (22), and choline
oxidase (Kd = 50 µM) [this study; (44)]. In all cases, it was found that the formation of the flavinsulfite adduct is dependent on sulfite concentration, temperature, and pH, but it is not affected by
oxygen or light (21).
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Spectrophotometrically, the flavin-N(5)-sulfite adduct is characterized by a bleaching of
the UV-visible absorbance spectrum of the enzyme-bound flavin, and the subsequent appearance
of a new absorption band at ~320-330 nm, with a spectrum similar, but not identical, to the
anionic reduced flavoprotein (Figure 1.7 and Figure 4.6; Chapter IV) (19, 44). It was also found
that the formation of the reversible flavin-N(5)-sulfite adduct is a characteristic feature of those
flavoenzymes that react readily with molecular oxygen as an electron acceptor (1, 2, 19, 21). In
contrast, no sulfite reaction was observed with flavoprotein dehydrogenases (19, 21). Therefore,
the formation of covalent N(5)-flavin adduct with sulfite has become a common feature that
distinguishes flavoprotein oxidases from dehydrogenases (6, 19, 21). The oxidized flavin is
electron deficient, and sulfite is a powerful nucleophiles; thereby flavin in its oxidized state can
react with either SO32- or HSO3- (21). In addition, elemental analysis as well as the hydrolysis of
the crystalline flavin-sulfite complex showed that one SO32- was bound per flavin (21).
A linear correlation between the dissociation constant of the flavin-N(5)-sulfite adduct
and the oxidation reduction potentials of the bound flavin has been proposed (21). Recently, a
linear relationship was shown between the rate constants of flavin-N(5)-sulfite adduct formation
(kon) and the midpoint redox potentials of enzyme bound flavins of the reconstituted lactate
oxidase with different FMN analogs bearing various substitutions at the flavin 6- and 8-positions
(45). In this study, the kon values for sulfite formation showed a pattern similar to those of the kred
values for lactate, with increasing values as the redox potential was raised, until a breakpoint was
reached at ~-120 mV, beyond which these values remain unchanged (45). The koff values of
sulfite, however, showed a consistent decrease with increasing the redox potentials of the
enzyme-bound flavin with no obvious breakpoint (45). Interestingly, it was also proposed in this
study that the linear relationship between the rate constants of flavin reductions and flavin-N(5)-
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sulfite adduct formation and the flavin redox potential below the observed breakpoint indicated
the development of significant negative charge in the transition states of the reactions (45).
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Figure 1.6. Mode of reaction of sulfite with oxidized flavin.
P+, protein positively charged amino acid residue or α-helix dipole.

Figure 1.7. Effect of sulfite on lactate oxidase.
Curve 1, untreated enzyme (24 µM with respect to FMN content) in 100 mM sodium phosphate,
pH 7, at 25 °C. Curves 2 to 5, after adding sodium sulfite to concentrations of 6.18 µM, 12.3 µM,
24.4 µM, and 216 µM, respectively. Taken without permission from ref. (19).
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1.1.2. Stabilization of Anionic Semiquinone by Flavoprotein Oxidases
The flavosemiquinone forms of all the simple flavoproteins studied, i.e., flavoprotein
oxidases, flavoprotein monooxygenases, and electron transferases, were either the anionic (red)
or neutral (blue) semiquinone forms, each of which has very different and distinctive absorption
spectra (Figure 1.4) (5). This conclusion has been supported by the use of model flavins to
provide further evidence for the preferred tautomeric structures of the flavin radicals (Figure 1.3)
(4, 46). In addition, it can be concluded, with few exceptions, that while the flavoprotein
oxidases and hydroxylases stabilize the anionic form of the semiquinone upon the one-electron
reduction of the enzymes, the flavoprotein dehydrogenases stabilize the neutral form of the
semiquinone (Table 1.1) (1, 2, 19). With the exception of glucose oxidase, which showed an
ionization with a pKa value of ~7.5 (Figure 1.4) (5), most of the flavoproteins studied did not
show such ionization; instead, they either stabilize the anionic or the neutral radical species over
the whole pH range at which the enzyme is stable. Therefore, it has been concluded that the
particular protein to which the flavin is attached stabilizes either the anionic or the neutral
semiquinone (19). Furthermore, it has been proposed that either a positively charged amino acid
residue or a dipole of an α-helix close to the flavin N(1) position is responsible for the
thermodynamic stabilization of the anionic flavin semiquinone through an electrostatic
interaction with the negative charge that develops at the N(1)-C(2)=O of flavosemiquinone
species (16, 23, 24). A positively charged residue could also be responsible for the formation of
flavin-N(5)-sulfite adduct by facilitating the nucleophilic attack of sulfite to the N(5) locus of
the oxidized flavin.
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Table 1.1. Some Characteristic Properties of Selected Flavoproteins
Flavoenzyme
Choline oxidase

N(5)-sulfite

8-Mercapto-

6-Mercapto-

8-Hydroxy-

6-Hydroxy-

adduct

flavin

flavin

flavin

flavin

Red

Yes

nd

nd

nd

nd

Red/Blue

Yes

Resolved

nd

nd

Anion

Cofactor

Radical

a

FAD

b

FAD

Glucose oxidase

pK 7.3
Cholesterol oxidase

c

FAD

benzoquinoid

Red

Yes

pK < 5.6

Resolved

nd

nd

nd

nd

nd

nd

Resolved

Anion

Anion

Anion

benzoquinoid

pK < 5

pK < 4

pK < 5

Resolved

Anion

Anion

benzoquinoid

pK < 5

pK < 5

nd

benzoquinoid
Glycolate Oxidase

d

FMN

Red

Yes

FMN

Red

Yes

Resolved
benzoquinoid

Lactate oxidasee
D-Amino acid oxidase
Sarcosine oxidase

f

FAD

g

Red

FAD

Pyranose 2-oxidase

h

Yes

Red

Yes

nd

Red/Blue

No

Thiolate

nd

nd

FAD

i

FAD

Polyamine oxidase

Vanillyl-alcohol oxidase

j

FAD

p-Hydroxy-benzoate hydroxylase

k

FAD

pK < 6.9
+

Ferrodoxin-NADP reductase
Glutathione reductase

l

FAD

m

Blue

FAD

No

Red

No

Undefined

Neutral

benzoquinoid

pK ≥ 10

Undefined

Anion

Binds

benzoquinoid

pK < 4.5

poorly
pK ~7.2

n

FMN

Flavodoxin

Trimethylamine dehydrogenase

o

Dihydroorotate dehydrogenase
Flavocytochrome b2q
Old yellow enzyme

r

p

Blue

No

Undefined

Neutral

Neutral

Neutral

benzoquinoid

pK 6.4

pK 6.1

pK ~9

Smooth

Anion

Neutral

Anion

FMN
FMN
FMN
FMN

Red

No

benzoquinoid
a

b

c

d

e

f

pK 6.2
g

h

I

j

pK 5.7
k

, (25, 44, 47-49); , (5, 18, 19, 50-52); , (16); , (2, 19, 42); , (5, 18, 50-52); , (5, 18, 50-52); , (22); , (31); , (53); , (54, 55); , (18, 5052); l, (5, 56); m, (57); n, (5, 18, 50-52); o, (30); p, (58, 59); q, (60, 61); r, (5, 18, 50-52); nd, not determined.
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1.1.3. Stabilization of the Benzoquinoid Anionic Form of 6- and 8-Substituted Hydroxyand Mercaptoflavins by Flavoprotein Oxidases
The use of modified flavin chromophores at the active sites of many flavoenzymes is a
powerful tool to probe the protein microenvironment of the bound flavins (2). The presence of a
positively charged amino acid or a dipole of an α-helix at the active site of many flavoprotein
oxidases was proposed long before the crystal structures of enzymes became available (6, 14, 1820). This proposal was mainly based on the use of modified flavin chromophores that can exist
in different tautomeric and/or mesomeric forms, such as 6- and 8- hydroxy and mercaptoflavins.
As an example, 8-Mercaptoflavin has significant spectral differences between the neutral and the
anionic species, as well as between the corresponding benzenoid and paraquinoid forms (Figure
1.8) (2). The spectral properties of these chromophores were confirmed by binding to
flavoproteins with known crystal structure, such as flavodoxin, glutathione reductase, phydroxybenzoate hydroxylase, glucose oxidase, and riboflavin-binding protein (62-65). For both
glutathione reductase and p-hydroxybenzoate hydroxylase, in which a positive charge from the
α-helix dipole is oriented toward the N(1)-C(2)=O locus of the bound flavin (63-65), the
expected spectrum of the anionic paraquinoid species of 8-mercaptoflavin (species D, Figure 1.8)
was obtained. Similarly, for flavodoxin, in which the flavin C(8) locus is solvent accessible (66),
the expected spectrum of the anionic paraquinoid species of 8-mercaptoflavin (species C, Figure
1.8) was also obtained. The most significant effects of binding of 8-mercaptoflavin to the
proteins were observed with both glucose oxidase (Figure 1.9) and riboflavin-binding protein.
While in glucose oxidase the anionic paraquinoid resonance (species D, Figure 1.8) was
stabilized, a typical spectrum corresponding to the neutral benzenoid form (species A, Figure
1.8) was obtained upon the binding of 8-mercaptoflavin to riboflavin-binding protein, consistent
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with the preference of this protein to bind neutral flavin (67). The anionic paraquinoid form of 8mercaptoflavin was also observed upon the binding of 8-mercaptoflavin to other flavoprotein
oxidases, such as D-amino acid oxidase, lactate oxidase, and old yellow enzyme (18).
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Figure 1.8. Tautomeric and mesomeric forms of 8-mercaptoflavin.
A, neutral benzenoid species; B, neutral paraquinoid species; C, anionic benzenoid species (8thiolate); D, anionic paraquinoid species. Modified from ref. (2).

Figure 1.9. Spectral changes upon binding of 8-mercapto-FAD to the apoprotein of glucose
oxidase.
Solid curve, 8-mercapto-FAD; broken curve, bound to apo-glucose oxidase. Taken without
permission from ref. (18).
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Overall, by the use of 8-mercaptoflavin as a probe of the flavin microenvironment in
many flavoproteins, three conclusions have been drawn. 1) The 8-thiolate (anionic) form of 8mercaptoflavin (species C, Figure 1.8) is stabilized by flavoproteins that catalyze one-electron
transfer reactions, such as flavodoxin and NADPH-cytochrome P-450 reductase (2, 6, 18). These
proteins also stabilize the neutral (blue) semiquinone species upon reduction. 2) The anionic
paraquinoid form of 8-mercaptoflavin (species D, Figure 1.8) is stabilized by flavoproteins of the
oxidase/dehydrogenase class, such as glucose oxidase, lactate oxidase, D-amino acid oxidase,
and old yellow enzyme (2, 6, 18). These proteins also stabilize the red anionic form of
semiquinone and the flavin-N(5)-sulfite adduct as well. 3) Other flavoproteins do not conform to
the classification above, showing properties of both classes, such as flavoprotein
transhydrogenases and hydroxylases (Table 1.1) (18).
The effect of binding of 8-hydroxyflavins on flavoproteins could be explained by
following the same principles and structures used with 8-mercaptoflavin. However, the spectral
changes attributed to the ionized paraquinoid species of 6-hydroxyflavin are consistent with the
charge being localized in the pyrimidine ring (8). This could be attributed to the difference
between oxygen and sulfur in electronegativity and in undergoing π-interactions (2).
The effects of binding of 6-hydroxy- and 6-mercaptoflavin to flavoproteins could be also
described by the same structures and reasoning used for 8-substituted analogs. In solution, while
the neutral species is protonated at C(6) locus, the anionic form exhibits a longer (red shifted)
wavelength absorbance spectrum, consistent with N(1)-blocked 6-hydroxyflavins (Figure 1.10)
(9, 67, 68). Therefore, it has been suggested that the anionic paraquinoid species of 6hydroxyflavin can provide significant information about the charge distribution around the
bound flavin (2).
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The microenvironment of the bound flavin could be also probed by monitoring the shifts
in pKa values of these oxidized flavin analogs upon binding to apoproteins (the pKa values of 8SH, 8-OH, 6-SH, and 6-OH flavin analogs are 3.8, 4.8, 5.9, and 7.1, respectively) (2).
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Figure 1.10. Structures of the neutral and the anionic form of 6-hydroxy- and 6-mercaptoflavins.
Modified from ref. (2).
In conclusion, from the use of 6- and 8-sustituted flavin analogs, along with the
stabilization of the anionic flavin semiquinone radical or hydroquinone, and the flavin-N(5)sulfite adduct as different probes for the flavin microenvironment of many flavoprotein before
their X-ray crystal structures become available, it has been proposed that a flavoprotein with a
positive charge (amino acid residue or α-helix dipole) in the vicinity of the flavin N(1) locus
should: 1) stabilize the anionic semiquinone as well as the hydroquinone species of flavin; 2)
stabilize a reversible flavin-N(5)-sulfite adduct; 3) stabilize the benzoquinoid anion form of 8mercaptoflavin; 4) lower the pKa of the 6- and 8-substituted flavin analogs. Most interestingly, it
was also proposed that protein-flavin interaction would enhance the uptake of the redox
equivalents through position N(5) during catalysis, thereby a contribution on the redox potential
of the enzyme-bound flavin should be also observed as well (18, 20, 26, 27, 69).
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1.1.4. Positive Charge in Proximity of N(1)-C(2)=O and Flavinylation
Singer and his coworkers firstly established the covalent attachment of flavins to proteins
in 1955 in their study of mammalian succinate dehydrogenase enzyme (70-72). Subsequently,
many flavoproteins have been identified as covalently attached to the flavin cofactors (FAD or
FMN). In all the flavoproteins studied, the mode of covalent attachment of the flavin cofactor to
the polypeptide chain of the host protein was found to be one of five modes (Figure 1.11), which
are summarized for convenience in Table 1.2. These observations raised the question of the
correlation between the covalent attachment of the flavin cofactor and the mechanism of the
resulting enzyme. Williamson and Edmondson, by studying the effects of pH on the oxidationreduction potentials of 8α-N-imidazolylflavins showed that as the pH increases, the redox
potential decreases (73). This result strongly suggests that the modulation of the flavin
microenvironment through the histidyl group pKa of the 8α-N-imidazolylflavins could influence
the oxidation-reduction potential of the flavin (73). In addition, Edmondson and de Francesco, by
studying modified aminoacyl flavins, have proposed a correlation between the covalent
attachment of the flavins and their redox properties (74). The results obtained in their studies
showed that the oxidation-reduction potentials of aminoacyl flavins were ~50-60 mV more
positive compared to the unmodified flavins. Furthermore, a number of recent studies of flavindependent enzymes containing covalently bound flavins, namely cholesterol oxidase (75),
vanillyl-alcohol oxidase (54), and p-cresol methylhydroxylase (76), showed that, irrespective of
the type of flavin linkage and protein, the removal of the covalent linkage between the flavin and
the enzyme results in a decrease of the E΄m, 7 value for the bound flavin of ~100 mV. Therefore,
a clear correlation between the covalent attachment of the flavin cofactor and the protein and the
oxidation-reduction potentials of the formed enzymes could be made.
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Table 1.2. Examples of Flavoproteins Containing Covalently Linked Flavin Redox Centersa
Mode of Attachment
6-S-Cysteinyl FMN

8-α-N1-Histidyl FAD

8-α-N3-Histidyl FAD

8-α-O-Tyrosyl-FAD
8-α-S-Cysteinyl FAD

Enzyme
Dimethylamine dehydrogenase

(77)

Trimethylamine dehydrogenase

(30)

Cholesterol oxidase

(75, 78)

Thiamin dehydrogenase

(79, 80)

L-Galactonolactone oxidase

(81)

Choline oxidase

(82)

Pyranose 2-oxidase

(31)

Fumarate reductase

(83)

Sarcosine dehydrogenase

(84)

Succinate dehydrogenase

(85)

Vanillyl-alcohol oxidase

(54, 55)

6-Hydroxy-D-nicotine oxidase

(86)

D-Gluconolactone oxidase

(87)

p-Cresol methylhydroxylase

(88)

Monoamine oxidase A

(89, 90)

Monoamine oxidase B

(89, 90)

Monomeric sarcosine oxidase
a

Modified from ref. (92).

References

(91)
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The mechanism of covalent flavinylation has been proposed and reviewed in several
flavoproteins, among which p-cresol methylhydroxylase (8-α-O-Tyrosyl-FAD) (88), 6-hydroxyD-nicotine oxidase (8-α-N3-Histidyl FAD) (86), monomeric sarcosine oxidase (8-α-S-Cysteinyl
FAD) (91), trimethylamine dehydrogenase (6-S-Cysteinyl FMN) (30), and N-methyltryptophan
oxidase (8-α-S-Cysteinyl FAD) (93). In all these cases, it was suggested that a positively
charged amino acid residue in proximity to the N(1)-C(2)=O region of the bound flavin is
important to stabilize the negative charge that develops at the N1/C2 region during the
flavinylation reaction and is therefore suggested to facilitate flavinylation of the enzyme (30, 86,
88, 91, 92). For p-cresol methylhydroxylase, Arg447 was found to be located at a distance of ~3
Å from the N1/C2 locus of the bound flavin (88). This residue was proposed to facilitate the
flavinylation process by stabilizing the negative charge that develops at the N(1)-C(2)=O locus
of the iminoquinone methide flavin intermediate during the flavinylation process (88). Similarly,
Arg67, which is located in the vicinity of the N(1)-C(2)=O locus of the bound flavin of 6hydroxy-D-nicotine oxidase, was identified as being critical for the flavinylation process (94).
Mutagenesis studies of that residue have demonstrated the requirement of a positive charge at
this position (N1/C2) to facilitate the flavinylation process (94). Furthermore, Mewies et al., in
their studies of the differentially charged mutants at position 222 of trimethylamine
dehydrogenase, concluded that the positively charged guanidino group of Arg222 stabilizes the
negative charge as it develops at the N1 position of FMN during flavinylation of the enzyme
(Figure 1.12) (30). When Arg222 was substituted with Lys (R222K) a significant decrease in the
amount of the active flavinylated enzyme was observed. However, the removal or reversal of that
positive charge, as in case of R222V and R222E, resulted in the production of completely
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inactive enzymes that were totally devoid of FMN, consistent with a critical role of such
positively charged residue at this position (30).

Figure 1.12. Flavinylation mechanism of trimethylamine dehydrogenase.
ImH+, the protonated imidazole side-chain of residue His29 that is thought to assist in the
nucleophilic attack of Cys30 at the C6 atom of flavin by formation of an imidazolium/thiolate
ion-pair. The role of Arg-222 in stabilizing negative charge as it develops at the N1/O2 positions
of the flavin is shown. Re-oxidation of the reduced flavin is by internal electron transfer to the
4Fe-4S center. Taken without permission from ref. (30).
A self-catalytic flavinylation mechanism was also proposed for monomeric sarcosine
oxidase (8-α-S-Cysteinyl FAD) through the FAD interactions with the positive side chains and
the helix dipole (95). The X-ray crystal structure of monomeric sarcosine oxidase showed that
FAD is covalently attached to Cys315 (22, 91). In addition, the crystal structure also showed that
the bound FAD is located in a highly basic environment that contains seven basic residues.
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Lys348 was found to be located at a distance of ~2.8 Å from the N(1) locus of the bound FAD
and hydrogen bonded to C(2)=O of the flavin ring (22, 91). Similarly, the positive charge of the
α-helix dipole (αF4) was also found to be pointed to the same C(2)=O locus of the bound flavin
(22, 91). Therefore it was proposed that the negative charge that develops on the N(1)-C(2)=O
region of the isoalloxazine ring during the process of covalent flavinylation of monomeric
sarcosine oxidase is stabilized by the positive charge of Lys348 together with the positive charge
of the α-helix dipole and that this stabilization facilitates the flavinylation process (95).
Recently, it was observed that the addition of a small excess of sodium borohydride to
either monomeric sarcosine oxidase or its homologue, N-methyltryptophan oxidase, followed by
the binding of substrate and reaction with oxygen, resulted in a tautomeric rearrangement
reaction of 3,4-dihydroflavin to 1,5-dihydroflavin (Figure 1.13) (93). Intermediate I (Figure 1.13)
in the proposed tautomerization mechanism of 1,3-dihydroflavin was found to be similar to the
quininoid flavin intermediate produced in the flavinylation process of monomeric sarcosine
oxidase (95). Therefore, this tautomerization reaction provided insight for a similar flavin
tautomerization reaction that has been proposed as a key step during the covalent flavinylation
process of these enzymes.

A

B

Figure 1.13. Mechanism of flavinylation of monomeric sarcosine oxidase and Nmethyltryptophan oxidase.
A, mechanism of tautomerizaton of 3,4-dihydroflavin to an air senstive 1,5-dihydroflavin; B, the
mechanism proposed for the covalent attachment of flavin to MSOX or MTOX. Taken without
permission from ref. (93).
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1.2. GMC Oxidoreductase Enzyme Superfamily
The Glucose-Methanol-Choline (GMC) oxidoreductase enzyme superfamily is composed
of a group of flavoenzymes that are able to catalyze the conversion of alcohols to the
corresponding aldehydes or ketones (Scheme 1.1) (96). This family includes glucose oxidase
(34, 39, 62), cholesterol oxidase (16, 38, 97, 98), cellobiose dehydrogenase (32, 99), pyranose 2oxidase (31, 33, 100), methanol oxidase (101), choline dehydrogenase (96, 102, 103) (see
detailed description in Section 1.5), and choline oxidase (25, 47, 48) (see detailed description in
Section 1.4). The X-ray crystal structures of glucose oxidase (39, 62), cholesterol oxidase (97),
cellobiose dehydrogenase (32), pyranose 2-oxidase (31, 33), and choline oxidase1, showed a phydroxybenzoate hydroxylase (PHBH) – like fold in the monomeric structures of these enzymes
(Figure 1.14). In addition, the overall structures of these enzymes showed that with the exception
of pyranose 2-oxidase, which has a tetrameric structure, they all share dimeric structures, and the
polypeptide chain of each monomer folds into two domains, a highly conserved FAD binding
domain and a substrate binding domain. Although GMC enzymes exhibit little sequence
similarity in their substrate binding domains, the crystal structures of choline oxidase, glucose
oxidase, cholesterol oxidase, cellobiose dehydrogenase, and pyranose 2-oxidase show that they
all share highly conserved catalytic sites, suggesting a similar activation mechanism for the
oxidation of their substrates (Figure 1.15) (31-33, 39, 62, 97). Although the X-ray crystal
structure of methanol oxidase has not been solved, an unambiguous mechanism has been
proposed for that enzyme, which will be discussed in this chapter (see 1.2.5). However, the
mechanism of other GMC oxidoreductase enzymes with known structures is still ambiguous

1

Recently, the X-ray crystal structure of choline oxidase has been resolved at 1.86 Å resolution (Lountos, G. T.,
Fan, F., Gadda, G., and Orville, A. M; unpublished data; see Section 1.4.1. for detailed description).
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because of the masking of their catalytic steps (reductive or oxidative process) by other rate
limiting steps in their reaction mechanisms (104-106).

A

B

E

C

D

Figure 1.14. The three-dimensional structures of members of the GMC oxidoreductase enzyme
superfamily.
A, glucose oxidase from Aspergillus niger (PBD code 1CF3); B, cholesterol oxidase from
Streptococcus (PBD code 1COY); C, pyranose 2-oxidase from Trametes ochracea (PBD code
1TT0); D, cellobiose dehydrogenase from Phanerochaete chrysosporium (PDB code 1NAA); E,
choline oxidase from Arthrobacter globiformis (Lountos, G. T., Fan, F., Gadda, G., and Orville,
A. M; unpublished data).
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Scheme 1.1. Reactions catalyzed by GMC oxidoreductases.
A, Glucose oxidase; B, cholesterol oxidase; C, cellobiose dehydrogenase; D, pyranose-2 oxidase;
E, methanol oxidase (alcohol oxidase).
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A
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E
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D

Figure 1.15. The active site residues of GMC oxidoreductase enzyme superfamily.
A, Glucose oxidase from Aspergillus niger (PBD code 1CF3); B, cholesterol oxidase from
Brevibacterium sterolicum (PBD code 1COY); C, pyranose 2-oxidase from Trametes ochracea
(PBD code 1TT0); D, cellobiose dehydrogenase from Phanerochaete chrysosporium (PDB code
1NAA); E, choline oxidase from Arthrobacter globiformis (Lountos, G. T., Fan, F., Gadda, G.,
and Orville, A. M; unpublished data).
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1.2.1. Glucose Oxidase
Glucose oxidase (E.C. 1.1.3.4) is an FAD-dependent enzyme that catalyzes the oxidation
of β-D-glucose to δ-gluconolactone (Scheme 1.2) (62). Glucose oxidase is used in commercial
applications, such as the production of gluconic acid (a food preservative), and as an important
biosensor for the quantitative determination of glucose in bodily fluid, foodstuffs, beverages and
fermentation liquors (62, 107). The active form of the enzyme has been identified and purified
from several molds. The most common fungal sources of glucose oxidase are Penicillium
amagasakiense and Aspergillus niger (108-110). In addition, the enzyme has been recently
purified from Phanerochaete chrysosporium and Talaromyces flavus fungi as well (62). Glucose
oxidases from Penicillium amagasakiense and from Aspergillus niger showed high degrees of
identity (66%) and similarity (79%) (111) and comparable kinetic parameters (112).
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Scheme 1.2. The enzymatic reaction catalyzed by glucose oxidase.
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Glucose oxidase is a homodimer with molecular mass ranging from 150 to 180 kDa,
depending on the degree of glycosylation. Each monomer contains one tightly attached but not
covalently bound FAD (109). The X-ray structural data of glucose oxidase revealed that the
monomeric molecule has a compact spheroid structure with PHBH fold (Figure 1.14) (62). The
prosthetic group of the enzyme, FAD, was found to be located near the dimer interface, but
without actual interaction with this interface (62). His516, His559, and Glu412 were identified as
highly conserved residues in the active site of glucose oxidase with respect to other GMC
enzymes (Figure 1.15) (62). His516, which is fully conserved among the seven GMC enzymes,
was proposed as the catalytic base that abstracts the proton from the substrate hydroxyl group
and initiates the reductive half-reaction in which the substrate glucose is oxidized to
gluconolactone with the subsequent reduction of the bound FAD (39, 62, 104, 111). The results
obtained from both the pH profiles and the kinetic isotope effects of the mutant enzyme (H516A)
with respect to wild-type enzyme suggested that the protonated form of this highly conserved
active site histidine residue functions also as a general acid during the oxidative half-reaction
(111, 113). NMR studies on the anaerobically reduced species of glucose oxidase at pH 5.6
indicated the presence of a negative charge at the N(1)-C(2)=O locus of the bound flavin, which
is stabilized by a positively charged residue (114). The crystal structure of the enzyme showed
that His516Nε2 is located at a distance of ~3.8 Å from the N(1) locus of the flavin and therefore
could stabilize in its protonated state the negative charge developing on the N(1)-C(2)=O locus
of the flavin (62).
The other active site histidine residue, His559, was found to be hydrogen bonded with
Glu412 and a water molecule (W110) (62). The studies that preceded the elucidation of the Xray crystal structure of glucose oxidase suggested that the carboxylate group of glutamate at
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position 412 of glucose oxidase plays a major role in substrate binding and specificity (104). The
modeled enzyme-substrate complex structure of glucose oxidase revealed that substrate binding
to the enzyme was banned upon protonation of Glu412, which in turn disrupted the hydrogen
bond with His559 and resulted in reorganization of the active site (39). It was also found that the
binding of β-D-glucose to the active site was stabilized by hydrophobic contacts to Phe414,
Trp426, as well as to Tyr68 and FAD. In addition to these important hydrophobic interactions,
hydrogen bonds were also observed between glucose and several residues in the active site such
as, Tyr68, Asn514, Arg512, His516, His559, and Thr/Ser110 (39). The disruptions of these
hydrogen bonds via mutagenesis or by the use of substrate analogs resulted in significant
decrease in the binding affinity and specificity of the substrate to the active site of the enzyme
(39). Arg512 and Asn514 were also found to be involved in substrate binding. This study also
showed that there is a direct interaction between the substrate and His516 (39), which differs
from the water-mediated interaction between substrate and enzyme in cholesterol oxidase (97,
115).
Mechanistically, the chemical reaction catalyzed by glucose oxidase can be summarized
as follows. 1) During the reductive half-reaction, after the substrate glucose binds to the free
enzyme, it is oxidized to gluconolactone with the subsequent reduction of the bound FAD. 2)
During the oxidative half-reaction, the reduced enzyme-bound flavin complexed with the
oxidized substrate releases product, with the subsequent oxidation of the reduced flavin by
molecular oxygen (second substrate) and with the production of hydrogen peroxide, consistent
with a ping-pong oxidation mechanism of glucose catalyzed by glucose oxidase (116). Kinetic
isotope effects studies with either glucose or 2-deoxyglucose as substrate showed that while with
glucose the product release is a first order rate-limiting step of the reaction, with 2-deoxyglucose
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substrate oxidation becomes partially rate limiting for the overall turnover of the enzyme; the
product release does not limit the enzyme turnover (116). pH dependence studies on kinetic
parameters (kcat and kcat/Km) of glucose oxidase showed that with increasing pH, the reoxidation
of the enzyme in the oxidative half-reaction becomes rate limiting rather than the product release
(117). Kinetic isotope effects showed a small ratio of ~2-3 comparing 1-[2H]-D-glucose
(deuterated substrate) and D-glucose, which in turn hindered the accurate determination of the
chemical mechanism of glucose oxidase (104). In contrast, no solvent deuterium isotope effect
has been detected on any step in the mechanism with either glucose or 2-deoxyglucose as
substrate (104). These results clearly suggest that the OH and CH bonds are cleaved in different
steps in catalysis (Scheme 1.3, pathway II) (104, 118).
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1.2.2. Cholesterol Oxidase
Cholesterol oxidase (E.C. 1.1.3.6) is an FAD-containing enzyme that catalyzes the
oxidation and subsequent isomerization of the trans ∆5-∆6-3β-hydroxysteroids to the
corresponding ∆4-∆5-3-ketosteroids (Scheme 1.1). Cholesterol oxidase has been isolated from
several microbial sources including Streptomyces sp., Brevibacterium, Pseudomonas,
Rhodococcus, and Schizophyllum (16). Cholesterol oxidase has also shown a wide range of
industrial and clinical applications (16). Although the enzyme has shown a wide range of
substrate steroid specificities, the presence of a 3β-hydroxyl group on the substrate steroid ring is
essential for enzymatic activity (119-121). The highest enzymatic activity is observed when
cholesterol is used as a substrate.
Structurally, cholesterol oxidase is a dimeric protein with a monomeric molecular mass
of ~55 kDa, and one FAD molecule for each monomer (97). The mode of FAD attachment to the
enzyme differs in enzymes from different sources, i.e., while FAD is uncovalently bound to
cholesterol oxidase from Streptomyces sp., the crystal structure of cholestrol oxidase from
Brevibacterium sterolicum showed that FAD is covalently attached to the protein backbone via
an 8-hytidinyl-FAD residue (122). The X-ray crystal structure of cholesterol oxidase from either
Streptomyces sp. or B. sterolicum shows that the monomeric molecule has a compact spheroid
structure with PHBH fold (Figure 1.14) (40, 97). The prosthetic group of the enzyme, FAD, was
found to be deeply buried in the protein structure and was involved in extensive contacts, mainly
with the FAD binding domain (40, 97). In addition, the highly conserved active site residues of
cholesterol oxidase compared to other GMC enzymes have been identified to be His447,
Asn485, and Glu361 (Figure 1.15) (40, 97). A hydrogen bonding network between these
conserved residues along with Wat541 has been previously proposed to help the substrate

31
positioning and to coordinate general base and electrophilic catalysis (105). Furthermore,
hydrogen bonding between the side chain of Asn485 and the π system of bound FAD that
modulates the redox potential in the reaction catalyzed by cholesterol oxidase was also proposed
by Yin et al. (115).
The role of the fully conserved active site residue His447 (Figure 1.15) was extensively
studied through the kinetic characterizations of His447 mutant enzymes (105). The results
suggested that His447 might have the potential to act as the general base that abstract the
substrate hydroxyl proton to initiate catalysis (105). However, the recent availability of a crystal
structure of an unliganded form of cholesterol oxidase at sub-Ångstrom resolution (~0.9 Å), in
which it was shown that the Nε2 position of the active site His447 residue pointing at the substrate
hydroxyl group is protonated (35), clearly does not support this histidine residue acting as a
specific base in catalysis. These structural observations prompted the authors to suggest that the
conserved histidine residue might act as a hydrogen bond donor to the hydroxyl oxygen of the
substrate, which would assist in positioning the substrate with respect to the flavin for efficient
catalysis (35). His447 was accordingly suggested to play two roles. The first role is to position
the substrate with respect to the flavin and Glu361. The second role is to increase the basicity of
Wat541 instead of being a general base directly (35); i.e., His477 plays a role in a network of
hydrogen bonds rather than acting directly as a catalytic base that abstracts the hydroxyl proton
from the steroid during hydride transfer (105, 106). Most interestingly, the X-ray crystal
structure of cholesterol oxidase also showed that His447Nε2 is located at a distance of ~3.9 Å
from the N(1) locus of the flavin (35, 97); therefore it could stabilize in its protonated state the
negative charge in proximity of N(1)-C(2)=O locus of the bound flavin. This point, however, has
not been addressed in any study.
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Mechanistically, and based on the structural studies, Li et al. proposed a radical
mechanism for cholesterol oxidase (97), with a single electron being transferred from the
hydroxyl oxygen of the substrate to the flavin, followed by the transfer of the proton from C3 of
the substrate to the N5 position of the flavin ring (Scheme 1.3, pathway III). Alternatively, a
hydride transfer mechanism was also proposed (97). In this case, the abstraction of the substrate
hydroxyl proton prompts the transfer of the hydride to the flavin moiety (Scheme 1.3, pathway
I). Similar to glucose oxidase, an unambiguous characterization of the chemical mechanism for
CH bond cleavage in cholesterol oxidase was also limited due to the substrate isomerization step
occurring after the cholesterol oxidation being slow. Indeed, kinetic isotope effects showed a
small deuterium isotope effect of ~2.2 with 3α-[2H]-cholesterol, and no solvent isotope effects
for the wild type enzyme (105).

1.2.3. Cellobiose Dehydrogenase
Cellobiose dehydrogenase (E.C. 1.1.99.18) is an extracellular flavocytochrome that is
secreted by various cellulolytic fungi (123). Cellobiose dehydrogenase has been purified from
various filamentous fungi of which the enzyme from the white-rot fungus, Phanerochaete
chrysosporium, is the best characterized (123, 124). Similar to cellulases, the expression of
cellobiose dehydrogenase is triggered by the presence of cellulose in the medium and repressed
in the presence of glucose (125). FAD and porphyrin IX are the two cofactors of the enzyme;
these have been reported to interact with two distinct domains of the single polypeptide chain of
cellobiose dehydrogenase (125, 126). These two domains are connected by a glycosylated,
hydroxyamino-rich linker peptide, which is highly susceptible to cleavage by pepsin, allowing
the separations of theses two domains (125, 126). Recently, the X-ray crystal structure of each of
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the two separate domains, the flavin domain (32), and the heme domain (127), has been reported.
The crystal structure of the flavoprotein domain of the enzyme showed an overall fold that is
similar to that of other members of GMC family, i.e., a PHBH fold (32). Similar to other GMC
enzymes, the monomeric polypeptide chain folds into two structurally distinct domains, the FAD
binding and the substrate binding domains (Figure 1.14). The uncovalently attached FAD was
found as 6-hydroxy FAD, consistent with the spectral properties of the flavin chromophore (32).
In addition, the isoalloxazine ring of the bound flavin was found to be sharply bent along N(5)N(10) axis (butterfly bending). The partial positive charge provided from the dipole of an αhelix, which is located in proximity of N(1)-C(2)=O of the bound flavin, together with the
butterfly bending of the flavin ring, were suggested to modulate the redox potential of the
semiquinone as well as the hydroquinone of the bound flavin (32). Two highly conserved and
critical residues have been identified in the active site of cellobiose dehydrogenase, which are
His689 and Asn732 (Figure 1.15). Both residues form hydrogen bonds to W1214 (32). Based on
the structural data and site directed mutagenesis studies, His689, which is fully conserved among
the GMC family, was suggested to play the role of the general base that abstracts the substrate
hydroxyl proton to initiate catalysis (32, 128). Moreover, site directed mutagenesis studies of the
conserved active site residue Asn732 suggested that this residue plays an important role for the
positioning of the substrate 1-αH and 1-β-OH relative to FAD and His689, respectively, which
in turn promotes the deprotonation as well as the oxidation of the substrate (128). The X-ray
crystallographic structure of the flavin domain of cellobiose dehydrogenase showed that
His689Nε2 is located at a distance of ~4 Å from the N(1) locus of the flavin (32). Therefore,
His689 in its protonated state could stabilize the negative charge that develops in proximity of
N(1)-C(2)=O locus of the bound flavin.
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Mechanistically, the crystal structure of the flavoprotein domain of cellobiose
dehydrogenase with bound inhibitor (cellobiono-1,5-lactam) suggested a hydride transfer
mechanism for the dehydrogenation of the substrate (99). In this mechanism, His689 acts as a
general base that abstracts the substrate hydroxyl proton, followed by a concerted hydride
transfer from the axially aligned C(1)-H of the substrate to the flavin N(5) via a transition state
characterized by partial planarization of C(1) (Scheme 1.3, pathway I) (99).

1.2.4. Pyranose 2-Oxidase
Pyranose 2-oxidase (EC 1.1.3.10) is a 270 kDa homotetramer, which catalyzes the
oxidation of several aldopyranoses regioselectively at the C2 position to the corresponding 2ketoaldoses and with the production hydrogen peroxide (Scheme 1.1) (33, 100). Pyranose 2oxidase is located in the hyphal periplasmic space and it is widely distributed among wooddegrading basidiomycetes (129). Pyranose 2-oxidase has been purified and characterized from
various fungi, among which Phanerochaete chrysosporium and Trametes ochracea are the best
studied and have three-dimensional structures available (33, 100). Besides oxidizing a number of
pyranose sugars at the C2 position, pyranose 2-oxidase acts also on the C3 position of certain
substrates such as 2-deoxy-D-glucose, 2-keto-D-glucose and methyl β-D-glucosides (130, 131).
In addition, it has been shown that the enzyme is able to utilize not only oxygen but also various
quinones as electron acceptors (132). Therefore, it has been proposed that pyranose 2-oxidase
might be involved in ligninolysis as an H2O2-producing enzyme and as a quinone-reducing
enzyme (132).
The monomeric structure of pyranose 2-oxidase folds similarly to other GMC
oxidoreductase enzymes (Figure 1.14). The FAD molecule is buried inside the protein, and is
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covalently bound via its 8α-methyl group to Nε2 of His167, resulting in 8α-(N3)-histidyl
flavinylation of the enzyme (133). Similar to cellobiose dehydrogenase (32), a butterfly bending
of the isoalloxazine ring of the flavin cofactor was also observed but to a lesser extent with
pyranose 2-oxidase (33). A water molecule (W678) was observed to form a hydrogen bond with
the N5 atom of the FAD isoalloxazine (33). This bending of the isoalloxazine ring has been
explained due to the presence of acetate in the active site, which originates from the acetate
buffer used for crystallization (33). Acetate (Kis = 9.3 mM) and other organic monocarboxylic
acids such as propionate, formate, and valerate have been determined to be competitive
inhibitors with respect to β-D-glucose as substrate for pyranose 2-oxidase (33). The highly
conserved active site residues of pyranose 2-oxidase have been identified to be His548 and
Asn593 (Figure 1.15) (33). In addition, His548, which is fully conserved throughout the GMC
family, has been proposed to play the role of the catalytic base that abstracts the substrate
hydroxyl proton during catalysis (33). Mechanistically, the putative docking model of β-Dglucose into the active site of pyranose 2-oxidase showed that the β-hydrogen atom of either C2
or C3 of glucose points directly toward the N5 atom of isoalloxazine nucleus of the bound FAD
(Figure 1.16). Accordingly, a hydride transfer mechanism was proposed for the oxidation of
glucose catalyzed by pyranose 2-oxidase (Scheme 1.3, pathway I) (33).
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Figure 1.16. Docking of β-D-glucose to the pyranose 2-oxidase active site.
A, Glucose oriented for oxidation at C2. B, Glucose oriented for oxidation at C3. Taken without
permission from Ref. (33).

1.2.5. Methanol Oxidase (Alcohol Oxidase)
Although the X-ray crystallographic structure of methanol oxidase has not been solved
yet, unambiguous mechanistic characterization of the enzyme from Hansenula polymorpha has
been performed (101). This study was performed through the use of substrate and solvent kinetic
isotope effects with benzyl alcohol as a substrate or its analogues (101). With benzyl alcohol as
substrate, a deuterium isotope effect value of 1.0 and a solvent isotope effect of 2.0 were
observed, suggesting that CH bond cleavage is masked and that OH bond cleavage is a ratelimiting step. With 2-substituted ethyl alcohol as substrate, however, the primary deuterium
isotope effects increased to ~5, while solvent isotope effects decreased to ~1. Based on these
results, an asynchronous hydride transfer mechanism was suggested (Scheme 1.3, pathway II). In
short, the OH bond is cleaved prior to the CH bond cleavage, forming an alkoxide intermediate
(101).
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1.3. Other Structurally and Mechanistically Relevant Flavoproteins
In this section, some of the structurally and mechanistically relevant flavoenzymes will
be discussed in details in the following sub-sections. Those flavoenzymes have been kinetically
well studied and their three dimensional structures are available. Thereby, providing insights on
the correlation between their structure and the mechanism of reactions that they catalyzed with
respect to GMC oxidoreductase superfamily to which choline oxidase belong. For convenience,
all the structurally and mechanistically relevant features of selected flavoenzymes including
GMC family members are summarized in Table 1.3.

Table 1.3. Some Structural and Mechanistic Features of Selected Flavoenzymes
Flavoenzyme
(PDB file)
Choline Oxidase
(na)
Glucose Oxidase
(1CF3)
Cholesterol Oxidase
(1COY)
Cellobiose Dehydrogenase
(1NAA)
Pyranose 2-Oxidase
(1TT0)
D-Amino Acid Oxidase
(1DDO)
Polyamine Oxidase
(1B37)
Monomeric Sarcosine Oxidase
(1L9F)
p-Hydroxybenzoate Hydroxylase
(1PHH)
Vanillyl-Alcohol Oxidase
(2VAO)
Flavocytochrome b2
(1FCB)
Glycolate Oxidase
(1GOX)
Trimethylamine Dehydrogenase
(2TMD)
Dihydroorotate Dehydrogenase
(2DOR)
Old yellow Enzyme
(1OYB)

Cofactor

Folding
topology

FAD

PHBH

Protein residue
contacting
N(1)-C(2)=O
α-Helix/His466

FAD

PHBH

α-Helix/His516

FAD

PHBH

FAD

Proposed
mechanism

Ref
(134-138)

α-Helix/His447

Asynchronous
hydride transfer
Concerted
hydride transfer
Hydride transfer

PHBH

α-Helix/His689

Hydride transfer

(32, 99)

FAD

PHBH

α-Helix/His548

Hydride transfer

(33, 100)

FAD

PHBH

α-Helix/Arg285

Concerted
hydride transfer

(37, 140)

FAD

PHBH

α-Helix

FAD

PHBH

α-Helix/K348

FAD

PHBH

FAD
FMN

2 domains
α+β
(α/β)8 Barrel

K349

FMN

(α/β)8 Barrel

K230

FMN

(α/β)8 Barrel

R222

(30, 147)

FMN

(α/β)8 Barrel

K164

(58, 59)

FMN

(α/β)8 Barrel

R243

(148)

(62)
(97, 139)

(53)

Polar /Hydride
transfer

(95)
(141, 142)
(143, 144)

R504
Asynchronous
hydride transfer
Hydride transfer

(60, 61)
(145, 146)
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1.3.1. Glycolate Oxidase
Glycolate oxidase (E. C. 1.1.3.15) is an FMN dependent enzyme that catalyzes the
oxidation of the α-hydroxy acid glycolates to the corresponding α-keto acids (glyoxalates)
(Scheme 1.4) (36, 42). Glycolate oxidase is a member of the family of the α-hydroxy acid
oxidases. In plants, the oxidation of glycolates to glyoxalates catalyzed by the peroxisomal
glycolate oxidase is considered as a key step in photorespiration (36). In animals, the enzyme is
located in liver peroxisomes; it is involved in oxalate production and is therefore related to
oxalate-mediated disorders, including renal lithiasis and hyperoxaluria (36, 146).
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Scheme 1.4. Reaction catalyzed by glycolate oxidase.

Glycolate oxidase in solution is a homotetramer/octamer with molecular mass of ~43 kDa
for each monomer (36). Similar to other members of the α-hydroxy acid oxidase family, the Xray crystal structure of spinach glycolate oxidase showed that the polypeptide chain of the
enzyme folds into the (αβ)8 barrel structural motif (Figure 1.17) (149, 150). However, additional
helices were observed besides the (αβ)8 barrel, forming a “lid” structure that covers the top of
the active site (149). The FMN cofactor molecule is deeply buried in the barrel, with only the N5
atom being exposed to the solvent (149). Most interestingly, Lys230, which is located near the
N(1)-C(2)=O of the bound FMN, has been proposed to stabilize the negative charge that
develops in proximity of N(1)-C(2)=O locus of the bound flavin (Figure 1.17) (17, 36, 42, 149,
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150). This positively charged side chain in this region has also been proposed to be responsible
for some of the typical flavoprotein oxidase characteristics such as the formation of flavin-N(5)sulfite adducts and the stabilization of the red anionic flavin semiquinone and of the
benzoquinoid form of 8-mercaptoflavin (2). It has been shown that glycolate oxidase maintains
all these features and thereby can be considered as a typical member of this class of flavoproteins
(42).
A

C

B

D

Figure 1.17. The three-dimensional structures of FMN-dependent enzymes that oxidize αhydroxy acids.
A and C, flavocytochrome b2 from Saccharomyces cerevisiae (PBD code 1FCB); B and D,
glycolate oxidase from spinach (PBD code 1AL8); PYR, pyruvic acid; DHP, 3-decyl-2,5-dioxo4-hydroxy-3-pyrroline (TKP).
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The detailed structural investigation of the active site of glycolate oxidase showed that a
number of residues are conserved in comparison with other FMN-dependent α-hydroxy acid
oxidizing enzymes (Figure 1.17) (17, 36, 149, 150). The positively charged residues Arg257 and
Arg164, along with Tyr24, were proposed to interact with the carboxylate-group of the substrate
(Figure 1.17) (36). Glycolate oxidase was also crystallized in complex with two inhibitors, 3decyl-2,5-dioxo-4-hydroxy-3-pyrroline (TKP) or 4-carboxy-5-(1-pentyl)hexylsulfanyl-1,2,3triazole (TACA) (Figure 1.18) (146). The carboxyl group of the ligands was observed to form
hydrogen bonds with the side chains of Arg257 and Tyr24, as well as that of Arg164. The only
notable exception was Trp108, which, while it forms hydrogen bond with TKP, it is not
interacting with TACA (146). Therefore, it has been suggested that Trp108 is playing an
important role in determining the substrate specificity via size exclusion (146).
Mechanistically, it has been proposed based on the available structural data that the
carboxyl part of glycolate is bound to Arg257 and Tyr24, while the hydroxyl group bound to
Tyr129 (Figure 1.19). Site directed mutagenesis studies of Tyr24 and Tyr129 confirmed these
assumptions, and also indicated a role for Tyr129 in stabilizing the transition state intermediate
during catalysis (17, 145). In addition, His254 was proposed to be responsible for proton
abstraction from the substrate during catalysis (36, 146). Previously, a carbanion mechanism was
generally accepted for the catalytic mechanism of glycolate oxidase. Although little kinetic
characterization of glycolate oxidase is available, the carbanion mechanism was proposed for
glycolate oxidase in analogy to previous studies on flavocytochrome b2, which suggested that the
substrate α-proton is abstracted by the conserved His254 prior to the electron transfer to FMN
(36). However, there is no firm evidence that rules out a hydride transfer mechanism for
glycolate oxidase (151). Therefore, the mechanism of glycolate oxidase is still ambiguous,
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although a hydride transfer mechanism seems to be more likely for glycolate oxidase as the case
of the most recently proposed mechanism for flavocytochrome b2 (152), yet more detailed
studies with glycolate oxidase have to be carried out to validate this mechanism.

Figure 1.18. The hydrogen bonding pattern of the inhibitors at the active site of glycolate
oxidase.
The holoenzyme is colored red, the TACA complex green, and the TKP complex blue. Distances
less than 3.2 Å from the inhibitors are marked with dashed lines. Taken without permission from
ref. (146).

Figure 1.19. Schematic presentation of the proposed transition state of glycolate oxidase.
Taken without permission from ref. (146).
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1.3.2. Flavocytochrome b2
Flavocytochrome b2 (E. C. 1.1.2.3) is the best studied member of the α-hydroxy acid
oxidases family. Flavocytochrome b2 is an FMN-dependent enzyme that catalyzes the oxidation
of L-lactate to pyruvate (Scheme 1.5), which is the product of lactate oxidation for the Krebs
cycle (153). The expression of flavocytochrome b2 is induced by oxygen and L-lactate (154).
Besides its role in producing pyruvate, flavocytochrome b2 also participates in a short electron
transport chain involving cytochrome c and cytochrome oxidase. This leads to the transfer of the
reducing equivalents gained from L-lactate oxidation to oxygen, yielding one molecule of ATP
for every L-lactate molecule consumed (155). Flavocytochrome b2 is a homotetramer with a
molecular mass of ~58 kDa for each monomer. Each monomer contains two noncovalently
bound cofactors, FMN and heme (155).
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OH
L-Lactate

O
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Pyruvate

Scheme 1.5. Reaction catalyzed by flavocytochrome b2.

The X-ray crystallographic structure of flavocytochrome b2 showed that each subunit of
the tetrameric structure of the enzyme folds into two domains, the heme-binding domain (11 kDa
at N-terminal) and the flavin-binding domain (45 kDa at C-terminal). The two domains are
connected by a short, yet flexible, hinge peptide (61). In addition, the polypeptide chain of the
flavin domain folds into an (α/β)8 barrel structure, consistent with other members of the αhydroxy acid oxidases family (Figure 1.17) (61). The FMN cofactor molecule was found to be
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buried in the central β-barrel, suggesting that the flavin cofactor is sequestered from the solvent
(61).
The X-ray crystallographic structure of the enzyme complexed with its product pyruvate
implied that the product is stabilized in the active site of the enzyme through the interactions of
its carboxylate group with the side chains of Arg376 and Tyr143 (Figure 1.17), suggesting an
important role for Arg376 and Tyr143 in substrate binding and specificity (61). On the other
hand, His373 and Tyr254 were observed to interact with the ketooxygen atom of pyruvate and
were therefore suggested to play important roles in catalysis (Figure 1.17) (61, 154). It was
proposed that Lys349, which was found to be located close to the N(1)-C(2)=O locus of the
bound FMN, is responsible for the stabilization of the anionic semiquinone and hydroquinone as
well as the formation of a tight flavin-N(5)-sulfite adduct through its electrostatic interactions
with the negative charge that develops at that region (Figure 1.17) (61).
Mechanistically, kinetic characterizations were carried out on the wild type enzyme and
enzymes containing mutations on catalytic relevant residues, such as His373 and Tyr254, to gain
insights into flavocytochrome b2 (156). Kinetic studies on the mutant form of the proposed active
site histidine, H373Q, showed ≥ 105 decrease in the rate of lactate oxidation compared to the
wild type enzyme (156), suggesting an important role of His373 in catalysis. However, this does
not distinguish between the postulated carbanion mechanism and the hydride transfer
mechanism. Sobrado et al. performed a thorough mechanistic characterization of
flavocytochrome b2 using kinetic isotope effects as probes, via both steady state and pre-steady
state kinetics (60). The results obtained from these studies suggested that the CH and OH bonds
are cleaved in a stepwise manner during catalysis. However the kinetic characterization of the
mutant form of enzyme in which Tyr254 was replaced with phenylalanine (Y254F) was
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consistent with the cleavages of OH and CH bonds becoming concerted compared to the wild
type enzyme (152). This change was explained with a reduced stabilization of the alkoxide
intermediate in the phenylalanine variant, which is formed after the proton abstraction by His373
in a hydride transfer mechanism (Scheme 1.6). Tyr254 was therefore suggested to play a role in
stabilizing the alkoxide intermediate by forming a hydrogen bond with the charged lactate
hydroxyl oxygen. The alternative carbanion mechanism appears unlikely because it is hard to
reconcile with the more concerted mechanism observed in the Y254 mutant enzyme. If a
carbanion mechanism were adopted by the enzyme, losing the interaction between Tyr254 and
substrate hydroxyl oxygen should substantially slow down the latter step and result in more
stepwised CH and OH bond cleavages (152). Based on these observations, the authors suggested
a stepwise hydride transfer as the mechanism for the chemical step in wild type flavocytochrome
b2 and, by extension, the family of enzymes that oxidizes α-hydroxy acids (Scheme 1.6).

Scheme 1.6. Proposed mechanism of L-lactate oxidation by flavocytochrome b2.
Taken without permission from ref. (152).
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1.3.3. D-Amino Acid Oxidase
D-Amino acid oxidase (EC 1.4.3.3, DAAO) catalyzes the dehydrogenation of D-isomers
of amino acids to the corresponding α-imino acids, which after subsequent hydrolysis yield αketo acids and ammonia (Scheme 1.7). The kinetic mechanism of DAAO, as is common in
flavoprotein oxidases, is divided into a reductive half-reaction, in which the amino acid is
oxidized with the concomitant reduction of the bound flavin, and an oxidative half-reaction, in
which the reduced flavin is oxidized by molecular oxygen with the subsequent release of the
product (Scheme 1.8). This FAD-dependent enzyme was shown to play a vital role in the
modulation of serine levels in mammalian brain (157, 158).
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Scheme 1.7. Reaction catalyzed by D-amino acid oxidase.

Scheme 1.8. Kinetic mechanism of D-amino acid oxidase.
Taken without permission from ref. (140).
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Although the enzyme is well studied, no unequivocal mechanism for the dehydrogenation
of the substrate has yet been established (28, 140, 159). Over the years, two different
mechanisms have been proposed for the reaction catalyzed by this flavoprotein oxidase: the
hydride transfer mechanism and the carbanion mechanism. Evidence that favors a direct hydride
transfer mechanism comes from the transfer of the α-hydrogen of the substrate to the C(5)
position of the enzyme reconstituted with 5-deaza-FAD (160). Similarly, the elimination of
halide from β-chloro-D-alanine validates the hypothesis that the reductive half-reaction of
DAAO involves the initial formation of a carbanion intermediate after the abstraction of the αhydrogen of the substrate as a proton (161). Finally, a direct hydride transfer mechanism was
considered in which α-H+ abstraction is coupled with the hydride transfer (162).
Two different research groups have described the X-ray crystallographic structure of
DAAO from pig kidney with the inhibitor benzoate bound (37, 163). The X-ray structure of the
enzyme showed that there is no active site residue properly placed to act as a base for carbanion
formation. The only notable interaction of the inhibitor with the active site residue includes the
carboxylic group of benzoate with Arg283 and Tyr228 (37, 163). A similar interaction was
observed between the carboxylic group of D-3,3,3-F3-alanine and the homologous arginine and
tyrosine residues (Arg285 and Tyr223) in a recent structure of DAAO from Rhodotorula gracilis
(Figure 1.20) (164). In addition, the amino group of D-3,3,3-F3-alanine was also observed to
form a hydrogen bond with a water molecule and the carbonyl oxygen of Ser335 (164). In all
structures the carbon atom of the inhibitor, which corresponds to the α-carbon of the amino acid
substrate, was found to be located at a distance of ~3.4 Å from the N(5) of the isoalloxazine ring
of the bound flavin (37, 163, 164). These structural data clearly suggest a direct hydride transfer
mechanism as well as argue against the carbanion mechanism that was proposed earlier.
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Figure 1.20. Active site of R. gracilis DAAO with D-3,3,3-F3-alanine bound (PDB code 1C0L).
FLA, D-3,3,3-F3-alanine.
The currently available structures of DAAO from different sources in complex with
ligands have showed that Arg285 interacts with the carboxylate group of the ligand and that the
negative charge that develops at the vicinity of N(1)-C(2)=O locus of the bound flavin is
stabilized by the dipole of α-helix F5 (37, 163). This result argued against the previously
proposed role of Arg285 in stabilizing the negative charge that develops in proximity of N(1)
locus of the bound flavin. Consequently, this result disagreed with the involvement of Arg285 in
the stabilization of the anionic flavin semiquinone and hydroquinone, and for the formation of
tight flavin-N(5)-sulfite adduct as well as in the modulation of the electrophilicity of the bound
flavin by increasing the oxidation-reduction potentials of the bound FAD (165). Recently,
Pollegioni et al., through their biochemical and spectroscopic analyses of different mutant forms
of DAAO in which Arg285 was replaced by selected residues (R285A, R285K, and R285D),
concluded that in the free enzyme, Arg285 is still involved in the stabilization of the negative
charge on the N(1)-C(2)=O locus of the flavin (159). This conclusion was based on the
assumption that although the guanidinium group of Arg285 was found to be located at a distance
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of ~7 Å from the N(1)-C(2)=O locus of the flavin in the structures of the enzyme in complex
with substrate or ligands, in the absence of substrate or ligands the side chain of Arg285 would
be able rotate to a distance of ~3 Å from the N(1)-C(2)=O locus of flavin (159). The role of
Arg285 in stabilizing the negative charge at the vicinity of the N(1)-C(2)=O locus of the bound
flavin in DAAO is still ambiguous due to the unavailability of the X-ray crystal structure of the
unliganded enzyme
Fitzpatrick and his co-workers in the last few years have performed a thorough kinetics
characterization of DAAO by using substrate and solvent kinetic isotope effects approaches to
probe the order of CH bond cleavage and the C=N bond formation (140, 166-168). The results
obtained from the analysis of isotope effects studies agree well with the structural studies
allowed Fittzpatrick to conclude that the mechanism of DAAO is a direct hydride mechanism, in
which both the CH bond cleavage and the C=N bond formation occur in the same transition state
(Scheme 1.9). In agreement with this conclusion, a recent computational studies also suggested a
direct hydride transfer mechanism involving the anionic form of the amino acid substrate (169).
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Scheme 1.9. Proposed direct hydride transfer mechanism of D-amino acid oxidase.
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1.4. Choline Oxidase
Mann et al. first reported the isolation of choline oxidase in 1938. In that study, choline
oxidase of rat liver was shown to be a typical dehydrogenase (170). It was assumed that choline
oxidase system was composed of choline dehydrogenase, cytochrome c, and cytochrome
oxidase. The oxidation of choline was inhibited by betaine, as well as the HNMe3+
(trimethylammonium) and NH4+ ions. In addition, it was also concluded that the
trimethylammonium headgroup of choline is important for the specific binding of the substrate to
the enzyme (170). A second active form of choline oxidase, which oxidized choline to betaine
aldehyde with the uptake of one or two mol of oxygen at pH 6.7 or 7.8, respectively, was also
isolated from rat liver in 1938 (171). This form of active choline oxidase was also found in rat
kidney but not in blood, muscle, or brain (171).
The Arthrobacter globiformis choline oxidase was first purified by fractionations with
ammonium sulfate and acetone, followed by column chromatography using the anionic
exchanger DEAE-cellulose and gel filtration Sephadex G-200 columns (172). The purified
enzyme showed absorbance maxima at 363 and 450 nm, consistent with the purified protein
being a flavoenzyme (172). The enzyme showed a molecular mass of ~71 kDa by SDS-PAGE
and ~83 kDa by gel filtration, and an isoelectric point (pI) around pH 4.5 (172). The catalytic
activity of the purified enzyme was tested using either choline or betaine aldehyde as substrate.
The enzymatic activity assays showed the ability of choline oxidase to utilize both choline and
betaine aldehyde as substrate, with the subsequent production of glycine betaine (172). On the
other hand, the enzymatic activity of choline oxidase was significantly decreased by using a
number of substrate analogs, suggesting high substrate specificity of the enzyme for either
choline (100%) or betaine aldehyde (46%) (172). A Km value of 1.2 mM and 8.7 mM was
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determined for choline and betaine aldehyde, respectively. Therefore, it was proposed that
choline oxidase from Arthrobacter globiformis catalyzes the oxidation of choline or betaine
aldehyde with the production of glycine betaine in a reaction where oxygen is acting as electron
acceptor and with the production of hydrogen peroxide (Scheme 1.10) (172, 173).
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Scheme 1.10. Reaction catalyzed by choline oxidase.

The prosthetic group of A. globiformis choline oxidase was also investigated by
subjecting the enzyme to trypsin-chymotrypsin digestion (82). One of the purified peptide
fragments yielded a UV-visible absorbance spectrum similar to that of flavin (FMN or FAD). To
identify whether the prosthetic group of choline oxidase was FMN or FAD, the fluorescence
intensity of the purified flavin peptide was tested after enzymatic hydrolysis with nucleotide
pyrophosphatase at pH 3. The flavin fluorescence intensity increased by 2-fold upon releasing
AMP by hydrolysis with nucleotide pyrophosphatase, consistent with FAD rather than FMN
being the cofactor (82). The position of flavin attachment was investigated using aminoacyl
riboflavin, for which covalent linkage occurs at the 8α-methylene group of the isoalloxazine ring
(82). The fluorescence excitation spectrum of aminoacyl riboflavin along with the purified flavin
peptide of choline oxidase at pH 3 showed a ~25 nm hypsochromic shift of the visible peak
centered at 346 nm as compared to free riboflavin (from 373 nm to 346 nm), suggesting that in
choline oxidase flavinylation occurs at the 8α-methylene group of the isoalloxazine moiety (82).
To establish whether N(1) or N(3) of the histidine residue of the protein bound to the 8α-
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methylene group of FAD, reduction with sodium borohydride and the fluorescence properties of
the bound flavin were examined. The purified flavin peptide was not reduced with sodium
borohydride, consistent with the covalently bound flavin isolated from the A. globiformis choline
oxidase being 8α-[N(3)-histidyl]-FAD. Indeed, it had been reported previously that the N(1)
isomer of histidyl flavin can be reduced with borohydride and its fluorescence is quenched, while
the N(3) isomer cannot (174). The electrophoretic mobility of the hydrolysate of the methylated
histidylflavin of choline oxidase from Alcaligens sp. at pH 6.25 also confirmed 8α-[N(3)histidyl]-FAD as the prosthetic group (25). The covalently bound FAD showed maxima at 358
and 453 nm and a shoulder at 480 nm, with a stoichiometric amount of 1 mol of FAD per mol of
enzyme. Furthermore, the covalently bound FAD was reduced anaerobically upon addition of
choline or betaine aldehyde, and re-oxidized upon aeration (25).
A comprehensive study on the spectroscopic properties of choline oxidase from
Alcaligens sp. was conducted for better understanding of the properties of the covalently bound
FAD of choline oxidase (48). The authors drew several conclusions based on the spectroscopic
properties of the covalently bound FAD. 1) Choline oxidase from Alcaligens sp. was able to
stabilize the anionic flavin semiquinone as an intermediate during the course of the enzyme
reduction using either dithionite or by photo-irradiating the enzyme in the presence of EDTA. 2)
The presence of a catalytic amount (3.7 µM) of free riboflavin significantly enhanced the
photoreduction rate not only to the semiquinone state but also to the fully reduced form of flavin.
3) The produced semiquinone did not showed any reactivity toward the substrates choline or
betaine aldehyde and most importantly, did not show any reactivity toward oxygen, which is an
unusual feature among flavoprotein oxidases. 4) The oxidized enzyme was able to form a
complex with glycine betaine (the product of the reaction); the dissociation constant of such
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complex was determined through spectroscopic titration to be 17 mM at pH 7.5. 5) No
significant anionic semiquinone was observed upon the reduction of the enzyme-bound glycine
betaine by either dithionite or by photoreduction in the presence of EDTA. 6) The biphasic
reactivity of the fully reduced form of the enzyme-bound glycine betaine toward oxygen (rapid
and slow phases) led the authors to propose a mechanism for the photoreaction of the enzymeproduct complex, wherein a C(4a)-adduct (slowly reacting with oxygen) and the fully reduced
flavin via an N(5)-adduct (rapidly reacting with oxygen) were formed (48).
In the past 10 years, studies on choline oxidase were mainly focused on the
biotechnological applications of the enzyme (175-179), which will be discussed in detail in
Section 1.5.
In a recent study by Rand et al. aimed at identifying the type of flavin linkage as well as
the amino acid residue to which FAD is attached in choline oxidase from A. globiformis, it was
concluded that choline oxidase contains 8α-[N(1)-histidyl]-FAD at position 87 in the
polypeptide chain (49). The results obtained in this study were mainly dependent on the
nucleotide sequence of codA gene coding for A. globiformis choline oxidase, which had been
previously reported in Genbank (accession number X84895) (180). The sequencing analysis of
the recently cloned codA gene from A. globiformis genome in our laboratory indicated that the
nucleotide sequence of codA originally reported in GenBank (accession number X84895)
contains seven flaws, resulting in a translated protein with a significantly altered amino acid
sequence between position 298 and 410. Therefore, the results obtained here in this study might
lack of accuracy. Indeed, the recently solved X-ray crystal structure of A. globiformis choline
oxidase showed that FAD is covalently linked to His99Nε2 (for details see 1.4.1), confirming the
inaccuracy of the results obtained in that study.
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Recently, the kinetic mechanism of the commercially available choline oxidase from A.
globiformis (Sigma-Aldrich, St. Louis, MO) was characterized in our laboratory using different
kinetic approaches (181, 182). The steady state kinetic data showed that choline oxidase
catalyzed the four-electron oxidation of choline to the carboxylic acid glycine betaine. This
reaction occurs through two sequential flavin-linked hydride transfers from choline and the
resulting betaine aldehyde intermediate to molecular oxygen (181). In addition, pH and
deuterium kinetic isotope effects studies on the oxidation of choline to betaine aldehyde in air
saturated buffer showed that a catalytic base with an apparent pKa value of ~8 is required for the
oxidation of choline to glycine betaine. When the pH is at least one pH unit below the pKa of
such catalytic base, the C-H bond cleavage becomes fully rate limiting for catalysis (182). In that
study, from an analysis of the amino acid sequence of choline oxidase from A. globiformis2 (180)
with respect to other members of GMC oxidoreductase superfamily (39, 97, 105, 183), histidine
466 was proposed to act as the catalytic base in choline oxidase (182).
Choline oxidase from A. globiformis was recently cloned in our laboratory (47). The
recombinant enzyme was expressed and purified to high purity and quantity, allowing detailed
biophysical, biochemical, and spectroscopic characterizations of the enzyme, as well as
mechanistic and structural studies with site-directed mutants (44, 47, 137, 138). These studies
will be discussed in detail in Chapters 3-7.
In a recent study that has been carried out in our laboratory on the recombinant enzyme,
choline and glycine betaine analogs have been used as substrates and inhibitors for the enzyme at
pH 6.5 to probe the structural determinants that are relevant for substrate specificity and binding
2

The sequencing analysis of the recently cloned codA gene from A. globiformis genome in our laboratory indicated
that the nucleotide sequence of codA originally reported in GenBank (accession number X84895) contains seven
flaws, resulting in a translated protein with a significantly altered amino acid sequence between position 298 and
410 (46).
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(184). As shown in Table 1.4, the Kis values that were determined for the competitive inhibition
patterns of glycine betaine, N,N-dimethylglycine, or N-methylglycine with respect to choline
were found to increase monotonically with decreasing number of methyl groups, consistent with
the importance of the trimethylammonium moiety of the ligand for substrate binding (Table 1.4)
(184). On the other hand, the Kis values did not show any changes upon substituting glycine
betaine with inhibitors containing methyl, ethyl, allyl, and 2-amino-ethyl esters, which strongly
suggests that the acetate moiety of the ligand does not participate in substrate binding (Table 1.4)
(184). In agreement with the inhibition data, the second-order rate constants kcat/Km (which
reflect the specificity of the enzyme for the organic substrate) decreased upon using N,Ndimethylethanolamine and N-methylethanolamine as substrate with respect to choline (Table 1.5)
(184). In addition to the methyl groups of the trimethylammonium moiety, the positive charge on
the same moiety has also been shown to be important for substrate binding and specificity. When
choline was substituted with its isosteric analogue 3,3-dimethyl-1-butanol as substrate for
choline oxidase, a significant decrease in both the turnover number (kcat) and the kcat/Km values
were observed (Table 1.5) (184). These results suggest that the positive charge on the
trimethylammonium headgroup of the substrate is important for substrate binding and catalysis
(184). An energetic contribution of ~29 kJ mol-1 was determined from the kinetic data for the
interaction of the quaternary ammonium portion of the substrate with the active site of choline
oxidase, i.e., ~7 kJ mol-1 from each methyl group and ~8 kJ mol-1 from the positive charge (184).
This value compares well with the value of ~33 kJ mol-1 that was determined before for the
contribution of the quaternary ammonium moiety of acetylcholine in acetylcholinestrase (185,
186). Similar observations have also been reported before for enzymes that use molecules
containing choline moiety as substrates, including acetylcholine, phosphatidylcholine, and
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phosphocholine (185-188). Among these enzymes, phospholipase C, acetyl-cholinestrase, and
CTP:phosphocholine cytidyltranseferase have been well characterized for the substrate binding
properties (185-188). The X-ray crystal structures of those enzymes complexed with their
specific inhibitors suggested that the trimethylammonium headgroup of the ligands is stabilized
by π-cation interaction to specific active site aromatic residues (185-188).
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Table 1.4. Inhibition Studies of Choline Oxidase at pH 6.5 a
Type of
Inhibitor
Structure
inhibition
CH3
N
COOCH3
CH3
N
COOH
H
N
COOH
CH3
N CH3
CH3
CH3
N H
CH3
CH3
N H
H
H
N H
H
CH3
N C2H5
CH3
CH3
N C2H5
H
H
N C2H5
H
CH3
N
CH3

Glycine betaine

H3C

N,N-Dimethylglycine

H3C

N-Methylglycine

H3C

Tetramethylamine

H3C

Trimethylamine

H3C

Dimethylamine

H3C

Methylamine

H3C

Trimethylethylamine

H3C

Dimethylethylamine

H3C

Methylethylamine

H3C

Allyltrimethylamine

H3C

2-Amino-trimethylethylamine

CH3
H3C N
CH3

a

NH3

Kis, mM

R2

competitive

15 ± 2

0.984

competitive

57 ± 1

0.995

competitive

405 ± 2

0.998

competitive

11 ± 1

0.997

competitive

2.4 ± 0.2

0.998

competitive

6±1

0.998

competitive

26 ± 1

0.996

competitive

13 ± 2

0.988

competitive

9±1

0.995

competitive

8±1

0.995

competitive

15 ± 1

0.999

competitive

9 ± 1b

0.993

Choline oxidase activity was measured at varying concentrations of both choline and
inhibitor in air-saturated 50 mM sodium pyrophosphate, pH 6.5 and 25 oC. b Value
determined for the protonated form of 2-amino-trimethylethylamine. Modified from ref.
(184).
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Table 1.5. Steady State Kinetic Parameters for Choline and N-Substituted Choline Analogs as
Substrates for Choline Oxidase at pH 8a
Substrate
Structure
kcat, s-1
kcat/Km, M-1s-1b
R2
Choline
N,N-Dimethylethanolamine
N-Methylethanolamine
3,3-Dimethyl-1-butanol
a

CH3
H3C N
OH
CH3
CH3
H3C N
OH
H
CH3
H N
OH
H
CH3
H3C C
OH
CH3

86 ± 1

200,000 ± 10,000

0.995

5.9 ± 0.1

18,400 ± 300

0.996

0.37 ± 0.01

710 ± 10

0.994

8.0 ± 0.1

7,900 ± 980

0.980

Choline oxidase activity was measured at varying concentrations of organic substrate and
oxygen in 50 mM sodium pyrophosphate, pH 8, and 25 oC. b kcat/Km is the kcat/Km value for the
organic substrate. Modified from ref. (184).
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In a subsequent study by our group, primary deuterium and solvent kinetic isotope effects
were used to investigate the mechanism of substrate oxidation (CH and OH bond cleavages) by
recombinant choline oxidase using both rapid kinetics and steady-state kinetics techniques (134).
That study showed that in the reductive half-reaction, the CH bond cleavage is not masked by
other kinetic steps as indicated by the pH independent value (in the pH range 6.5-10) of ~10.6
for D(kcat/Km) with deuterated choline (Figure 1.21) (134). In good agreement with that value, at
pH 10 a Dkred value of ~8.9 was also determined for the anaerobic reduction of the bound-flavin
by choline, irrespective of whether protio or deuterated solvent was used (134). In addition, the
study also showed that while the Dkcat and
D2O

(kcat/Km) and the

D2O

kcat values were 7.3 and 1.1, respectively, the

D2O

kred values were equal to unity with either choline or deuterated choline

(134). Overall, the results obtained have indicated that chemical steps of choline oxidation
catalyzed by choline oxidase are fully rate limiting for both the overall turnover and the
reductive half-reaction in which choline is oxidized to betaine aldehyde. In addition, the removal
of the substrate hydroxyl proton and the hydride transfer from the substrate α-carbon to the N(5)
locus of the flavin cofactor occur in a stepwise fashion with the formation of a transient alkoxide
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Figure 1.21. pH-Dependence of the deuterium isotope effects.
pH-dependence of the deuterium isotope effects on kcat/Km (•) and kcat (ο) values. Activity assays
of choline oxidase were performed in 50 mM buffer with choline and 1,2-[2H4]-choline as
substrate, at 25 °C. Data were fit by y = 10.6 and y = 7.5 for kcat/Km and kcat values, respectively.
Taken without permission from ref. (134).
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Modified from ref. (134).
In another recent study on recombinant choline oxidase, the effects of temperature and
oxygen concentration on the kinetic isotope with deuterated choline have been investigated
(135). At saturating oxygen concentrations, the Dkcat and the D(kcat/Km) values with 1,2-[2H4]choline were pH-independent, whereas at oxygen concentration ≤ 0.97 mM, they decreased at
high pH to limiting values that depended on oxygen concentration (Figure 1.22 and Table 1.6)
(135). In addition, the kcat and kcat/Km pH profiles also showed similar patterns reaching plateaus
at high pH. By using choline as a substrate at oxygen concentration of ≤ 0.25 mM, both the
limiting kcat/Km at high pH and the pKa values moved to lower values (Table 1.7) (135). These
data suggested that oxygen availability is the major determinant that dictates whether the reduced
enzyme-betaine aldehyde complex proceeds forward to catalysis or reverts to the oxidized
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enzyme-choline alkoxide complex during turnover of the enzyme with choline (135). To test the
involvement of quantum mechanical tunneling in the hydride transfer mechanism catalyzed by
choline oxidase, the effect of temperature on the Dkcat and the D(kcat/Km) values at saturating
oxygen concentration were determined (135). The effect of temperature on the kinetic isotope
effects can provide evidence on whether hydride transfer occurs quantum mechanically or by
following the classical over-the barrier behavior (135). The D(kcat/Km) was temperature dependent
and with value similar to the isotope effects on the preexponential factors (AH'/AD'). The large
isotope effect on the preexponential factors (AH'/AD') determined from the temperature
dependence of the kcat/Km values with choline and 1,2-[-2H4]-choline, with a value of ~14, rules
out a classical over-the-barrier behavior for hydride transfer, for which AH'/AD' values between
‡

0.7 and 1.7 are expected (135). Similar enthalpies of activation (∆H ) with values of 18 ± 2 and
18 ± 5 kJ mol-1 were determined for choline and 1,2-[2H4]-choline, respectively. Overall, these
data suggested that the reversible hydride transfer mechanism of choline catalyzed by choline
oxidase occurred quantum mechanically. In such mechanism, the tunneling behavior of the
hydride transfer is mainly affected by the distance between the hydride donor and acceptor (135).

61

15

8

B

6

k

cat

9
D

6

D

cat

k /K

m

12

10
A

3

4
2

0

0
5

6

7
pH

8

9

10

5

6

7

8

9

10

pH

Figure 1.22. pH dependence of D(kcat/Km) and Dkcat values with 1,2-[2H4]-choline as substrate for
choline oxidase at 0.07 (□), 0.25 (■), 0.97 mM (○) and saturating (●) oxygen concentrations.
Activity assays of choline oxidase were performed in 50 mM buffer with choline or 1,2-[2H4]choline as substrate, at 25 oC. Taken without permission from ref. (135).
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Table 1.6. pH Dependence of Kinetic Isotope Effects at Different Oxygen Concentrations a
D
D
[O2],
(kcat/Km)
kcat
mM

YLb

YHb

pKa

YL

YH

pKa

∞c

10.6 ± 0.6

10.6 ± 0.6

n.a.d

7.5 ± 0.3

7.5 ± 0.3

n.a.d

0.97

10.3 ± 0.4

5.6 ± 0.4

7.2 ± 0.3

7.2 ± 1.0

5.5 ± 0.3

5.9 ± 0.9

0.25

10.5 ± 0.4

3.7 ± 0.4

7.5 ± 0.2

7.3 ± 0.3

3.2 ± 0.2

6.3 ± 0.1

0.07

10.1 ± 0.2

2.6 ± 0.2

7.2 ± 0.2

7.5 ± 0.6

1.8 ± 0.1

6.0 ± 0.1

Conditions: 50 mM buffer, pH from 5 to 10 and 25 oC. b YL and YH are the limiting values at
low and high pH, respectively. c Data are from ref. (134). d n.a., not applicable. Taken without
permission from ref. (135).
a

Table 1.7. pKa Values for Steady State Kinetic Parameters with Choline or 1,2-[2H4]-Choline as
Substrate a
kcat/Km, M-1s-1
kcat, s-1
substrate

[O2], mM

pKa

Yb

pKa

Yb

choline

∞c

7.6 ± 0.2

130,000 ± 30,000

7.1 ± 0.1

58 ± 8

0.97

7.5 ± 0.1

150,000 ± 13,000

6.9 ± 0.1

41 ± 3

0.25

7.3 ± 0.1

66,000 ± 9,000

6.5 ± 0.1

21 ± 1

0.07

7.0 ± 0.1

47,000 ± 5,000

6.0 ± 0.1

6.6 ± 0.3

7.8 ± 0.2

14,000 ± 5,000

7.1 ± 0.2

7.5 ± 1.2

0.97

7.5 ± 0.2

29,000 ± 6,000

7.0 ± 0.1

7.6 ± 0.9

0.25

7.6 ± 0.1

18,000 ± 3,000

6.9 ± 0.1

6.7 ± 0.4

0.07

7.6 ± 0.1

18,000 ± 3,000

6.7 ± 0.1

3.6 ± 0.2

2

1,2-[ H4]-choline

∞

c

Conditions: 50 mM buffer, pH from 5 to 10 and 25 oC. b Y, limiting value at high pH. c Data are
from ref. (134). Taken without permission from ref. (135).
a
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Recently, another study on recombinant choline oxidase was carried out in our laboratory
aimed at understanding the mechanism of betaine aldehyde oxidation through the kinetic and
spectroscopic analyses of the oxidation of betaine aldehyde and its isosteric analog 3,3dimethylbutyraldehyde (136). While the anaerobic stopped-flow mixing of the enzyme with
either choline or betaine aldehyde at pH 8 resulted in complete reduction of the bound flavin
with similar kred values ≥48 s-1, only 10 to 26% of the enzyme-bound flavin was reduced by 3,3dimethylbutyraldehyde between pH 6 and 10 (136). In addition, 3,3-dimethylbutyraldehyde was
found to act as a competitive inhibitor versus choline in the reaction catalyzed by choline oxidase
(136). At air-saturation oxygen concentrations, the pH dependence of the kinetic parameters kcat
and kcat/Km with betaine aldehyde indicated that a catalytic base with pKa value of ~6.7 is
required for the oxidation of betaine aldehyde catalyzed by choline oxidase (136). Previous
studies showed that, at saturating oxygen concentrations, flavin reduction is the rate-limiting for
the overall turnover number of betaine aldehyde, with a limiting value of 135 s-1, at high pH
(134). Because kcat/KO2 value for the oxidation of the reduced enzyme bound betaine aldehyde
complex (k5) is ~9 × 104 M-1 s-1 (44), therefore, the rate constant for oxidation of the reduced
enzyme bound betaine aldehyde at a concentration of oxygen of 0.25 mM at 25 °C (atmospheric
conditions) is expected to be ~22 s-1. Accordingly, the apparent pKa value observed in the kcat/Km
pH profile of betaine aldehyde would be perturbed to lower values by 0.85 pH unit with respect
to the intrinsic pKa value of 7.5, which has been recently determined from the kcat/Km pH profile
with choline and its analogues as substrate for choline oxidase (44, 184). Therefore, it was
proposed that an active site base triggers the hydride transfer mechanism of betaine aldehyde,
which is most likely the same base that triggers the hydride transfer mechanism of choline (136).
The NMR spectroscopic analyses of both betaine aldehyde and its isosteric analog 3,3-
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dimethylbutyraldehyde revealed that while betaine aldehyde exists predominantly (99%) as a
diol form in aqueous solution, 3,3-dimethylbutyraldehyde favors the aldehyde (≥65%) over the
hydrated form in the pH range between 6 and 10 (Table 1.8) (136). Overall, the results obtained
in this study suggested that choline oxidase oxidizes the hydrated form of betaine aldehyde
through a base-catalyzed hydride transfer mechanism from the organic substrate to the enzymebound flavin (Scheme 1.12) (136).
Overall, based on the results obtained from the different biochemical and kinetic studies
carried on the wild-type as well as some selected mutant proteins of choline oxidase (this thesis),
our proposed model of the mechanism of reactions for the four-electron oxidation of choline to
glycine betaine catalyzed by choline oxidase can be summarized as follows. 1) During the
reductive half-reaction, an unidentified active site base with a pKa of 7.5 activates the alcohol
substrate with formation of an alkoxide species (species 1 and 2 in Scheme 1.13) (44, 134). 2)
This alkoxide intermediate is transiently stabilized in the active site through electrostatic
interaction with the Nε2 atom of the imidazolium side chain of His466 (species 3 in Scheme 1.13,
Chapter 5) (137). 3) Similarly, the protonated His466 also stabilizes electrostatically the negative
charge that develops on the N(1)-C(2)=O locus of the reduced flavin (anionic species) through its
Nε2 atom (species 3 in Scheme 1.13, Chapter 6) (138). 4) The hydride transfer from the αcarbon of the substrate to the N(5) locus of the bound flavin occurs quantum mechanically from
the activated choline alkoxide species (species 3 in Scheme 1.13) (135). 5) During the oxidative
half-reaction, the electron delocalization form the N(1) locus of the anionic hydroquinone along
with the proton transfer from the unidentified catalytic base result in the formation of the C(4a)hydroperoxo-flavin (species 5 in Scheme 1.13). 6) The highly unstable C(4a)-hydroperoxo-flavin
abstracts the second proton from the hydride at the N(5) locus of the FAD with the subsequent
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release of H2O2 and the formation of oxidized enzyme-bound FAD (species 6 and 7 in Scheme
1.13). 7) Finally, the oxidation of the hydrated betaine aldehyde occurs through a base catalyzed
transfer of a hydride ion from the organic substrate to the enzyme-bound FAD, with a
mechanism that is similar to that proposed for the oxidation of choline as proposed recently in a
study by our group on the mechanism of aldehyde oxidation (136).
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Table 1.8. NMR Determination of Hydration Ratio of Betaine
Aldehyde and 3,3-Dimethylbutylraldehyde in Aqueous Solution a
betaine aldehyde

3,3-dimethylbutylraldehyde

pD

[diol]/[aldehyde]

[diol]/[aldehyde]

5.9

nd b

0.42

6.9

99

nd

7.3

99

0.35

8.5

99

0.27

9.5

99

0.22

10.7

99

0.20

12.1

99

0.14

a
b

Conditions: 50 mM aldehyde, dissolved in 99.9% D2O, at 25 oC.
nd, not determined. Taken without permission from ref. (136).
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1.4.1. X-ray Structure of Choline Oxidase
The X-ray crystallographic structure of choline oxidase from A. globiformis was recently
determined at 1.86 Å resolution (George Lountos, Fan Fan, Giovanni Gadda, and Allen M.
Orville, unpublished results).
Overall structure. The crystal structure of choline oxidase at resolution of 1.86 Å was
solved by molecular replacement using the coordinates of glucose oxidase [1CF3, (39)] as a
template. The crystallographic data confirmed our previously obtained results for the
oligomerization state of the enzyme in solution (47), and showed that choline oxidase has a
dimeric structure, with approximate dimensions of 88 Å x 70 Å x 46 Å (Figure 1.23). The two
monomers interact with each other in an antiparallel manner. The overall structure of choline
oxidase was found to be similar to the PHBH-fold (p-hydroxy-benzoate hydroxylase) previously
reported for other GMC enzymes (31, 33, 34, 39, 62, 97). In addition, the polypeptide chain of
each monomer folded into two domains, the substrate-binding domain and the FAD binding
domain, with the active site being located between these two domains (Figure 1.23).
Flavin-binding domain. The flavin-binding domain comprises residues 1-159, 201-311,
and 464-527. The secondary structure of the flavin-binding domain consists of six-stranded βsheets flanked by three-stranded antiparallel β-sheets and α-helices, consistent with other GMC
enzymes (Figure 1.23) (31, 33, 34, 39, 62, 97). In addition, a typical Rossmann fold (βαβ)
(residues 16-44) was observed for the binding of the ADP sp. of the FAD (Figure 1.24). This
ADP-binding motif includes the highly conserved sequence, GXGXXG (residues 20-25:
GGGSAG). Among these residues, Ser23 forms several interactions with the flavin, with its
main chain being 3.3 Å from the first phosphate group of the ADP moeity, and its side chain
being 2.7 and 3.4 Å from the oxygen atoms of ribityl (O4*) and second phosphate group of ADP,
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respectively (Figure 1.24). Glu44Oε2 is located 2.7 and 3.2 Å from the ribose O2´ and O3´,
respectively, of the adenosine sp. (Figure 1.24). With the exception of these two residues, no
direct interactions between the enzyme and flavin adenine and ribitol were observed, which
clearly shows the importance of covalent flavinylation in positioning the FAD in choline
oxidase. For other GMC enzymes, in which FAD is not covalently attached to the protein such
as, glucose oxidase and cellobiose dehydrogenase, intensive interactions were observed between
the enzyme and the flavin. The increased interactions may compensate the noncovalently linked
FAD in glucose oxidase and cellobiose dehydrogenase (189-192). A conserved loop structure
composed of residues 65 – 95, which covers the entrance of the active site, was also observed
(Figure 1.23). A similar active site loop structure was reported before for cholesterol oxidase
(193). In that enzyme it was proposed through mutagenesis studies that such loop plays an
important role in facilitating the movement of the substrate into and of the product out of the
enzyme active site (193).
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A

B

C

Figure 1.23. Three-dimensional structure of choline oxidase from Arthrobacter globiformis.
Choline oxidase is shown in dimeric (A) and monomeric (B and C) structures. In B, the structure
is colored by secondary structure elements (cyan: α-helix, magenta: β-sheet, wheat: loop); in C,
the structure is rotated by ~45o with respect to the structure in B, and colored to show different
domains (blue: substrate binding domain, cyan: flavin binding domain, red: active site loop
structure). In all structures, the FAD molecule is colored in yellow.
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Figure 1.24. Rossmann fold (ADP-binding motif) structure of choline oxidase.
Rossmann fold (βαβ) (cyan: α-helix, magenta: β-sheet, wheat: loop); the FAD molecule is
colored in yellow.
Electron density clearly showed that the FAD is covalently linked to His99Nε2 (Figure
1.25). This result disagrees with a previous mass spectrometric study on choline oxidase, which
concluded that choline oxidase contains 8α-[N(1)-histidyl]-FAD at position 87 in the
polypeptide chain (49). The electron density maps shown in Figure 1.25 demonstrate that the
isoalloxazine ring of the bound flavin is not planar. The plane of the pyrimidine ring was at an
angle of ~130° with respect to the relatively flat piperizine and dimethylbenzene rings (Figure
1.25). The pyrimidine ring was also significantly distorted from planarity with a “half-boat”
configuration. All atoms in the distorted pyrimidine ring were in the same plane with the
exception of C4a, which was observed as sp3 hybridized. In addition, the C10a was also observed
as partially sp3 hybridized. This structure is significantly different from both the oxidized flavin,
and the reduced flavins, which typically exhibit an angle of ~150° along the N5-N10 axis defined
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by the dimethylbenzene and pyrimidine rings (194-196). A possible rationale that explains such
an unusual distortion of the flavin in choline oxidase is that it could be due the formation of
flavin-C4a- and C10a-adducts. The formation of the FAD-C4a-O2 in situ could occur in two
steps: 1) the bound FAD is reduced by the high brilliance synchrotron X-ray (photoreduction); 2)
molecular oxygen within the aerobic crystal diffuses to the C4a position of the reduced FAD
resulting in the formation of a FAD-C4a-O-O- adduct (197, 198). Further studies are currently
underway to investigate the possible reasons of such unusual flavin distortion in choline oxidase.
Substrate-binding domain. The substrate-binding domain of choline oxidase consists of
residues 160-200 and 312-463. It comprises three α-helices and a slightly distorted five-stranded
β-sheet; two strands in the β-sheet form the bottom of the active site. A large hydrophobic
residue, Trp331, was observed within β-sheet strand, which lies about ~8.5 Å from FAD. This
distance fits well with substrate choline sandwiched between Trp331 and FAD, consistent with
the role of Trp331 in substrate binding. In addition to Trp331, a number of hydrophobic residues
were observed also in the active site in the substrate binding domain, including, Trp330, Ile333,
Tyr352, as well as Phe357 (Figure 1.26). Furthermore, Glu312 was also observed in the substrate
binding domain facing towards the active site, suggesting a role of this residue in facilitating
substrate binding (vide infra).
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Figure 1.25. Approximately orthogonal views of the 50 - 1.86 Å resolution electron density
maps for the FAD isoalloxazine ring in choline oxidase.
The refined atomic model is shown superimposed with C, N, and O atoms are colored grey, blue
and red, respectively. From Lountos, G. T., Fan, F., Gadda, G., and Orville, A. M.; unpublished
data.

Figure 1.26. Active site structures of choline oxidase, fitting with DMSO.
The important residues from substrate- and FAD-binding domains are shown.
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Active site. The enzyme active site is located between the substrate binding domain and
the flavin binding domain, with a conserved loop structure (residues 65-95) covering its entrance
(Figure 1.23). One water molecule was observed in the enzyme active site, consistent with other
GMC enzymes such as glucose oxidase, cholesterol oxidase, pyranose 2-oxidase, and cellobiose
dehydrogenase (31, 33, 34, 39, 62, 97). Electron density showed a small molecule, not from the
enzyme in the active site. By carefully reviewing all the reagents used in crystallization, DMSO
was observed to fit well within the observed density map (Figure 1.26). The substrate choline
was docked into the structure based on the density map with DMSO (Figure 1.27). Two histidine
residues, His351 and His466, were also observed in the active site of choline oxidase (Figure
1.27). Earlier mechanistic studies on cholesterol oxidase, cellobiose dehydrogenase, and glucose
oxidase, suggested that a histidine residue, which is fully conserved within the GMC family and
corresponds to His466 of choline oxidase, might act as the specific base that participates in the
oxidation of the alcohol substrate (39, 105, 113, 128, 199, 200). However, our recent
biochemical and mechanistic studies of His466 mutant proteins (CHO-H466A and CHO-H466D)
suggested that His466 is most likely not the active site base that abstracts the substrate hydroxyl
proton during catalysis (these studies will be discussed in detail in Chapters 5 and 6). The X-ray
crystallographic structure of the enzyme docked with choline showed that while His466 is
located at a distance of ~4.8 Å from the hydroxyl group of the docked substrate choline, His351
is located at a distance of ~3.3 Å from the same region. Therefore, His351 might function as the
specific base that abstracts the hydroxyl proton of the substrate during catalysis. Val464 is also
likely to interact with choline, as suggested by the close distances to choline, i.e., 2.5 Å from its
main chain and 3.5 Å from its side chain (Figure 1.27).
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As pointed out earlier, the trimethylammonium headgroup of choline is the major
determinant for substrate binding and specificity (184). The X-ray structural data of choline
oxidase showed that three residues (Glu312, Trp331, and Phe357) are located close to the
trimethylammonium moiety of the docked choline in the active site (Figure 1.27). In this respect,
these three residues are likely to be the components of the previously proposed π-cation
interactions of the substrate to selected active site residues of the enzyme (184), i.e. Glu312 can
form an ion pair with the positive charge of the trimethylammonium moiety, and the two
hydrophobic residues can interact with the methyl groups to form π-cation interactions, which in
turn facilitates the substrate binding and positioning for catalysis. Similar observations have been
reported before in many choline-binding enzyme such as phospholipase C, CTP: phosphocholine
cytidyltranseferase, and acetyl-cholinestrase, where π-cation interactions between their substrates
and specific active site residues were the major determinant for substrate binding and specificity
(185-188).
The X-ray crystallographic data of choline oxidase also showed that the Nε2 atom of the
conserved active site residue His466 is located at a distance of ~3.3 Å from the N(1) locus of the
enzyme-bound FAD (Figure 1.28), consistent with other GMC enzymes (31, 33, 34, 39, 62, 97),
and suggesting an important role of such residue in catalysis and modulation of the bound flavin
as well (this hypothesis will be discussed in details in Chapter 5 and 6). Most interestingly, the
X-ray structure of choline oxidase showed that another histidine residue, His310, is located at a
distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1) (Figure 1.28). Polarographic preliminary
results on the enzyme obtained by substituting His310 by an alanine residue showed that the
purified mutant enzyme completely lost its catalytic activity with choline as a substrate.
Spectrophotometrically, CHO-H310A was still able to bind choline with the subsequent
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reduction of the enzyme-bound flavin, which occurred relatively slower than that of wild-type
choline oxidase (16 h vs 1 s) and in a biphasic way. These results, together with the structural
information, suggest an essential role of His310 in catalysis and the modulation of the enzymebound flavin, which will be discussed in detail in Chapter 7.
In conclusion, the X-ray crystallographic structure of choline oxidase was resolved at
1.86 Å resolution. The overall structure of choline oxidase resembles that of PHBH as previously
observed for other GMC enzymes. A covalent linkage between the His99Nε2 and FADC8M atoms
was observed. The electron density maps for the FAD reveal an unusually distorted isoalloxazine
ring system that can be rationalized as a C4a- or C10a-covelant adduct. The substrate choline
was docked into the active site of choline oxidase structure based on the density map of DMSO,
which was found in the active site structure. The resulting orientation of substrate is consistent
with His351 being the active site catalytic base that abstracts the substrate hydroxyl proton
during catalysis. The distance and the orientation of the Glu312, Trp331, and Phe357 to the
trimethylammonium headgroup of choline are consistent with π-cation interactions between the
quaternary ammonium moiety of the substrate and these residues. The distance between the
modeled choline α-carbon and flavin N5 locus was found to be ~3 Å, consistent with hydride
transfer mechanism for the oxidation of choline catalyzed by choline oxidase. This in turn, also
provides structural basis for the tunneling behavior of hydride transfer.
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A

B

Figure 1.27. Active site structures of choline oxidase, showing its cavity (A) and docking with
choline (B).
The important residues from the substrate- and FAD-binding domains are shown.

78

Figure 1.28. Active site structures of choline oxidase showing the proton-transfer network.
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1.5. Choline Dehydrogenase
Choline dehydrogenase (E.C. 1.1.99.1) is an inner mitochondrial membrane protein that
catalyzes the four-electron oxidation of choline to glycine betaine via a betaine aldehyde
intermediate and requires an electron acceptor other than oxygen (103, 201, 202) (Scheme 1.14).
This reaction is of considerable interest for both biomedical and biotechnological applications,
because the reaction product, glycine betaine, enables tolerances towards various environmental
stresses, such as hypersalinity and low and high temperatures in both transgenic plants (176-179)
and pathogens (203-205) (see Section 1.6).
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Scheme 1.14. Oxidation of choline to glycine-betaine catalyzed by choline dehydrogenase.
X, Primary electron acceptor. Modified from ref. (102).
To date, no in depth biochemical or kinetic characterization has been performed on
choline dehydrogenase, mainly due to the difficulty in its purification because of the instability
of the enzyme in vitro. Although choline dehydrogenase has been grouped in the GMC flavindependent oxidoreductase superfamily (96), the presence of FAD as a cofactor is still ambiguous
for this enzyme. Pyrroloquinoline quinone (PQQ) has been proposed to be the prosthetic group
of the purified Pseudomonas choline dehydrogenase (103). Choline dehydrogenase has been also
purified from rat liver mitochondria (201). The purified enzyme from either rat liver
mitochondria or from Pseudomonas sp. showed to use phenazine methosulfate as a primary
electron acceptor instead of oxygen (103, 201). In another study, the mitochondrial choline
dehydrogenase showed a similar kcat and Km (0.8 mM) values with either phenazine methosulfate
or ubiquinone as electron acceptors at infinite concentration (206).
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Recently, we have reported the first recombinant choline dehydrogenase expressed and
purified in E. coli by cloning the betA gene that codes for choline dehydrogenase from the
moderate halophile Halomonas elongata (102). The purified enzyme showed its ability to react
with either choline or betaine aldehyde as substrate with similar specificities, using phenazine
methosulfate as the primary electron acceptor. Similar to the Pseudomonas enzyme, no evidence
for the presence of FAD was observed in H. elongata choline dehydrogenase. The enzyme also
showed ability to react with molecular oxygen as electron acceptor, but with four- to seven-fold
decrease in kcat values with respect to phenazine methosulfate (10.9 vs 1.5 µmol of O2/min/mg
for choline as substrate, and 5.7 vs 1.4 µmol of O2/min/mg for betaine aldehyde as substrate, in
50 mM potassium phosphate, pH 7, at 25 °C), suggesting that the enzyme can act as an oxidase
when electron acceptors other than molecular oxygen are not available (102).
Choline dehydrogenase from E. coli K12 was also cloned, and expressed in E. coli strain
BL21(DE3) in our laboratory (Powell, N., Dissertation, Chemistry Department, Georgia State
University). The recombinant enzyme was partially purified, and showed a molecular mass of
~62 kDa on SDS-PAGE. The partially purified enzyme also showed ability to react with both
choline and betaine aldehyde as substrate, and to utilize either phenazine methosulfate or
molecular oxygen as primary electron acceptor. The UV-visible absorbance spectrum of the
purified enzyme showed absorbance maxima at ~275, ~375, and ~455 nm, as expected for a
flavin-containing enzyme, but with relative intensities of the peaks in the near UV and visible
regions of the spectrum suggesting that the bound flavin was present as a mixture of oxidized
and anionic semiquinone states (Figure 1.29) (Powell, N., Dissertation, Chemistry Department,
Georgia State University). This recombinant form choline dehydrogenase was highly unstable in
vitro, which hindered any further biochemical and mechanistic investigations of that enzyme.
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Figure 1.29. UV-visible absorbance spectrum of choline dehydrogenase containing a His-tag
from Escherichia coli K 12, in air saturated 100 mM potassium phosphate, pH 7.0, at 25 oC.
Taken from (Powell, N.; Dissertation, Chemistry Department, Georgia State University).

The amino acid sequence alignment comparison of choline oxidase from A. globiformis
with choline dehydrogenase from H. elongata and choline dehydrogenase from E. coli revealed
that the identities and the similarities between choline oxidase and choline dehydrogenase are
35% and 65%, respectively (Figure 1.30). The amino acid sequence alignment comparison of the
two enzymes showed highly conserved residues in both the flavin binding domain and the active
site of the enzymes (Figure 1.30). Due to the important roles of glycine betaine in bacterial
survival under stressful environmental conditions (see Section 1.6 for details), the study of
choline dehydrogenase has potential for the development of therapeutic agents that can inhibit
the biosynthesis of glycine betaine in many humans’ pathogenic diseases. However, due to the
high insolubility and instability of choline dehydrogenase, studies of cytosolic choline oxidase,
which shares ~65% similarity with choline dehydrogenase and catalyzes the same enzymatic
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reaction, can shed light on the catalytic properties of choline dehydrogenase. The analysis of the
sequence alignment comparison of choline oxidase with choline dehydrogenase showed that the
major difference between the two proteins is limited to a short hydrophobic peptide (23
residues), which is absent in choline oxidase (Figure 1.30). This peptide might play an important
role in anchoring choline dehydrogenase to the mitochondrial membrane. In addition, the crystal
structure of choline oxidase showed that this region is located on the surface of the protein
(Figure 1.31). Therefore, it is conceivable that a soluble and stable choline dehydrogenase might
be obtained by mutagenizing choline dehydrogenase through the deletion of the nucleotides
encoding for such short hydrophobic peptide.
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Figure 1.30. Alignment of choline oxidase with choline dehydrogenase.
CHO-Ag, choline oxidase from A. globiformis (GenBank accession no. AAP68832); CHD-He, choline
dehydrogenase from Halomonas elongata (GenBank accession no. CAB77176); CHD-Ec, choline
dehydrogenase from Escherichia coli (GenBank accession no. P17444). Yellow highlighted sequence,
conserved flavin binding domain; gray highlighted sequence, conserved active site; cyan highlighted
sequence, site of the major differences between CHO and CHD; *, identical residues; :, conserved
substitution; ., semi-conserved substitution.
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Figure 1.31. The surface of the monomeric structure of choline oxidase.
Red highlighted residues, are Pro322, Met323, Val324, and Ala325. The FAD molecule is
colored in yellow.
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1.6. Biological Applications
The chemical reaction catalyzed by choline oxidase is of considerable interest for
biotechnological and biomedical applications, because accumulation of glycine betaine in many
economically relevant crop plants and human pathogens enables their stress resistance toward
hyperosmotic environments (207). Therefore, the study of choline oxidase has potential for the
development of therapeutic agents that inhibit the biosynthesis of glycine betaine and render
pathogenic bacteria susceptible to either conventional treatments or the innate immune system,
and for the improvement of water stress resistance in genetically engineered crops lacking
efficient glycine betaine biosynthetic systems.
The exposure of microorganisms to high osmolality environments enhances rapid fluxes
of water outside the cell, thereby resulting in dehydration and reduction in turgor of the
cytoplasm. Microorganisms counteract the outflow of water from their cytoplasm by increasing
the uptake of potassium ions and organic osmolytes (also called compatible solutes or
osmoprotectants) to increase their intracellular solute pool and prevent the cytoplasmic outflow
of water (208). Osmoprotectants are defined as exogenously provided organic solutes that
promote bacterial growth under hyperosmotic environments. These compounds may act as
precursors that can be enzymatically converted into compatible solutes or they may themselves
be compatible solutes (207). The intracellular uptake of compatible solutes is not restricted to
bacteria but is also used as a common strategy among fungi, plants, animals, and even human
cells to compensate the adverse effects of high osmolality and high ionic strength (209, 210). In
microorganisms, only a limited number of organic compounds serve as compatible solutes,
including sugars (trehalose), free amino acids (glutamate and proline) and derivatives thereof
(proline betaine and ecotine), polyols (glycerol and glucosylglycerol), and quaternary amines and
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their sulfonium analogs (glycine betaine, carnitine, and dimethylsulfoniopropionate) (Figure
1.32) (207). In general, compatible solutes are highly soluble and at physiological pH their net
charges are equal to zero. Compatible solutes can reach high intracellular concentration without
interfering with the vital physiological functions of the cells (211). Glycine betaine (N,N,N–
trimethylglycine) is one of the most commonly used compatible solutes that is accumulated in
the cytoplasm of microorganisms to counteract hyperosmotic environments (212).
In microorganisms, the intracellular accumulation of glycine betaine is achieved either
through transporters (osmotically stimulated uptake systems) that enhance the intracellular
uptake of exogenous glycine betaine across the cell membrane or by endogenous intracellular
biosynthetic pathways (207). In E. coli and Salmonella typhymurium, two transporters are mainly
responsible for the intracellular uptake of exogenous glycine betaine across the cell membrane,
ProP and ProU (Figure 1.33). The penetration of exogenous glycine betaine through the outer
membrane of those two bacterial species is achieved by passive diffusion through the nonspecific
porin transporters, i.e., OmpC and OmpF (Figure 1.33). The expression of porin structural genes
is regulated by medium osmolality. OmpC synthesis prevails in hypertonic media, while the
production of OmpF predominates under hypotonic environments (213). E. coli can synthesize
glycine betaine by the two-step oxidation of its precursor choline catalyzed by the membrane
bound choline dehydrogenase (Figure 1.33) (214). A limited number of other bacterial strains
such as A. globiformis, H. elongata, S. aureus, and P. aeruginosa can also accumulate glycine
betaine intracellulary by stepwise methylation of glycine (204, 215). In Bacillus subtilis, while
the intracellular uptake of proline is controlled by the highly substrate-specific transport system
OpuE (osmoprotectants uptake), the intracellular uptake of glycine betaine is controlled by 3
highly effective transporters, OpuA, OpuC, and OpuD, which enhance the exogenous uptake of
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glycine betaine from the environment up to a cellular concentration level that exceed 1 M under
osmotic stress conditions (Figure 1.34) (207).

Figure 1.32. Structures of selected osmoprotectants.
Taken without permission from ref. (207).
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Figure 1.33. Osmostress response systems of E. coli.
GB glycine betaine, Glc glucose, Glc-6-P glucose-6-phosphate, Tre trehalose, Tre-6-P trehalose6-phosphate, UDP-Glc uridine disphosphate-glucose. Taken without permission from ref. (207).
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Figure 1.34. Osmostress response systems of Bacillus subtilis.
Taken without permission from ref. (207).
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1.6.1. Glycine Betaine as an Osmoprotectant
Glycine betaine (N,N,N–trimethylglycine) is a zwitterionic molecule that is widely
distributed in a large variety of microorganisms, animals, and plants. The high intracellular
concentration of glycine betaine does not interfere with the normal physiological functions
within the cytoplasm of the cells but instead it maintains cell turgor and stabilizes the structure
and function of several macromolecules (216). Consequently, the intracellular accumulation of
glycine betaine enhances cells growth and proliferation under stress conditions. Glycine betaine
acts as an osmoprotectant by stabilizing the highly ordered structures of proteins and membranes,
particularly the quaternary structures of complex proteins (212).
The osmoprotective effects of glycine betaine on bacteria (E. coli) were first reported in
an experiment that showed that in the presence of glycine betaine in the medium, E. coli can
grow under inhibitory high concentration of NaCl (0.8 M) (217). Cayley et al. reported that the
amount of glycine betaine increased monotonically in the cytoplasm of E. coli K12 with
increasing osmolality (218). Similarly, it was observed that glycine betaine was responsible for
the survival of the halophilic bacterium Halomonas elongata in a salinity range of 0.1-4 M NaCl
(219). It has also been reported that the addition of glycine betaine can restore the depreciated
growth rate of E. coli under high osmolality (211, 220). Such reversion of the inhibitory effect of
high osmolality was also observed in other non-halophilic bacteria, such as Bacillus subtilis, and
Salmonella oranienburg (221, 222).
In plants, glycine betaine has been shown to be a critical determinant of stress tolerance.
The presence of glycine betaine as osmoprotectant is usually associated with enhanced growth
and germination of plants in dry or saline environments (210). Moreover, the exogenous
inclusion of glycine betaine has shown a significant effect on the growth and survival of a wide
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range of plants under different stress conditions (178). The protective functions of glycine
betaine for plants were confirmed by transforming betaine-synthesizing genes into plants that
were deficient in glycine betaine. The gene that encodes for choline oxidase (codA), which
converts choline to glycine betaine, has been the most commonly used in these transformations.
The transformation of Arabidopsis thaliana with the codA gene from Arthrobacter globiformis
resulted in a significant accumulation of glycine betaine in different organs of the transformed
plants (178). The transgenic Arabidopsis have shown a significant tolerance to high-salt
conditions (100 - 600 mM NaCl) during seed germination and during the growth of seedlings
and mature plants (Figure 1.35) (178). Similarly, the imbibition and the germination of the seeds
as well as the growth of the seedlings of transgenic plants showed enhanced tolerance to nonfreezing low temperatures (5 °C) compared to those of wild-type plants (175, 178). In addition,
the accumulation of glycine betaine in transgenic Arabidopsis plants resulted in a considerable
tolerance to high-temperature (35-42 °C) during imbibition and germination (176). Finally,
transformed Arabidopsis thaliana has shown a significant tolerance to high-intensity light
stresses compared to wild type plants, which results from the fast recovery of the photosystem II
complex from the light-induced inactivated state (177). Therefore, the accumulation of glycine
betaine in many pathogens and plants enables their stress-resistance towards hyperosmotic
environments.
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Figure 1.35. Enhanced tolerance of transgenic Arabidopsis to salt stress.
Enhanced tolerance to salt at various developmental stages of transgenic Arabidopsis that
accumulates GB as a consequence of the introduction of the codA gene from A. globiformis. A,
Seeds were germinated on gel-solidified medium supplemented with 100 mM NaCl and
incubated for 20 d. The left two plants are transformed plants and the right two plants are wild
type. B, Two-week-old seedlings were exposed to 600 mM NaCl for 4 h, and after transferring to
normal conditions they were allowed to grow for 3 weeks. Left, Transformed plants; right, wildtype plants. C, Thirty-day-old plants were watered with 200 mM NaCl for 10 d. Left,
Transformed plant; right, wild-type plant. Taken without permission from ref. (216).
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1.6.2. Biotechnological Application of Glycine Betaine
Several economically relevant crop plants such as soybean, rice, and potato are deficient
in osmoprotectants (223). As previously discussed (Section 1.6.1), several studies have strongly
confirmed that glycine betaine is one of the most potent osmoprotectant in transgenic plants.
Genetically engineered plants are expected to accumulate glycine betaine in their cytoplasm due
to their inability to catabolize glycine betaine. Consequently, numerous studies have been carried
out with the goal of genetically engineering increased stress tolerance in economically relevant
crop plants (176, 177, 180, 224-226).
The introduction of betaine-producing enzymes (choline dehydrogenase) enhanced the
survival of transgenic tobacco under varying salinity and temperature conditions (224).
Transgenic lines of Indica rice have been transformed with the codA gene from Arthrobacter
globiformis (227). The exposure of the genetically modified plants to salt stress (0.15 M NaCl)
for one week, followed by a recovery period, showed that more than 50% of the transgenic plants
could survive salt stress and set seed whereas wild-type plants failed to recover (227).
Recently, tomato plants, which normally do not accumulate glycine betaine and are
susceptible to chilling stress, have been transformed with the codA gene from Arthrobacter
globiformis (228). The genetically engineered plants have shown a notable improvement of
chilling stress tolerance compared to wild-type plants in various developmental phases. The
overall yield of the transgenic tomato plants during reproduction was enhanced by an average of
10–30% more fruit following chilling stress. It has been assumed that the increased levels of
H2O2 in codA transgenic plants, as a byproduct of choline oxidase-catalyzed glycine betaine
synthesis, might activate an H2O2-inducible protective mechanism, resulting in improved chilling
and oxidative tolerances in glycine betaine accumulating codA transgenic plants. Overall, the
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introduction of a biosynthetic pathway of glycine betaine into tomato through genetic
engineering is a valuable approach for improving chilling tolerance (228).
1.6.3. Biomedical Applications of Glycine Betaine
The accumulation of the major osmoprotectant glycine betaine has been observed in a
number of human pathogens, including Listeria monocytogenes, Staphylococcus aureus, and
Pseudomonas aeruginosa (203, 205, 208). Hyperosmolarity is frequently encountered at human
infection sites (229), where glycine betaine precursors, i.e., choline, acetylcholine,
phosphatidylcholine, and phosphorylcholine, are abundant (230-232). Therefore, pathogens can
employ these precursors not only to produce glycine betaine as a potent osmoprotectant, but also
as carbon and nitrogen sources to survive at infectious sites.
P. aeruginosa is a human opportunistic microbe, which causes a variety of human
systemic infections. For P. aeruginosa, glycine betaine does not only act as the major
osmoprotectant of the pathogen, but it also serves as a metabolic intermediate as well (215). To
examine the role of glycine betaine accumulation for bacterial growth under stressful infectious
conditions, disulfiram was tested as an inhibitor for P. aeruginosa betaine aldehyde
dehydrogenase (an enzyme that catalyzes the last irreversible step of glycine betaine synthesis
from choline), with the goal of development of potent therapeutic agents for P. aeruginosa
infection (215). Although in vivo studies are necessary before drawing any further conclusions,
disulfiram totally and irreversibly inhibited the activity of betaine aldehyde dehydrogenase,
suggesting a significant role for this inhibitor as an antimicrobial agent.
Several studies have shown that L. monocytogenes, which is causative agent of human
food poisoning, can survive and tolerate a variety of environmental stress conditions due to the
accumulation of glycine betaine (233, 234). The intracellular accumulation of glycine betaine in
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the cytoplasm of L. monocytogenes enables the pathogens to tolerate not only external adverse
environmental conditions such as high or low temperature prior to ingestion to host, but also the
internal environment within the host with high salt concentration ranges from 0.3 to 0.7 M (205).
The effects of glycine betaine accumulation on the virulence of L. monocytogenes were studied
by mutating the glycine betaine transporter OpuC. In murine studies, the mutated pathogen
showed a significant reduction in glycine betaine accumulation as well as a significant decrease
of the bacterial colonies in small intestine of the host cell (205). These results strongly suggest an
important role of glycine betaine synthesis in the virulence of pathogen.
E. coli is considered as the most frequent causative agent of human urinary tract
infections. The osmolality of human urine can widely vary in a range between 0.04 to 1.4 mol/kg
(235, 236). The human urinary tract experiences a wide range of pH fluctuations upon washing
with urine that contains high levels of organic acid. The pH of human urine can vary between 5
to 8, depending on the nature of ingested diet (235). As a direct prove of the role of glycine
betaine in enhancing the ability of E. coli to survive and grow in human urinary tract, glycine
betaine was detected to be accumulated during the growth of E. coli in medium containing 1.2 M
NaCl (235).
Staphylococcus aureus is now considered as the second most common cause (after E.
coli) of urinary tract infection. This organism is also considered the most osmotolerant among
the non-halophilic eubacteria (204). S. aureus has also shown its ability to withstand a wide
range of osmolarity, it can grow well either at high (3.5 M NaCl) or low osmolalities, consistent
with a highly developed system in regulating cytoplasmic osmolality (204). The urinary isolates
of S. aureus accumulate glycine betaine in both the presence and absence of osmotic stress.
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Unlike E. coli, S. aureus did not accumulate other betaines in presence of glycine betaine,
suggesting the crucial role of glycine betaine for the survival and pathogenity of S. aureus (204).
Overall, the accumulation of glycine betaine in many human pathogenic bacteria, which
enables their growth and survival at human infection sites under hyperosmotic conditions, points
potential of studying choline oxidase or its analog choline dehydrogenase for the development of
therapeutic agents that inhibit the formation of glycine betaine and render pathogenic bacteria
susceptible to either conventional treatments or the innate immune system.
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1.7. Goals
Choline oxidase (E.C. 1.1.3.17) from A. globiformis is a flavin-dependent enzyme that
catalyzes the four-electron oxidation of choline to glycine betaine, one of a limited number of
compounds that accumulates to high levels in the cytoplasm of cells to counteract the adverse
effects of hyperosmotic environments (207). The accumulation of glycine betaine has been
observed in a number of human pathogenic bacteria, such as Staphylococcus aureus,
Mycobacterium tuberculosis, Pseudomonas aeruginosa, Listeria monocytogenes, Enterococcus
faecalis, Klebsiella pneumoniae, Vibrio sp. and E. coli O157: H7 (203-205, 208, 235, 237, 238).
Osmotic stress conditions are frequently observed at human infection sites where glycine betaine
precursors, i.e., choline and its analogues, are very abundant (229, 230, 232). Consequently, the
study of choline oxidase or its analog choline dehydrogenase has potential for the development
of therapeutic agents that inhibit the formation of glycine betaine and render pathogenic bacteria
susceptible to either conventional treatments or the innate immune system. Furthermore, the
recent findings that many crop plants accumulate glycine betaine in their cytoplasm in response
to adverse environmental conditions, such as high or low temperature, high salts, and water
deficiency, have motivated considerable interest in studying glycine betaine biosynthesis, with
the objective of genetically engineering enhanced resistance towards environmental stress in
economically relevant crop plants (176, 177, 180, 224-226).
Up to 2003, despite a wealth of studies on the biomedical and biotechnological
applications of the enzyme, minimal biochemical and mechanistic studies on choline were
reported. The biotechnological and biomedical potentials for choline oxidase require a
meticulous biochemical, biophysical, kinetic, and structural characterization of the enzyme,
which is the goal of this study. This study will provide a solid background for the different
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biomedical and biotechnological applications of choline oxidase. It will also provide new
insights for other flavoproteins that are structurally and functionally related to choline oxidase.
The biophysical, biochemical, structural, and mechanistic characterization of an enzyme
usually require large quantities of the pure, active and stable form of such enzyme.
Consequently, the first step in this project was aimed to clone codA gene that encodes for choline
oxidase from A. globiformis. The cloned gene can then be used not only for production of
enzyme, but also for the preparation of a number of mutant forms of choline oxidase to
investigate the role of specific active site residues. In addition, efficient approaches for protein
expression and purification, which can provide large quantities of pure and stable the enzymes,
are required as well.
For a newly purified enzyme, it is important to understand firstly the different
biophysical, biochemical, spectrophotometrical, kinetic, and mechanistic properties of the wildtype form prior of the further investigation of the role of specific active site residues by preparing
different mutant forms of the enzyme. Thus, biophysical, biochemical, spectrophotometrical,
kinetic, and mechanistic properties of the wild-type choline oxidase were studied in parallel with
similar studies on selected mutant forms of the enzyme. From a structural standpoint, the X-ray
crystallographic structures of most flavoprotein oxidases including choline oxidase (George
Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished results) have shown that
a positively charge amino acid residue or a dipole of an α-helix is oriented to the N(1)-C(2)=O
locus of the enzyme-bound flavin (31-33, 35-40, 95, 183), with mechanistic implications for the
modulation of flavin reactivity. While the effects of replacing the positive charge with a neutral
amino acid on the flavin properties have been investigated for lactate monooxygenase (239), no
studies have addressed the characterization of the flavin properties of an oxidase in which the
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positive charge close to the flavin N(1) was reversed. The main goals of this study were aimed to
obtain insights on the roles played by the positively charged conserved active site residue, His466,
proximal to the N(1) locus of the bound flavin in choline oxidase; and for the first time to
characterize a flavoprotein oxidase with a negative charge near the flavin N(1) locus. Mutant
forms of choline oxidase were prepared in which the conserved active site residue, His466, was
substituted with either a neutral (alanine) or a negatively charged (aspartate) amino acid,
followed by the biophysical, biochemical and mechanistic characterizations of those mutant
forms with respect to the wild-type choline oxidase.
Since unambiguous biochemical, structural, and mechanistic characterizations of other
related flavoprotein oxidases that oxidize alcohols were hindered, the biochemical and the
mechanistic studies of wild-type choline oxidase along with its active site mutants can shed light
on other flavoproteins that are structurally and functionally related to choline oxidase.
Interestingly, for the first time obtaining insights for flavoprotein oxidase with a negative charge
near the flavin N(1) locus. From biotechnological and biomedical standpoints, these biochemical
and mechanistic studies of choline oxidase will be the foundation for future rational design of
efficient transition state analogs and inhibitors that could be used for the development of
therapeutic agents that inhibit the formation of glycine betaine, and in turn render pathogenic
bacteria susceptible to conventional treatments.
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CHAPTER II
Material and Methods
Materials
Escherichia coli strain JM109 harboring plasmid pGAH/codA was a kind gift from Dr.
Murata, National Institute for Basic Biology, Okazaki, Japan (1, 2). A freeze-dried culture of
Arthrobacter globiformis (ATCC 8010) was obtained from American Type Culture Collection.
Restriction endonucleases Nde I and EcoR I, calf intestinal alkaline phosphatase, T4 DNA ligase,
Taq DNA polymerase, deoxynucleotide triphosphates, and bovine serum albumin were
purchased from Promega. Cloned Pfu DNA polymerase, DpnI, and E. coli strain XL1-Blue were
obtained from Stratagene (La Jolla, CA). Bgl II, BamH I, and Hind III were from New England
Biolab. Luria-Bertani agar, Luria-Bertani broth, chloramphenicol, tetracycline, kanamycin,
isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite (dithionite),
sodium sulfite, phenylmethylsulfonyl fluoride (PMSF), and betaine aldehyde bromide were
obtained from Sigma-Aldrich (St. Louis, MO). Carbenicillin, ampicillin, choline chloride, and
electrophoresis-grade agar were purchased from ICN Biomedicals (Aurora, OH). Nutrient Broth
and Nutrient Agar #3 were from Difco. 1,2-[2H4]-Choline bromide was from Isotec Inc.
(Miamisburg, OH). Deuterium oxide (D2O) was from Cambridge Isotope Laboratories Inc.
(Andover, MA). All other reagents were of the highest purity commercially available.
Oligonucleotides were custom synthesized on a Beckman Oligo model 1000 M by the DNA
Core Facility of the Biology Department of Georgia State University, or by Sigma Genosys (The
Woodlands, TX).
A. globiformis genomic DNA was purified using the DNeasy midi-kit from Qiagen
(Valencia, CA). Plasmids and products deriving from primer extension reaction and PCR were
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purified by using QIAprep Spin Miniprep kit from Qiagen. E. coli strains Novablue and
Rosetta(DE3)pLysS were from Novagen (Madison, WI). E. coli strain Novablue cells harboring
plasmid pET/codA1 or pET/codA2, strain XL1-Blue cells harboring plasmid pET/codA3, and
strain Rosetta(DE3)pLysS cells harboring plasmid pET/codA1 or pET/codA3 were stored at –80
o

C as 7% DMSO suspensions. E.coli MKH13 harboring pJB004 was a kind gift from Dr. Erhard

Bremer (Philipps Universität, Marburg, Germany). DNA sequencing was carried out with an
Applied Biosystems Big Dye kit on an Applied Biosystems model ABI 377 DNA sequencer by
the DNA Core Facility of the Biology Department of Georgia State University.
Instruments
UV-visible absorbance spectra were recorded using an Agilent Technologies diode-array
spectrophotometer model HP 8453 equipped with a thermostated water bath. Fluorescence
emission spectra were recorded with a Shimadzu Spectrofluorometer model RF-5301 PC
thermostated at 15 °C. Circular dichroism spectra were acquired using a Jasco J-810
spectropolarimeter at 5 °C. Enzyme activity was measured polarographically by monitoring the
rate of oxygen consumption with a Hansatech oxygen electrode (HansaTech Oxy-32)
thermostated at 25 oC. Rapid kinetics was carried out on a Hi-Tech 61 SF-DX2 Double mixing
stopped-flow spectrophotometer thermostated at 25 oC.
Subcloning and cloning of codA
E. coli strain JM109 harboring plasmid pGAH/codA was grown on Luria-Bertani agar
medium containing kanamycin at a final concentration of 15 µg/ml for 16 h at 37 oC. Single
colonies were used to inoculate 2 ml of Luria-Bertani broth medium containing kanamycin (15
µg/ml) and the resulting liquid cultures were grown at 37 oC for 7 h. After harvesting the cells by
centrifugation at 14,000 x g for 10 min, the plasmid vector was isolated by using a QIAquick
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Spin Miniprep kit (Qiagen) following the manufacturer’s protocol. The isolated plasmid DNA
was then used for primer extension reaction of the codA gene encoding for choline oxidase by
using the oligonucleotide primers Chox-for A and Chox-rev containing NdeI and EcoR I
restriction endonuclease sites designed to anneal to the 5’ and 3’ ends of the gene, respectively
(Table 2.1). The NdeI and EcoR I restriction sites introduced at the 5’ ends of the sense and
antisense primers allowed cloning of codA into the corresponding sites of pET20b(+). Primer
extension reaction was performed in the presence of DMSO at a final concentration of 2% for 1
min at 95 oC, followed by 31 three-step cycles of 0.5 min at 95 oC, 1 min at 55 oC, 4.5 min at 68
o

C, with a final 5-min step at 68 oC, in a total volume of 50 µl by using ~15 ng of template DNA,

2.5 U of Pfu DNA polymerase, and the manufacturer’s suggested protocol. The resulting
amplicons were purified by agarose gel electrophoresis using the QIAquick Gel Extraction kit
(Qiagen) following the manufacturer’s protocol.
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Table 2.1. Oligonucleotide primers used for primer extension amplification and PCR of
codA, as well as the mutagensis for pET/codA
Primer
Nucleotide sequence
Purpose
CGGCAAGGAGAACCATATGCACATCGACAACATCTG
ChoxforA
Cloning
CCCCGGAATTCGCCGCTCCCGCTTAGG
Choxrev
Cloning
CACTATAGGGAGACCACAACG
Sequencing
PET-for a
GCTTATGCTAGTTATTGCTCAGC
PET-revA
Sequencing
CAATGAAGTCGTGCTCTCC
Choxag 3
Sequencing
CGAAGTTCAACACC
Choxag 5
Sequencing
CGATGCAGGAGTTGTGG
Choxag 7
Sequencing
Mutagensis
Cho-H466Af CAACACCGTCTACGCCCCCGTGGGCACCGTGC
Cho-H466Ar CACGGTGCCCACGGGGGCGTAGACGGTGTTGTGC
Mutagensis
Cho-H466Df CAACACCGTCTACGACCCCGTGGGCACCGTGC
Mutagensis
Mutagensis
Cho-H466Dr CACGGTGCCCACGGGGTCGTAGACGGTGTTGTGC
Cho-H310Af CGAGCACCTGCAGGACGCCCCGGAAGGCGTGG
Mutagensis
Cho-H310Ar GCACCACGCCTTCCGGGGCGTCCTGCAGGTGCTCGCC
Mutagensis
Cho-H310Df GGGCGAGCACCTGCAGGACGACCCGGAAGGCGTGGTGC
Mutagensis
Cho-H310Dr GCACCACGCCTTCCGGGTCGTCCTGCAGGTGCTCGCC
Mutagensis
Mutagensis
Cho-H310Nf GGGCGAGCACCTGCAGGACAACCCGGAAGGCGTGGTGC
GCACCACGCCTTCCGGGTTGTCCTGCAGGTGCTCGCC
Cho-H310Nr
Mutagensis
Cho-E370Af CGGCTACCCCACCACGGCGAACGGCTTCAGCC
Mutagensis
Cho-E370Ar GAGGCTGAAGCCGTTCGCCGTGGTGGGGTAGCC
Mutagensis
GCAACTCCTTCATGCGCGCTGCCCGTGCCAAGGTC
Cho-H87Af
Mutagensis
CCTTGGCACGGGCAGCGCGCATGAAGGAGTTGC
Cho-H87Ar
Mutagensis
GCAACTCCTTCATGCGCTGTGCCCGTGCCAAGGTC
Cho-H87Cf
Mutagensis
CCTTGGCACGGGCACAGCGCATGAAGGAGTTGC
Mutagensis
Cho-H87Cr
Cho-Y465Af CACAACACCGTCGCCCACCCCGTGGGCACCGTGC
Mutagensis
Mutagensis
Cho-Y465Ar CACGGTGCCCACGGGGTGGGCGACGGTGTTGTGC
CACAACACCGTCCACCACCCCGTGGGCACCGTGC
Cho-Y465Hf
Mutagensis
Cho-Y465Hr CACGGTGCCCACGGGGTGGTGGACGGTGTTGTGC
Mutagensis
Underlined nucleotides indicate endonuclease restriction sites for NdeI and EcoR I enzymes in
cloning primers and mismatches sites in mutagensis primers.
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Cloning was performed from A. globiformis strain ATCC 8010, which was grown on
Difco #3 Nutrient Agar medium for 48 h at 26 oC. Single colonies were used to inoculate eight 5
ml of Difco #3 Nutrient Broth and the resulting liquid cultures were grown overnight at 26 oC.
The cells were harvested by centrifugation at 14,000 x g for 10 min, and the genomic DNA was
isolated using the DNeasy Midi-kit (Qiagen) according to the manufacturer’s instructions. The
isolated genomic DNA was then used for PCR of the codA gene with the oligonucleotide primers
described above. PCR was carried out with an Eppendorf Mastercycler in the presence of 4%
DMSO for 1 min at 95 oC, followed by 31 cycles of 1 min at 95 oC, 1 min at 50 oC, 2 min at 72
o

C, and a final 5-min step at 72 oC in a total volume of 50 µl by using ~200 ng of template DNA,

5 U of Taq DNA polymerase, 3 mM magnesium chloride, and the polymerase manufacturer’s
suggested protocol. The resulting amplicons were purified by agarose gel electrophoresis using
the QIAquick Gel Extraction kit (Qiagen) following the manufacturer’s protocol.
Endonuclease digestion of both the amplified codA from A. globiformis and pET20b(+)
with NdeI and EcoR I, dephosphorylation of the plasmid with calf intestine alkaline phosphatase,
and ligation were carried out as described above, and 1 µl of the ligation reaction mixture was
used directly to transform by electroporation 100 µl of E. coli strain Novablue competent cells.
The resulting transformant colonies obtained by plating on Luria-Bertani agar plates containing
50 µg/ml ampicillin and 12.5 µg/ml tetracycline were screened for the presence of codA by
colony PCR. PCR was performed with 5 U of Taq DNA polymerase in the presence of 2%
DMSO for 1 min at 95 oC followed by 31 three-step cycles of 1 min at 95 oC, 2 min at 55 oC, 2
min at 72 oC, and a 5-min final step at 72 oC, using sense and antisense oligonucleotide primers
designed to bind to DNA regions of pET20b(+) flanking the inserted gene. The correct
constructs, pET/codA1 and pET/codA2, were sequenced in both directions as described above. E.
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coli strain Rosetta(DE3)pLysS competent cells were transformed with plasmid pET/codA1 for
protein expression.
Enzyme preparation
Permanent frozen stocks of E. coli cells Rosetta(DE3)pLysS harboring plasmid
pET/codA1 were used to inoculate 50 ml of Luria-Bertani broth medium containing ampicillin
(or carbenicillin) and chloramphenicol at final concentrations of 50 and 34 µg/ml, respectively,
at 37 oC. After 9 h, 1 ml of the starter culture was used to inoculate 3 x 1.5 liters of the same
liquid culture medium at 30 oC. When the culture reached an optical density at 600 nm between
0.8 and 1.4, typically after 16 h, IPTG was added to a final concentration of 50 µM and the
temperature of the culture was lowered between 21 and 25 oC. Cells were harvested by
centrifugation at 20,000 x g for 20 min at 4 oC and stored at –20 oC. Typically, ~8 g of wet cell
paste were obtained from 1.5 liters of cells culture.
Unless otherwise stated, all the purification steps were carried out at 4 oC. The cell paste,
typically 25 g, was suspended in 6 volumes of a solution of 0.1 mM PMSF, 0.2 mg/ml lysozyme,
1 mM EDTA, and 50 mM potassium phosphate at pH 7 and allowed to incubate with stirring for
30 min on ice. The resulting slurry was passed three times through an SLM Aminco French
pressure cell at 20,000 lb/in2 and then centrifuged at 20,000 x g for 20 min. The supernatant was
collected, incubated with stirring for 30 min on ice with 20 µg/ml RNase and 50 µg/ml DNase in
the presence of 10 mM magnesium chloride, and centrifuged as described above. The soluble
fraction was brought to 30% ammonium sulfate saturation, incubated for 30 min on ice, and
separated from the insoluble fraction by centrifugation as described above. Choline oxidase was
then collected in the pellet fraction by treatment with ammonium sulfate at a final saturation of
65%, followed by centrifugation as described above. The resulting pellet was suspended in 25 ml
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of 200 mM Tris-Cl, pH 8, and dialyzed against three 1-liter changes of the same buffer over 20
h. After dialysis, precipitated proteins were removed by centrifugation at 18,700 x g for 20 min
and the resulting supernatant was loaded onto a DEAE-Sepharose Fast Flow column (3 x 28 cm)
connected to an Åktaprime Amersham Pharmacia Biotech system equilibrated with 200 mM
Tris-Cl at pH 8. The column was eluted with 2 volumes of the same buffer, followed by a linear
gradient from 0 to 0.5 M NaCl developed over 5 volumes at a flow rate of 2 ml/min. The
fractions with the highest purity as judged by enzymatic activity and UV-visible absorbance
spectroscopy were pooled together and concentrated with the addition of 65% ammonium sulfate
saturation followed by centrifugation. Oxidized FAD-containing choline oxidase was prepared at
4 oC by dialysis against three 1-liter changes of 20 mM sodium phosphate, 20 mM sodium
pyrophosphate, pH 6, over 24 hours, followed by two 1-liter changes of 20-200 mM Tris-Cl, pH
8 over five hours. This enzyme could be stored at -20 oC for at least 7 months without losses in
enzymatic activity.
Site-directed mutagenesis
A QuikChange kit was used to prepare the mutant enzymes choline oxidase-H466A
(CHO-H466A), choline oxidase-H466D (CHO-H466D), choline oxidase-H310A (CHO-H310A),
choline oxidase-H310D1 (CHO-H310D), choline oxidase-H310N2 (CHO-H310N), choline
oxidase-E370A3 (CHO-E370A), choline oxidase-H87A (CHO-H87A), choline oxidase-H87C
(CHO-H87C), choline oxidase-Y465A (CHO-Y465A), and choline oxidase-Y465H (CHOY465H). The method used was essentially according to the manufacturer’s instructions, using
1

Ongoing project.
Ongoing project.
3
E370A mutant form of choline oxidase has been expressed and purified. The biochemical and the kinetic
characterization of that mutant form showed that there is no significant different between that mutant and the wildtype enzyme. Furthermore, the recently solved X-ray crystallographic structure of choline oxidase showed that this
residue is located at the surface of protein, consistent with its similarity to the wild-type enzyme.
2
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pET/codA1 plasmid (3) as a template and the corresponding forward and reverse primers (Table
3.1). DNA was sequenced at the DNA Core Facility at Georgia State University using an
Applied Biosystems Big Dye Kit on an Applied Biosystems model ABI 377 DNA sequencer.
Sequencing confirmed the presence of the mutant genes in the correct orientation. E. coli strain
Rosetta(DE3)pLysS competent cells were transformed with the mutated plasmid by
electroporation.
Expression and purification of the mutated enzymes
Permanent frozen stocks of E. coli cells Rosetta(DE3)pLysS harboring the mutated
plasmid were used to inoculate 4.5 liters of Luria-Bertani broth medium containing 50 µg/ml
ampicillin and 34 µg/ml chloramphenicol, and liquid cultures were grown overnight at 37 °C.
The cultures were induced for protein expression by adding 0.05 mM IPTG and then incubated
for an additional 5 h at 22 °C. 100 µl aliquots was taken 5 h after induction with IPTG to be used
for visualization of the expressed proteins using sodium dodecyl sulfate polyacrylamide gel
electrophoresis following the Laemmli method (4). The gel was stained with Commassie
Brilliant Blue G-250. The mutant enzymes (CHO-H466A, CHO-H466D, CHO-H310A, and
CHO-E370A) were purified to homogeneity using the same procedure used previously for the
purification of the wild-type enzyme (3).
Enzyme assays
The concentration of choline oxidase was determined with the method of Bradford (5), by
using the Bio-Rad protein assay kit with bovine serum albumin as the standard. The oxidized
flavin content of choline oxidase as purified was determined from the ∆A452 after treatment of
the enzyme with 5 mM dithionite in air-saturated 200 mM Tris-Cl, pH 8, using an ε452 value of
8.4 mM-1cm-1, which corresponds to the difference between the extinction coefficients for the
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enzyme-bound oxidized flavin (ε452 = 8.4 mM-1cm-1) and semiquinone flavin (ε452 = 3 mM-1cm-1)
(6). Enzyme activity was measured with the method of the initial rates (7) in air-saturated 50 mM
potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a computerinterfaced Oxy-32 oxygen-monitoring system (Hansatech Instrument Ltd.) thermostated at 25
o

C. The reactions were started by the addition of choline oxidase to a 1 ml reaction mixture, with

the final concentration of enzyme in the 0.1 to 0.5 µM range; the concentration of choline or
betaine aldehyde was between 0.02 and 35 mM. The effect of pH on the kinetic parameters of
CHO-H466A were determined over a pH range from 5.5 to 11 by a series of enzyme activity
assays at varying choline concentrations ranging from 0.025 to 45 mM in air-saturated 50 mM
sodium pyrophosphate at 25 °C. The kinetic isotope effects of CHO-H466A were obtained by
determining the kinetic parameters of the enzyme using either choline or 1,2-[2H4]-choline as
substrate in either aqueous or deuterated solvent, in air-saturated 50 mM sodium pyrophosphate
at 25 °C and pL 10. For the determinations of solvent isotope effects, buffers were prepared
using 99.9% deuterium oxide by adjusting the pD value with NaOD. The pD values were
determined by adding 0.4 to the pH electrode readings (8). For all steady state kinetic isotope
effects, activity assays were carried out by alternating substrate or solvent isoptomers. Product
inhibition studies were carried out by varying the concentrations of both glycine betaine, in the
range between zero and 60 mM, and choline, in the range between 0.02 and 20 mM, in airsaturated 50 mM sodium pyrophosphate at 25 °C, over a pH range from 7 to 11. The effect of
imidazole on the turnover number of CHO-H466A was determined by measuring the enzymatic
activity with 10 mM choline as substrate for the enzyme in the presence of varying
concentrations of imidazole in the range from 0 to 250 mM in air-saturated 50 mM potassium
phosphate, pH 7, or 50 mM sodium pyrophosphate for other pH values.
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Spectral studies
The UV-visible absorbance and fluorescence emission or excitation spectra of CHOH466D, CHO-WT and CHO-H466A, were acquired in 20 mM sodium phosphate, 20 mM
sodium pyrophosphate and 10% glycerol, pH 64 at 15 °C. The UV-visible absorbance spectra of
the reduced form of enzymes were acquired using an anaerobic cuvette in 50 mM sodium
phosphate, 50 mM sodium pyrophosphate and 10% glycerol, pH 6 at 15 °C. The cuvette
contained one ml final volume of enzyme at a final concentration between 20 and 30 µM, 300
µM xanthine, and 10 µM methyl viologen. A sidearm attached to the cuvette contained xanthine
oxidase at a final concentration of ~0.5 µM. The cuvette and contents were made anaerobic by at
least 15 cycles of alternate degassing under vacuum and flushing with O2-free argon. The
enzyme solution was then mixed with xanthine oxidase in the side arm, and the reduction of the
enzyme-bound flavin was monitored spectrophotometrically. The extinction coefficient of the
wild-type or mutant forms of choline oxidase were determined in Tris-Cl, pH 8, after
denaturation of the enzymes either by incubation at 40 °C for one hour in the presence of urea at
a final concentration of 4 M or 0.1% SDS at 100 °C for 5 min, based upon the ε450 value of 11.3
mM-1 cm-1 for free FAD (9). The spectral properties of CHO-WT and CHO-H466A before and
after the addition of 200 mM of glycine betaine were determined at 15 °C in 100 mM sodium
pyrophosphate buffer, pH 6.5. All spectra were normalized to the molar extinction of the
uncomplexed enzyme and corrected for dilution. For reactions with sodium sulfite, the reagent
was prepared freshly as 1 M stock solution in 100 mM sodium pyrophosphate, pH 6.5. Different
amounts of sodium sulfite at final concentrations ranging from 25 to 100 mM were added to the
4

The spectral properties of the oxidized forms of CHO-WT, CHO-H466A, and CHO-H466D, were compared at pH
6 to avoid artifactual contributions on the UV-visible absorbance spectra due to pH, since the three enzyme variants
showed pH effects on the UV-visible absorbance spectra of the oxidized enzymes with pKa ≥ 8.2.
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enzyme solution in 100 mM sodium pyrophosphate, pH 6.5, at 15 °C, and the UV-visible
absorbance spectra were recorded at different times. The pH dependences of the UV-visible
absorbance spectra of oxidized enzymes were determined in 20 mM sodium phosphate, 20 mM
sodium pyrophosphate, 10% glycerol, at 15 °C, by titrating sodium hydroxide into the enzyme
solution at pH 6. The pH dependences of the UV-visible absorbance spectra of the reduced
enzymes were determined in an all-glass spectrophotometer custom made anaerobic cuvette
(Lillie Glassblowers, Smyrna, GA) that was fitted with a pH micro-electrode through a glass
joint and an anaerobic syringe containing sodium hydroxide. The cuvette contained 3 ml of
enzyme at a final concentration between 20 and 30 µM in 50 mM sodium phosphate, 50 mM
sodium pyrophosphate, and 10 % glycerol, pH 6. A sidearm attached to the cuvette was loaded
with choline at a final concentration of 150 mM. The cuvette and contents were made anaerobic
by at least 15 cycles of alternate degassing under vacuum and flushing with O2-free argon. The
enzyme solution was then mixed with choline in the side arm in order to reduce the enzymebound flavin. With CHO-H466D, which could not be reduced anaerobically with choline, a
syringe filled with anaerobic ~2 mM dithionite was inserted firstly into the cuvette under positive
argon

pressure,

and

the

reduction

of

the

enzyme-bound

flavin

was

monitored

spectrophotometrically until completion. In all the cases, once the UV-visible absorbance
spectrum of the hydroquinone species was observed, a pH micro-electrode and a syringe
containing anaerobic 3 M sodium hydroxide were mounted onto the anaerobic cuvette under
positive argon pressure. The pH of the anaerobic enzyme solution was then changed stepwise by
addition of the base, and both the pH and the UV-visible absorbance spectra were recorded after
each step.

130
The CD spectra of CHO-WT and mutant enzymes were recorded at 5 °C in 20 mM TrisCl, pH 8, at concentrations of enzyme of 5 and 15 µM for the far and the near UV, respectively.
The fluorescence emission spectra of CHO-WT and mutant enzymes were acquired in 20 mM
sodium phosphate, 20 mM sodium pyrophosphate and 10% glycerol, pH 6 at 15 °C.
For the quantitation of the ratio of the covalently to the uncovalently bound flavin to the
enzymes, ~ 20 µM of enzymes were incubated on ice for 30 min after the addition of 10 %
trichloroacetate, followed by removal of precipitated protein by centrifugation, and the
determination of the concentration of FAD in both the supernatant and the dissolved pellet in 4
M urea solution using an ε450

nm

value of 12 mM-1 cm-1. The nature of the flavin cofactor of

CHO-H466D was also verified through MALDI-TOF mass spectrometry in both the positive and
negative ion mode using a 50:50 methanol/acetonitrile matrix.
Potentiometric titrations
Potentiometric redox titrations were carried out to either the unliganded (CHO-WT,
CHO-H466A and CHO-H466D) or the glycine betaine-liganded enzymes (CHO-WT and CHOH466A) at 15 °C in a cell similar to the one described by Edmondson (1985). Potentials were
measured by using a Pt electrode relative to an Ag/AgCl double junction reference electrode with
an Orion Model 701A pH/mV meter (10). The reference electrode was calibrated prior to each
titration as described by Edmondson (10), using a deoxygenated, saturated quinhydrone solution
in 0.09 M KCl and 0.01 M HCl at 25 °C. In a typical titration, 2.5 ml of ~20-30 µM of either free
or glycine betaine-liganded choline oxidase (at a final concentration of 1.5 M) in 20 mM Tris-Cl,
pH 7, was scrubbed free of oxygen by at least 15 cycles of alternate degassing under vacuum and
flushing with O2-free argon. The following redox mediators were added to ensure complete
redox equilibration: 2 µM methyl viologen (-440 mV), 0.5 µM dichlorophenolindophenol (+217
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mV), 0.5 µM phenazine methosulfate (+80mV), 0.5 µM thionin (+60 mV), 0.5 µM duroquinone
(-5 to +5 mV), 0.5 µM resorufin (-50 mV), and 0.5 µM indigo carmine (-125 mV) (11, 12). The
ligand-bound enzyme solutions were titrated electrochemically as described by Dutton (13),
using freshly prepared sodium dithionite as reductant and potassium ferricyanide as oxidant in 20
mM Tris-Cl, pH 7 (13). Adequate time was permitted for electronic equilibration after each
addition of sodium dithionite or potassium ferricyanide prior to the spectrum being recorded;
equilibrium of the system was considered to be obtained when the measured potential drift was
less than 1 mV in 5 min, which was typically achieved after 30 to 60 min. UV-visible absorbance
spectra were recorded using an Agilent Technologies diode-array spectrophotometer model HP
8453 equipped with a thermostated cell holder and a magnetic stirrer beneath the cell holder. All
spectra were corrected for any drift in the baseline by subtracting the absorbance at 800 nm.
Steady state kinetics
Enzyme activity was measured polarographically by monitoring the rate of oxygen
consumption with a Hansatech oxygen electrode thermostated at 25 oC. The determination of the
steady state kinetic parameters was carried at varying concentrations of both choline (or betaine
aldehyde), in the range from 0.02 to 35 mM, and oxygen, in the range from 0.04 to 1.1 mM. The
reaction mixture was first equilibrated at the desired concentration of oxygen by bubbling the
appropriate O2/N2 gas mixture for at least 10 min. The reactions were then started by adding 5-25
µl choline oxidase at a final concentration of ~0.1-0.5 µM into a reaction mixture with a final
volume of 0.5-1 ml. Enzyme assays were conducted in 50 mM sodium pyrophosphate, except for
pH 7 and 7.5 where potassium phosphate was used. One unit of enzymatic activity corresponds
to the consumption of one µmol of oxygen per min.
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Rapid kinetics
Rapid kinetics was carried out on a Hi-Tech SF-61 stopped-flow spectrophotometer
thermostated at 25 oC. The rate of flavin reduction was measured by monitoring the decrease in
absorbance at 452 nm that results from the decreasing of oxidized flavin species upon mixing the
enzyme with the substrate. The enzyme solution was loaded into a tonometer and subjected to a
23-cycle degassing procedure by alternately applying vacuum and flushing with oxygen-free
argon (pre-treated with an oxygen scrubbing cartridge, Agilent, Palo Alto, CA). Subsequently,
the degassed enzyme solution was mounted onto the stopped-flow instrument, which had been
subjected to an overnight treatment with an oxygen scrubbing system composed of 100 mM
glucose and 30 units ml-1 glucose oxidase. The organic substrate (~2 ml), was dissolved in
desired buffer in H2O and then degassed by flushing oxygen-free argon for at least 15 min before
mounting onto the stopped-flow. The enzyme was mixed anaerobically with an equal volume of
substrate, yielding a reaction mixture containing ~15 - 40 µM choline oxidase and 0.05 to 10
mM choline.
Data analysis
Data were fit with KaleidaGraph software (Synergy Software, Reading, PA) and Enzfitter
software (Biosoft, Cambridge, UK). The steady state kinetic parameters for choline oxidase at
atmospheric oxygen were determined by fitting the data to the Michaelis-Menten equation for
one substrate (eq 1), where ka represents the Michaelis-Menten constant for choline (or betaine
aldehyde) (A) and kcat is the turnover number of the enzyme (e). The steady state kinetic
parameters at varying concentrations of both choline and oxygen were determined by fitting the
initial rate data to eqs 2 and 3, which describe ternary complex mechanisms with reversible and
irreversible catalytic steps, respectively. Data with betaine aldehyde were fit into eq 4, which
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describes a ternary complex mechanism with negligible Ka value. In these equations, e represents
the concentration of enzyme, kcat is the turnover number of the enzyme at infinite substrates
concentrations, Ka and Kb represent the Michaelis constants for the organic substrate (A) and
oxygen (B), respectively. For the kinetic isotope effects of wild-type choline oxidase with
choline as substrate, data obtained were divided into two sets, one with unlabeled substrate or
solvent, and one with isotopically labeled substrate or solvent. The steady state kinetic
parameters of the two sets were determined independently with eq 2 or 3, and the kinetic isotope
effects were determined by taking the ratios of the steady state kinetic parameters of interest. For
CHO-H466A, under atmospheric oxygen conditions at 25 oC (i.e., with a concentration of
dissolved oxygen of 0.25 mM), due to the low Km value for oxygen with a value of 5 ± 2 µM at
pH 10 (Ghanem, M., and Gadda, G.; unpublished data), CHO-H466A is > 97% saturated with
oxygen. Therefore, with CHO-H466A the true kinetic isotope effect could be determined from
the Dkcat/Km value under atmospheric conditions.

v
k A
= cat
e Ka + A

(1)

v
kcatAB
=
e KaB + KbA + AB + KiaKb

(2)

v
kcatAB
=
e KaB + KbA + AB

(3)

v
kcatAB
=
e KbA + AB + KiaKb

(4)

The pH dependencies of steady-state kinetic parameters were determined by fitting initial
rate data to eq 5, which describes a curve with a slope of +1 and a plateau region at high pH. The
pH dependence of inhibition by glycine betaine was determined by fitting the initial rate data to
eq 6, which describes a curve with a slope of -1 and a plateau region at low pH. C is the pH-
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independent value of the kinetic parameter of interest. Data of the pH dependencies of the
absorbance spectra for both the oxidized wild-type and mutant enzymes were fit to eq 7, which
describes a curve with a slope of -1 and plateau regions at low and high pH, where A and B
represent the absorbance values at 500 nm at low and high pH, respectively.
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Product inhibition studies were performed by varying the concentrations of both glycine
betaine and choline at a fixed concentration of oxygen. The data were fit to eqs 8 to 10, which
describe competitive, uncompetitive, and noncompetitive inhibition patterns of the product and
the organic substrate, respectively. P is the concentration of glycine betaine, Kis and Kii are the
inhibition constants for the slope and intercept term, respectively.

v
=
e

v
=
e

k cat A
⎡ ⎛ P
K a ⎢1 + ⎜⎜
⎣ ⎝ K is

⎞⎤
⎟⎟⎥ + A
⎠⎦

k cat A
⎡ ⎛ P
K a + A⎢1 + ⎜⎜
⎣ ⎝ K ii

⎞⎤
⎟⎟⎥
⎠⎦

(8)

(9)

135
v
=
e

k cat A
⎡ ⎛ P
⎡ ⎛ P ⎞⎤
⎟⎟⎥ + A⎢1 + ⎜⎜
K a ⎢1 + ⎜⎜
⎣ ⎝ K ii
⎣ ⎝ K is ⎠⎦

⎞⎤
⎟⎟⎥
⎠⎦

(10)

Data of the spectrophotometric titrations for complex formation between choline oxidase
and various ligands were fit to eq 11, where Y and A are the observed and maximal absorbance
changes at the selected wavelength, respectively, X is the concentration of the varied ligand, and
K is the complex dissociation constant. Data of the pH dependencies of the absorbance spectra of
the oxidized CHO-H466D were fit to eq 2, which describes a curve with a slope of +1 and
plateau regions at low and high pH, where A and B represent the absorbance values at 500 nm at
low and high pH, respectively. The midpoint reduction-oxidation potentials of the enzymes were
determined by fitting the data to eq 13, where Eh is the observed electrode potential at
equilibrium at each point in the titration, E′m is the midpoint reduction-oxidation potential, R is
the gas constant, with a value of 8.31 J mol-1 K-1 at 15 °C, T is the temperature in Kelvin, n is the
number of electrons transferred, and F is Faraday’s constant, with a value of 96.48 kJ V-1 mol-1.
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CHAPTER III

Cloning, Sequence Analysis, and Purification of Choline Oxidase From Arthrobacter
globiformis: a Bacterial Enzyme Involved in Osmotic Stress Tolerance

(This chapter has been published verbatim in Ghanem, M., Fan, F., and Gadda, G., (2004), Arch.
Biochem. Biophys. 142, 149-58. © 2003 Elsevier Inc. All rights reserved. The first two authors
share equal contribution to the publication. The sequence reported in this paper has been
deposited in the GenBank database with accession no. AY304485. In particular, my contribution
to this study pertains the cloning and sequencing the codA gene from the bacterial genome,
expression and purification of the recombinant enzyme, and the preliminary biophysical and
spectroscopic characterization of the recombinant enzyme).

Abstract

Choline oxidase catalyzes the four-electron oxidation of choline to glycine betaine, one of a
limited number of compounds that accumulate to high levels in the cytoplasm of cells to prevent
dehydration and plasmolysis in adverse hyperosmotic environments. In the present study, the
highly GC rich codA gene encoding for choline oxidase was cloned from genomic DNA of
Arthrobacter globiformis strain ATCC 8010 and expressed to high yields in Escherichia coli
strain Rosetta(DE3)pLysS. The resulting enzyme was purified to high levels in a single
chromatoghraphic step using DEAE-Sepharose, as shown by SDS-PAGE analysis. Denaturation
and mass spectroscopic analyses showed that the covalent linkage between the FAD cofactor and
the protein is preserved in recombinant choline oxidase, consistent with protein flavinylation
being a self-catalytic process. The enzyme was shown to be a homodimer of 120,000 Da by sizeexclusion chromatography and to be active with both choline and betaine aldehyde as substrate.
Sequencing analysis indicated that the nucleotide sequence of codA originally reported in
GenBank contains seven flaws, resulting in a translated protein with a significantly altered amino
acid sequence between position 298 and 410.
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Introduction

Choline oxidase (E.C. 1.1.3.17) catalyzes the four-electron oxidation of choline to
glycine betaine (N,N,N-trymethylglycine; betaine) via betaine aldehyde as intermediate.
Molecular oxygen acts as primary electron acceptor in the reaction (Scheme 3.1) (1). The
enzyme is of importance because glycine betaine is one of a limited number of compatible
solutes that accumulate to high levels in the cytoplasm of cells to prevent dehydration and
plasmolysis in adverse hyperosmotic environments (2-6). Regulation of intracellular osmolality
to hyperosmotic environments is also intimately connected to a number of physiological
responses, such as increased heat and cold tolerance, as well as regulation of the internal pH and
ionic strength (7-12). Hyperosmolarity is often encountered at human infection sites (13), where
choline and its precursors are very abundant (14-16), and is a major environmental signal
controlling the expression of genes associated with cellular invasion and virulence in a number
of human pathogens (17-24). For these reasons, the study of choline oxidase is of considerable
interest both for genetically engineering water and osmotic stress resistance in economically
relevant crop plants lacking efficient glycine betaine biosynthetic systems (10, 11, 25-29), and
for the potential development of therapeutic agents that inhibit the biosynthesis of glycine
betaine thereby making bacteria more susceptible to conventional treatments.
Choline oxidase has been purified from Cylindrocarpon didymum M-1 (30), Alcaligenes
sp. (31), and Arthrobacter globiformis (1). Based on amino acid sequence comparisons, the
enzyme can be grouped in the GMC oxidoreductase enzyme superfamily (32), which comprises
enzymes like glucose oxidase, cholesterol oxidase, or cellobiose dehydrogenase, that utilize FAD
as cofactor for catalysis and nonactivated primary alcohols as substrate. Despite a wealth of
studies on the biotechnological applications of the enzyme, minimal biochemical and
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mechanistic investigations of choline oxidase have been reported to date. In this respect, our
group has recently reported the analyses of the steady state kinetic mechanism and of the pH and
deuterium kinetic isotope effects on the oxidation of choline to betaine aldehyde catalyzed by
choline oxidase from A. globiformis (33, 34). One of the most critical impediments to future
studies is the obtainment of large quantities of choline oxidase for detailed biophysical,
mechanistic, and structural investigations. In the present study, we have cloned from A.
globiformis genomic DNA the codA gene encoding for choline oxidase and heterogously
expressed it in Escherichia coli. The resulting recombinant enzyme has been purified to
homogeneity in a single chromatographic step and characterized for its flavin content, catalytic
activity, and oligomerization state.

Scheme 3.1. Reaction catalyzed by choline oxidase.
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Materials and Methods
Materials. E. coli strain JM109 harboring plasmid pGAH/codA was a kind gift from Dr.

Murata, National Institute for Basic Biology, Okazaki, Japan (27, 28). A freeze-dried culture of
A. globiformis (ATCC 8010) was obtained from American Type Culture Collection. Restriction
endonucleases NdeI and EcoR I, calf intestinal alkaline phosphatase, T4 DNA ligase, Taq DNA
polymerase, deoxynucleotide triphosphates, and bovine serum albumin were purchased from
Promega. Pfu DNA polymerase was obtained from Stratagene or Roche Molecular Biomedicals.
Luria-Bertani agar, Luria-Bertani broth, chloramphenicol, tetracycline, kanamycin, isopropyl-βD-thiogalactopyranoside (IPTG), lysozyme, phenylmethylsulfonyl fluoride (PMSF), and betaine
aldehyde bromide were obtained from Sigma-Aldrich. Carbenicillin, ampicillin, choline chloride,
and electrophoresis-grade agar were purchased from ICN Biomedicals. Nutrient Broth and
Nutrient Agar #3 were from Difco. All other reagents were of the highest purity commercially
available. Oligonucleotides were custom synthesized on a Beckman Oligo model 1000 M by the
DNA Core Facility of the Biology Department of Georgia State University. A. globiformis
genomic DNA was purified using the DNeasy midi-kit from Qiagen. Plasmids and products
deriving from primer extension reaction and PCR were purified by using mini-kits from Qiagen.
E. coli strains Novablue (Novagen) and XL1-Blue (Stratagene) were used during cloning
procedures, whereas strain Rosetta(DE3)pLysS (Novagen) was used for protein expression. E.
coli strain Novablue cells harboring plasmid pET/codA1 or pET/codA2, strain XL1-Blue cells
harboring plasmid pET/codA3, and strain Rosetta(DE3)pLysS cells harboring plasmid
pET/codA1 or pET/codA3 were stored at –80 oC as 7% DMSO suspensions. DNA sequencing
was carried out with an Applied Biosystems Big Dye kit on an Applied Biosystems model ABI
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377 DNA sequencer by the DNA Core Facility of the Biology Department of Georgia State
University.
Sub-Cloning of codA into the Expression Vector pET20b(+). E. coli strain JM109

harboring plasmid pGAH/codA was grown on Luria-Bertani agar medium containing kanamycin
at a final concentration of 15 µg/ml for 16 h at 37 oC. Single colonies were used to inoculate 2 ml
of Luria-Bertani broth medium containing kanamycin (15 µg/ml) and the resulting liquid
cultures were grown at 37 oC for 7 h. After harvesting the cells by centrifugation at 14,000 x g
for 10 min, the plasmid vector was isolated by using a QIAquick Spin Miniprep kit (Qiagen)
following the manufacturer’s protocol. The isolated plasmid DNA was then used for primer
extension reaction of the codA gene encoding for choline oxidase by using the oligonucleotide
primers Chox-for A and Chox-rev containing NdeI and EcoR I restriction endonuclease sites
designed to anneal to the 5’ and 3’ ends of the gene, respectively (Table 3.1). The NdeI and
EcoR I restriction sites introduced at the 5’ ends of the sense and antisense primers allowed
cloning of codA into the corresponding sites of pET20b(+). Primer extension reaction was
performed in the presence of DMSO at a final concentration of 2% for 1 min at 95 oC, followed
by 31 three-step cycles of 0.5 min at 95 oC, 1 min at 55 oC, 4.5 min at 68 oC, with a final 5-min
step at 68 oC, in a total volume of 50 µl by using ~15 ng of template DNA, 2.5 U of Pfu DNA
polymerase, and the manufacturer’s suggested protocol. The resulting amplicons were purified
by agarose gel electrophoresis using the QIAquick Gel Extraction kit (Qiagen) following the
manufacturer’s protocol.
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Table 3.1. Oligonucleotide Primers Used for Primer Extension Amplification and PCR of codA.
Primer
Nucleotide sequence
Purpose
Chox-for A CGGCAAGGAGAACCATATGCACATCGACAACATCTG
Cloning
Chox-rev
CCCCGGAATTCGCCGCTCCCGCTTAGG
Cloning
PET-for A
CACTATAGGGAGACCACAACG
Sequencing
PET-rev A
GCTTATGCTAGTTATTGCTCAGC
Sequencing
Choxag 3
CAATGAAGTCGTGCTCTCC
Sequencing
Choxag 5
CGAAGTTCAACACC
Sequencing
Choxag 7
CGATGCAGGAGTTGTGG
Sequencing
Endonuclease restriction sites for NdeI and EcoR I enzymes are underline.

The pET20b(+) plasmid vector was isolated from an E. coli strain XL1-Blue grown for
16 h at 37 oC in 4 ml of Luria-Bertani broth containing ampicillin at a final concentration of 50
µg/ml by using the QIAprep Spin Miniprep kit from Qiagen, following the manufacturer’s
instructions.
Both the amplified codA and pET20b(+) vector were digested for 3 h at 37 oC with 30 U
of NdeI and 36 U of EcoR I in a total volume of 60 µl of 10 mg/ml bovine serum albumin, 0.15
mM sodium chloride, 6 mM magnesium chloride, 1 mM dithiothreitol, and 6 mM Tris-Cl at pH
7.9, followed by purification of the DNA by agarose gel electrophoresis using the QIAquick Gel
Extraction kit. To ensure minimal self-ligation of the plasmid, pET20b(+) was further treated
with 3 U of calf intestine alkaline phosphatase for 3 h at 37 oC, followed by purification of the
DNA by gel electrophoresis extraction. The codA gene (160 ng) was then ligated into the
pET20b(+) (120 ng) plasmid in the presence of 2% DMSO by incubation for 16 h at 4 oC with 3
U of T4 DNA ligase in a total volume of 60 µl, and 5 µl of the ligation reaction mixture were
used to transform directly 100 µl of E. coli strain XL1-Blue competent cells by using the
electroporation method. The resulting transformant colonies obtained by plating on Luria-Bertani
agar plates containing ampicillin (or carbenicillin) at a final concentration of 50 µg/ml were
screened for the presence of codA by colony primer extension amplification with 2.5 U of Pfu
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DNA polymerase in the presence of 2% DMSO using the protocol described above. Sense and
antisense oligonucleotide primers designed to bind to the DNA regions of pET flanking the
inserted gene were used in the screening (Table 3.1). The correct construct, pET/codA3, was
sequenced in both directions by using the oligonucleotide primers shown in Table 3.1, and E.
coli strain Rosetta(DE3)pLysS competent cells were then transformed with plasmid pET/codA3
following the procedures described above.
Cloning of codA from A. globiformis Genome into the Expression Vector pET20b(+).

A. globiformis strain ATCC 8010 was grown on Difco #3 Nutrient Agar medium for 48 h at 26
o

C. Single colonies were used to inoculate eight 5 ml of Difco #3 Nutrient Broth and the

resulting liquid cultures were grown overnight at 26 oC. The cells were harvested by
centrifugation at 14,000 x g for 10 min, and the genomic DNA was isolated using the DNeasy
Midi-kit (Qiagen) according to the manufacturer’s instructions. The isolated genomic DNA was
then used for PCR of the codA gene with the oligonucleotide primers described above. PCR was
carried out with an Eppendorf Mastercycler in the presence of 4% DMSO for 1 min at 95 oC,
followed by 31 cycles of 1 min at 95 oC, 1 min at 50 oC, 2 min at 72 oC, and a final 5-min step at
72 oC in a total volume of 50 µl by using ~200 ng of template DNA, 5 U of Taq DNA
polymerase, 3 mM magnesium chloride, and the polymerase manufacturer’s suggested protocol.
The resulting amplicons were purified by agarose gel electrophoresis using the QIAquick Gel
Extraction kit (Qiagen) following the manufacturer’s protocol.
Endonuclease digestion of both the amplified codA and pET20b(+) with NdeI and EcoR
I, dephosphorylation of the plasmid with calf intestine alkaline phosphatase, and ligation were
carried out as described above, and 1 µl of the ligation reaction mixture was used directly to
transform by electroporation 100 µl of E. coli strain Novablue competent cells. The resulting

145
transformant colonies obtained by plating on Luria-Bertani agar plates containing 50 µg/ml
ampicillin and 12.5 µg/ml tetracycline were screened for the presence of codA by colony PCR.
PCR was performed with 5 U of Taq DNA polymerase in the presence of 2% DMSO for 1 min
at 95 oC followed by 31 three-step cycles of 1 min at 95 oC, 2 min at 55 oC, 2 min at 72 oC, and a
5-min final step at 72 oC, using sense and antisense oligonucleotide primers designed to bind to
DNA regions of pET20b(+) flanking the inserted gene. The correct constructs, pET/codA1 and
pET/codA2, were sequenced in both directions as described above. E. coli strain
Rosetta(DE3)pLysS competent cells were transformed with plasmid pET/codA1 for protein
expression.
Expression of Choline Oxidase in E. coli. Permanent frozen stocks of E. coli cells

Rosetta(DE3)pLysS harboring plasmid pET/codA1 were used to inoculate 50 ml of Luria-Bertani
broth medium containing ampicillin (or carbenicillin) and chloramphenicol at final
concentrations of 50 and 34 µg/ml, respectively, at 37 oC. After 9 h, 1 ml of the starter culture
was used to inoculate 3 x 1.5 liters of the same liquid culture medium at 30 oC. When the culture
reached an optical density at 600 nm between 0.8 and 1.4, typically after 16 h, IPTG was added
to a final concentration of 50 µM and the temperature of the culture was lowered between 21 and
25 oC. Cells were harvested by centrifugation at 20,000 x g for 20 min at 4 oC and stored at –20
o

C. Typically, ~8 g of wet cell paste were obtained from 1.5 liters of cells culture.
Purification of Recombinant Choline Oxidase. Unless otherwise stated, all the

purification steps were carried out at 4 oC. The cell paste, typically 25 g, was suspended in 6
volumes of a solution of 0.1 mM PMSF, 0.2 mg/ml lysozyme, 1 mM EDTA, and 50 mM
potassium phosphate at pH 7 and allowed to incubate with stirring for 30 min on ice. The
resulting slurry was passed three times through an SLM Aminco French pressure cell at 20,000

146
lb/in2 and then centrifuged at 20,000 x g for 20 min. The supernatant was collected, incubated
with stirring for 30 min on ice with 20 µg/ml RNase and 50 µg/ml DNase in the presence of 10
mM magnesium chloride, and centrifuged as described above. The soluble fraction was brought
to 30% ammonium sulfate saturation, incubated for 30 min on ice, and separated from the
insoluble fraction by centrifugation as described above. Choline oxidase was then collected in
the pellet fraction by treatment with ammonium sulfate at a final saturation of 65%, followed by
centrifugation as described above. The resulting pellet was suspended in 25 ml of 200 mM TrisCl, pH 8, and dialyzed against three 1-liter changes of the same buffer over 20 h. After dialysis,
precipitated proteins were removed by centrifugation at 18,700 x g for 20 min and the resulting
supernatant was loaded onto a DEAE-Sepharose Fast Flow column (3 x 28 cm) connected to an
Åktaprime Amersham Pharmacia Biotech system equilibrated with 200 mM Tris-Cl at pH 8. The
column was eluted with 2 volumes of the same buffer, followed by a linear gradient from 0 to 0.5
M NaCl developed over 5 volumes at a flow rate of 2 ml/min. The fractions with the highest
purity as judged by enzymatic activity and UV-visible absorbance spectroscopy were pooled
together and concentrated with the addition of 65% ammonium sulfate saturation followed by
centrifugation. The resulting pellet was resuspended in 10 ml of 200 mM Tris-Cl, pH 8, and
dialyzed against three 250-ml changes of the same buffer over 20 h. After removal of the
precipitated protein by centrifugation, the enzyme stored at –20 oC was stable for at least six
months.
Enzyme Assays. The concentration of choline oxidase was determined with the method

of Bradford (35), by using the Bio-Rad protein assay kit with bovine serum albumin as the
standard. The oxidized flavin content per enzyme active site was determined as described in (36).
Enzyme activity was measured with the method of the initial rates (37) in air-saturated 50 mM
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potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a computerinterfaced Oxy-32 oxygen-monitoring system (Hansatech Instrument Ltd.) thermostated at 25
o

C. The reactions were started by the addition of choline oxidase to a 1 ml reaction mixture, with

the final concentration of enzyme in the 0.1 to 0.5 µM range; the concentration of choline or
betaine aldehyde was between 0.02 and 10 mM. UV-Visible absorbance spectra were recorded
using an Agilent Technologies diode-array spectrophotometer Model HP 8453 equipped with a
thermostated water bath. Fluorescence emission spectra were recorded with a Shimadzu
Spectrofluorometer Model RF-5301 PC thermostated at 15 oC.
Methods. The molecular mass of the enzyme was determined by MALDI-TOF mass

spectrometry on a Micromass TofSpec 2E at the Mass Spectrometry Laboratory of the Georgia
Institute of Technology, Atlanta. Samples were prepared for MALDI-TOF analysis by gel
filtration using a Sephadex G-25 column (PD-10, Amersham Pharmacia Biotech) equilibrated
with 5 mM Tris-Cl, pH 8. MALDI-TOF spectra were acquired in the positive ion mode using
sinapinic acid as the matrix, with an acceleration voltage of -20 kV and a pulse voltage of -16
kV. Cytochrome c [12,400], myoglobin [17,000], trypsinogen [24,000], and bovine serum
albumin [66,000] were used as standards for mass calibration. The molecular weight of the
enzyme under non-denaturing conditions was determined by size exclusion chromatography
through a Sephacryl S-400 column (1 x 50 cm) connected to an Åktaprime Amersham Pharmacia
Biotech system equilibrated with 300 mM KCl in 20 mM potassium phosphate, pH 7, at a flow
rate of 0.5 ml/min. The following proteins were used as standards: horse heart cytochrome c
[12,400], bovine serum albumin [66,000], yeast alcohol dehydrogenase [150,000], sweet potato
-amylase [200,000], and horse spleen apoferritin [443,000]. SDS-PAGE according to the
method of Laemmli (38) and PAGE under non-denaturing conditions were performed in 12%
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polyacrylamide slab gels, with visualization of the proteins by staining with Coomassie brilliant
blue G-250.
For denaturation experiments, choline oxidase was incubated at 40 oC for 1 h in the
presence of urea at a final concentration of 4 M in 100 mM Tris-Cl, pH 8, before recording the
UV-visible absorbance spectrum. The flavin content per monomer of enzyme was calculated
from the ratio of the concentration of flavin in the denatured enzyme using an ε450 nm value of
11.3 mM-1cm-1 (39) to the concentration of protein determined using the Bradford assay (35). To
establish whether the flavin is covalently bound to recombinant choline oxidase, the enzyme was
incubated with trichloroacetic acid at a final concentration of 10% for 5 min at 100 oC, followed
by removal of denatured protein by centrifugation at 14,000 x g for 10 min before measuring the
UV-visible absorbance spectrum of the resulting supernatant.
Data Analysis. Kinetic data were fit with the KaleidaGraph software (Adalbeck

Software, Reading, PA). Apparent kinetic parameters in atmospheric oxygen were determined by
fitting initial reaction rates at different substrate concentrations to the Michaelis-Menten equation
(eq. 1), where Ka represents the Michaelis constant for choline (or betaine aldehyde) (A) and kcat
is the turnover number of the enzyme (e).
v
k A
= cat
e Ka + A

(1)
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Results
Cloning of codA. The codA gene from A. globiformis encoding for choline oxidase was

previously cloned in the binary vector plasmid pGAH for in vivo experiments aimed at
conferring tolerance to salt stress in cyanobacteria and plants (10, 11, 25-28, 40, 41). In this
study, codA was amplified from pGAH/codA by primer extension reaction by using Pfu DNA
polymerase in the presence of 2% DMSO. Addition of DMSO was required to ensure complete
denaturation of the highly GC rich DNA template in the primer extension reaction. Directional
cloning of codA into pET20b(+) to construct plasmid pET/codA3 was achieved by inserting NdeI
and EcoR I endonuclease restriction sites at the 5' and 3' terminal ends of the gene, respectively.
Plasmid pET/codA3 was then used to transform E. coli competent cells strain XL1-Blue.
Successful construction of plasmid pET/codA3 was confirmed by nucleotide sequence analysis.
However, seven differences were found in the nucleotide sequence of codA with respect to the
sequence of the gene deposited in GenBank (accession no. X84895). Of the observed
discrepancies, three accounted for missing nucleotides at position 891, 1117, and 1232, resulting
in a translated sequence of 113 amino acid residues in the central portion of the protein being
different from the published sequence (GenBank accession no. S52489). Surprisingly, no internal
stop codons were created by the three single-point deletions, resulting in a translated protein of
546 amino acid residues. Two other differences were observed at position 764 and 1496, which
resulted in the substitution of an arginine with a histidine residue and of a glycine with an alanine
residue, respectively. Finally, two silent nucleotide substitutions that resulted in no change at the
amino acid level were observed at position 832 and 846. The nucleotide sequence of codA was
found to contain the same seven discrepancies when the gene was sequenced directly from
pGAH/codA, suggesting that the differences did not originate in the sub-cloning procedure.

150
To further verify that the nucleotide differences were not introduced in the sub-cloning
process from pGAH/codA, genomic DNA from A. globiformis strain ATCC 8010 was used as
template to amplify the codA gene by using PCR with Taq DNA polymerase. The rationale for
this strategy was that possible misincorporations of nucleotides occurring in the gene
amplification procedure most likely would occur at different positions in the nucleotide sequence
of the gene by using different DNA template, DNA polymerase, and PCR protocol. As a further
control, codA was cloned from genomic DNA in two independent experiments to produce the
constructs pET/codA1 and pET/codA2. The nucleotide sequence of the codA gene cloned from
genomic DNA was the same as that determined using pGAH/codA.
Heterologous Expression of codA in E. coli. Heterologous expression of soluble choline

oxidase from pET/codA1 was achieved within 5 h of induction with 50 µM IPTG at 25 oC in E.
coli strain Rosetta(DE3)pLysS, which supplies tRNAs for codons that are rarely used in E. coli.
The choice of such a bacterial host strain for protein expression was dictated by the observation
that, due to its high GC content, codA contains 27 of such rare codons. Recombinant choline
oxidase was purified to homogeneity, as judged by SDS-PAGE analysis (Figure 3.1), using 30 to
65% ammonium sulfate saturation followed by anion exchange chromatography onto a DEAESepharose Fast Flow column equilibrated in 200 mM Tris-Cl at pH 8. Typically, between 150
and 200 mg of pure choline oxidase could be obtained from 4.5 liters of liquid Luria-Bertani
culture medium (Table 3.2).
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Figure 3.1. Purification of recombinant A. globiformis choline oxidase heterogously expressed in
E. coli.
Lane 1, marker proteins; lane 2, cell-free extract of E.coli strain Rosetta(DE3)pLysS harboring
plasmid pET/codA1 induced with 0.05 mM IPTG for 5 hours at 22 oC; lane 3, sample treated
with 20 µg/ml RNase and 50 µg/ml DNase in the presence of 10 mM MgCl2; lane 4, sample
treated with 30 and 65% ammonium sulfate saturation; and lane 5, purified choline oxidase in
200 mM Tris-Cl, pH 8, after DEAE-Sepharose column chromatography. The molecular mass of
purified choline oxidase is indicated.

Table 3.2. Purification of Recombinant A. globiformis Choline Oxidase Heterogously Expressed
in E. coli.
Step
Total
Total activitya,
Specific activity, Yield,
-1
%
protein,
µmol O2 min
µmol O2 min-1 mg1
mg
Cell-free extract
1,830
1,080
0.59
100
Nuclease treated
1,500
1,060
0.71
98
30-65% Saturation of (NH4)2SO4
1,240
1,040
0.84
96
DEAE-Sepharose FF
185
940
5.3
87
a
Enzymatic activity was measured with 10 mM choline as substrate in air-saturated 50 mM
potassium phosphate, pH 7.0 and 25 oC, by monitoring the rate of oxygen consumption with a
Clark-type oxygen electrode.
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Physical Properties of Recombinant Choline Oxidase. The molecular weight of

recombinant choline oxidase was determined by MALDI-TOF mass spectrometry. Two peaks
with m/z+ values of 30,307.5 and 60,618.3 were observed using the positive ion mode,
corresponding to the doubly and singly protonated species of the protein, respectively (Figure
3.2). A molecular weight of 60,614 ± 5 was calculated from the mass spectroscopic data, in
agreement with the expected value of 60,612 calculated from the amino acid composition of the
protein with one linked FAD moiety [31,43,44].
The oligomerization state of choline oxidase was determined by size exclusion
chromatography onto a Sephacryl S-400 column under non-denaturing conditions. The results
indicated that at concentrations of 10 or 100 µM the enzyme has apparent molecular weights of
117,000 and 122,000, respectively (data not shown), indicating that the enzyme exists in solution
as a dimer. Non-denaturing PAGE conditions of the enzyme at concentrations in the range
between 2 and 48 µM yielded single bands with similar relative migration, suggesting that the
oligomerization state of choline oxidase is not dependent on the concentration of the enzyme
(data not shown).
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Figure 3.2. MALDI-TOF mass spectrometric analysis of recombinant choline oxidase.
Choline oxidase at a concentration of 46 µM was prepared as described in Experimental
Procedures. Peaks with m/z+ values of 60,618.3 and 30,307.5 represent the singly and doubly
protonated species of the protein.
Flavin Content of Recombinant Choline Oxidase. The UV-visible absorbance spectrum

of the enzyme as purified is shown in Figure 3.3. Absorbance maxima were observed at 272,
373, and 454 nm, as expected for a flavin-containing enzyme but with relative intensities of the
peaks in the near UV and visible regions of the spectrum suggesting that the bound flavin was
present as a mixture of oxidized and anionic semiquinone states 1 (42). Significant variability in
the relative intensities of the absorbance maxima in the near UV and visible regions of the
spectrum was observed among different preparations of enzyme, with A454/A373 ratios ranging
from 0.4 to 0.7 (data not shown). Upon denaturation of the enzyme by treatment with urea, a
1

A spectroscopic investigation of recombinant choline oxidase by using UV-visible and fluorescence spectroscopy,
electron spin resonance, and circular dichroism, is consistent with the presence of an anionic semiquinone flavin in
the enzyme as purified (36). Steady state kinetic data on the enzyme as purified suggest that the semiquinone flavin
of choline oxidase is not catalytically relevant (36).
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decrease in the 373 nm peak with concomitant increase in the absorbance in the 450 nm region
were observed (Figure 3.3), consistent with oxidation of the semiquinone to form fully oxidized
FAD in the denatured enzyme. This enzyme was devoid of enzymatic activity using 10 mM
choline as substrate at pH 7, suggesting that the treatment with urea completely denatured the
enzyme. No significant changes in the UV-visible absorbance spectrum of the denatured enzyme
were seen after dialysis with decreasing amounts of urea, consistent with FAD being covalently
bound to the enzyme (data not shown). Also, the UV-visible spectrum of a soluble fraction
prepared upon treatment of choline oxidase with 10% trichloroacetic acid followed by
centrifugation to remove the denatured protein was devoid of absorbance (Figure 3.3), further
consistent with FAD being covalently bound to the protein. A stoichiometry of 0.88 ± 0.12
FAD/monomer of enzyme could be calculated from the results of six independent experiments.
The visible fluorescence emission spectrum of purified choline oxidase showed a maximum in
the 525 to 530 nm region (with λex at 454 nm), with about 6% the intensity of an equimolar
solution of free FAD (Figure 3.3).
Kinetic Properties of Recombinant Choline Oxidase. The steady state kinetic parameters

for choline and betaine aldehyde as substrate for the enzyme as purified were determined in airsaturated 50 mM potassium phosphate at pH 7 and 25 oC. Apparent kcat values of 13.4 ± 0.5 and
11.6 ± 0.3 s-1 per active site oxidized flavin and Km values of 0.6 ± 0.1 and 2.3 ± 0.2 mM were
determined with choline and betaine aldehyde, respectively. While the Km values for
recombinant choline oxidase compared well with the values of 0.6 and 2.4 mM previously
reported for choline and betaine aldehyde as substrates for the native enzyme from A.
globiformis, the kcat values were between 3- and 6-fold larger, suggesting a higher purity of our
enzyme preparation as compared to that of the commercially available enzyme (33).
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Figure 3.3. UV-Visible absorbance spectrum of recombinant choline oxidase.
Solid line, choline oxidase as purified at a concentration of 112 µM in 200 mM Tris-Cl, pH 8;
dashed line, after treatment with 4 M urea at 40 oC for 40 min; dotted line, soluble fraction after
treatment of choline oxidase with 10% trichloroacetic acid for 5 min at 100 oC and centrifugation
to remove denatured protein. Inset, fluorescence emission spectrum of choline oxidase as
purified at a concentration of 28 µM in 200 mM Tris-Cl, pH 8 and 15 oC. The excitation
wavelength was at 454 nm.
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Discussion

Our group recently reported studies on the steady state kinetic mechanism, pH and
substrate kinetic isotope effects on choline oxidase from A. globiformis (33, 34). Those studies
define a framework for advanced biophysical and mechanistic studies on choline oxidase, for
which large amounts of enzyme are required. To date, the enzyme from A. globiformis is the
only choline oxidase for which the nucleotide sequence of the full gene has been reported (27).
In the present study, we have cloned and heterogously expressed in E. coli the gene encoding for
choline oxidase from A. globiformis genomic DNA, and purified to homogeneity the resulting
protein.
Purified choline oxidase expressed in E. coli contains covalently bound FAD, as
indicated by the mass spectroscopic analysis of the purified enzyme. Thus, the covalent linkage
between His-87 and the 8α position of the flavin ring is preserved in the recombinant enzyme
(43), consistent with flavinylation of the protein being a self-catalytic process. In this respect,
self-flavinylation of histidyl, tyrosyl, and cysteinyl residues to the 8α position of the flavin ring
was previously proposed to occur through initial flavin tautomerization to yield an electrophilic
iminoquinone methide, which is stabilized by the presence of a positive charge located near the
N(1)-C(2)=O(2) position of the flavin (43-46). Consistent with such a proposed mechanism for
protein flavinylation, the presence of a weak positive charge in proximity of the flavin N(1)C(2)=O(2) locus of choline oxidase is suggested by both stabilization of the anionic flavin
semiquinone and formation of a complex with sulfite (36,47).
Under non-denaturing conditions, choline oxidase is a dimer of identical subunits with
each subunit containing FAD in a 1:1 stoichiometry per monomer of protein. The
oligomerization state of the recombinant enzyme determined in this study does not agree with
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earlier results on native choline oxidase from A. globiformis and Alcaligenes sp., showing masses
of 83,000 and 72,000 Da, respectively (1, 31). In this respect, lower native masses were reported
for cholesterol oxidase from Schizophyllum commune (48) and Streptomyces hygroscopicus (49),
for which interactions of the enzyme with the matrix of the resins used for the size exclusion
chromatography experiments were proposed. In contrast, a dimeric oligomerization state was
determined in previous studies for the enzyme from Cylindrocarpon didymum M-1 (30).
Choline oxidase does not contain dissociable flavins, as suggested by acid treatment of
the enzyme followed by centrifugation to remove the precipitated protein. In this respect, the
enzyme is different from sarcosine oxidase, a well-characterized enzyme containing both 8αN(3)-histidyl-FMN and non-covalently bound FAD (50, 51). The mechanistic implication of
choline oxidase containing only one type of flavin, 8α-N(1)-histidyl-FAD (43), is that a possible
catalytic mechanism in which one flavin in the dimeric protein is responsible for choline
oxidation while the second flavin carries out the oxidation of betaine aldehyde seems unlikely2.
These observations are consistent with oxidation of choline to betaine aldehyde and of the
aldehyde intermediate to glycine betaine occurring at the same enzyme active site in two
subsequent catalytic steps (Scheme 3.1).
Our studies show that the A. globiformis genomic sequence originally reported in
GenBank for the gene encoding for choline oxidase contains seven flaws, resulting in an amino
acid sequence of the translated protein that is significantly different from the previously reported
one. Mass spectrometric analysis of the resulting enzyme expressed in E. coli confirmed the

2

The presence of a single type of flavin in choline oxidase also suggests that a catalytic mechanism in which one
flavin in the dimeric enzyme dehydrogenates the substrate whereas a second flavin is responsible for oxygen
reduction is also unlikely.
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validity of the sequencing results3. Furthermore, the protein homology between choline oxidase
and other members of the GMC oxidoreductase superfamily increased significantly when the
newly determined amino acid sequence was used instead of the previously determined one
(Figure 3.4). For example, the identities and similarities between choline oxidase and choline
dehydrogenase increased from 28 to 34% and from 57 to 63%, respectively. The errors in the
nucleotide sequence of the codA gene previously reported using the pGAH/codA construct likely
arose from the high GC content of the codA gene, which could affect the fidelity of DNA
polymerase in the sequencing reaction.
In summary, choline oxidase was cloned from genomic DNA of A. globiformis and
heterogously expressed to high yields in E. coli. The resulting recombinant enzyme was highly
purified and showed to be a dimer of identical subunits containing covalently bound FAD. To
our knowledge, this study represents the first instance in which recombinant choline oxidase has
been overexpressed and obtained in pure form. The availability of large quantities of
recombinant choline oxidase will prove an invaluable tool for detailed mechanistic and structural
studies aimed at a better understanding of four-electron oxidations of unactivated alcohols and of
the mechanism of CH bond cleavage of alcohols and aldehydes catalyzed by the same flavinlinked active site. Finally, the determination of the correct nucleotide sequence of the gene
encoding for choline oxidase will provide the basis for performing site-directed mutagenesis
studies in this enzyme of biotechnological and medical interest.

3

The mass of the enzyme with one linked FAD moiety is 60,612 Da when calculated by using the newly determined
amino acid sequence, and 59,648 Da by using the previously reported amino acid sequence. Therefore, the
experimentally determined mass of 60,614 Da for the enzyme as purified is in good agreement with the sequencing
results.
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Figure 3. 4. Alignment of choline oxidase with selected members of the GMC oxidoreductase
enzyme superfamily.
CHO, choline oxidase from A. globiformis (GenBank accession no. AAP68832); CHD, choline
dehydrogenase from Halomonas elongata (GenBank accession no. CAB77176); AO, alcohol
oxidase from Candida bodinii (GenBank accession no. JC1117); and GO, glucose oxidase from
Aspergillus niger (GenBank accession no. AF234246.2).
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CHAPTER IV
Spectroscopic and Kinetic Properties of Recombinant Choline Oxidase from Arthrobacter
globiformis

(This chapter was published verbatim in Ghanem, M., Fan, F., Francis, K., and Gadda, G.,
(2003), Biochemistry 42, 15179-88. © 2003 American Chemical Society. All rights reserved.
The first two authors share equal contribution to the publication. In particularly, my contribution
to this study pertains the spectrophotometric characterization of the enzyme bound flavin (EFADOx/ E-FADSq), the reaction of choline oxidase with sulfite, and the enzymatic turnover with
choline.)

Abstract

Choline oxidase catalyzes the four-electron oxidation of choline to glycine betaine, with
molecular oxygen acting as primary electron acceptor. Recently, the recombinant enzyme
expressed in Escherichia coli was purified to homogeneity and shown to contain FAD in a
mixture of oxidized and anionic semiquinone redox states [Fan et al. (2004) Arch. Biochem.
Biophys., 421, 149-58]. In this study, methods have been devised to convert the enzyme-bound
flavin semiquinone to oxidized FAD and vice versa, allowing characterization of the resulting
forms of choline oxidase. The enzyme-bound oxidized flavin showed typical UV-visible
absorbance peaks at 359 and 452 nm (with ε452 = 11.4 M-1cm-1), and emitted light at 530 nm
(with λex at 452 nm). The affinity of the enzyme for sulfite was high (with a Kd value of ~50 µM
at pH 7 and 15 oC), suggesting the presence of a positive charge near the N(1)C(2)=O locus of
the flavin. The enzyme-bound anionic flavin semiquinone was unusually insensitive to oxygen or
ferricyanide at pH 8, and showed absorbance peaks at 372 and 495 nm (ε372 = 19.95 M-1cm-1),
maximal fluorescence emission at 454 nm (with λex at 372 nm), circular dichroic signals at 370
and 406 nm, and an ESR peak-to-peak linewidth of 13.9 G. Both UV-visible absorbance studies
on the enzyme under turnover with choline and steady state kinetic data with either choline or
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betaine aldehyde were consistent with the flavin semiquinone being not involved in catalysis.
The pH dependence of the kinetic parameters at varying concentrations of both choline and
oxygen indicated that a catalytic base is required for choline oxidation but not for oxygen
reduction and that the order of the kinetic steps involving substrate binding and product release is
not affected by pH.
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Introduction

Choline oxidase (E.C. 1.1.3.17) catalyzes the four-electron oxidation of choline to
glycine betaine (N,N,N-trimethylglycine; betaine) via betaine aldehyde as intermediate (Scheme
4.1) (1). The enzyme contains covalently bound FAD and utilizes molecular oxygen as primary
electron acceptor (2-4). Among the members of the GMC oxidoreductase superfamily within
which the enzyme can be grouped (5, 6), choline oxidase is unique in that it catalyzes the
oxidation of a substrate primary alcohol to a carboxylic acid via an aldehyde intermediate. A
similar oxidation reaction of an alcohol to a carboxylic acid is catalyzed by histidinol
dehydrogenase (E.C. 1.1.1.23), a pyridine nucleotide-dependent enzyme well-characterized in its
mechanistic and biochemical properties (7-17). In contrast, limited kinetic information is
available on choline oxidase (18, 19). Consequently, the study of the mechanistic properties of
choline oxidase provides the opportunity to compare the biochemical and mechanistic properties
of the flavin-dependent oxidoreductases with those of the pyridine nucleotide-dependent
reductases able to carry out a four-electron oxidation of a substrate alcohol. The study of an
enzyme involved in glycine betaine biosynthesis is also of considerable interest for both
biotechnological and biomedical applications, because recent studies have shown that
accumulation of glycine betaine in the cytoplasm of cells allows growth in hyperosmotic
environments of transgenic plants lacking efficient glycine betaine biosynthetic systems (20-26)
and of clinical isolates of a number of human pathogens (27-34).
The analyses of the steady state kinetic mechanism and of the pH and deuterium kinetic
isotope effects on the oxidation of choline to betaine aldehyde catalyzed by Arthrobacter
globiformis choline oxidase were recently reported (18, 19). Briefly, with choline as substrate
(lower loop in Scheme 4.2), after formation of the E-FADox-C complex and oxidation of choline
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to yield betaine aldehyde bound to the reduced enzyme, oxygen reacts with the E-FADred-BA
complex. The catalytically competent E-FADox-BA species undergoes a second oxidation
reaction in which glycine betaine is formed. Finally, the E-FADred-GB complex reacts with
oxygen before release of glycine betaine from the oxidized enzyme. With betaine aldehyde as
substrate (upper loop in Scheme 4.2), after formation of the E-FADox-BA complex, betaine
aldehyde is oxidized to yield glycine betaine bound to the reduced enzyme. Turnover is
completed with reaction of the E-FADred-GB complex with molecular oxygen and the final
release of the product glycine betaine. A catalytic base with pKa 7.5 was proposed to participate
in catalysis based on pH and substrate kinetic isotope effect studies on the enzyme (19).
Our group recently cloned the gene encoding for choline oxidase from genomic DNA of A.
globiformis strain ATCC 8010 and expressed it to high yields in Escherichia coli (6). The
resulting protein was purified to homogeneity and shown to be a homodimer of 120,000 Da with
each subunit containing covalently-linked FAD in a mixture of semiquinone and oxidized redox
states (6). In the present study, we have devised methods to obtain homogeneous preparations of
recombinant choline oxidase with the flavin cofactor either in the oxidized or semiquinone state,
and have characterized the biochemical and kinetic properties of the resulting forms of enzyme.
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Experimental Procedures
Materials. Choline chloride was from ICN Pharnaceutical, Inc. Betaine aldehyde and

glycine betaine were from Sigma-Aldrich. Recombinant choline oxidase from A. globiformis
strain ATCC 8010 was expressed from plasmid pET/codA1 and purified to homogeneity as
described in (6). Choline oxidase as purified was stored at -20 oC in 200 mM Tris-Cl, pH 8, and
found to be stable for at least six months. All other reagents were of the highest purity
commercially available.
Enzyme Assays. The concentration of choline oxidase was determined with the method

of Bradford (35), by using the Bio-Rad protein assay kit with bovine serum albumin as the
standard. Enzyme activity was measured with the method of the initial rates (36) in air-saturated
50 mM potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a
computer-interfaced Oxy-32 oxygen-monitoring system

(Hansatech Instrument Ltd.)

thermostated at 25 oC. The reactions were started by the addition of choline oxidase to a 1 ml
reaction mixture, with the final concentration of enzyme in the 0.2 to 0.6 µM range; the
concentration of choline or betaine aldehyde was between 0.02 and 15 mM. When both choline
(or betaine aldehyde) and oxygen concentrations were varied, the assay reaction mixture was
equilibrated at the concentration of oxygen by bubbling the appropriate O2/N2 gas mixture for 10
min before the reaction was started by the addition of the enzyme. When the pH was varied, 50
mM potassium phosphate was used between pH 6 and 8, and 50 mM sodium pyrophosphate was
used in the pH ranges 5 to 6 and 8 to 10. Product inhibition studies were carried out by varying
the concentrations of both glycine betaine and choline (or betaine aldehyde) in air-saturated 50
mM potassium phosphate, pH 6.75. One unit of enzymatic activity corresponds to the
consumption of one µmol of oxygen per min.
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UV-Visible absorbance spectra were recorded using an Agilent Technologies diode-array
spectrophotometer Model HP 8453 equipped with a thermostated water bath. Fluorescence
emission spectra were recorded with a Shimadzu Spectrofluorometer Model RF-5301 PC
thermostated at 15

o

C. Circular dichroism spectra were acquired using a Jasco J-810

spectropolarimeter at 22 oC.
Methods. Oxidized FAD-containing choline oxidase was prepared at 4 oC by dialysis

against three 1-liter changes of 20 mM potassium phosphate, 20 mM sodium pyrophosphate, pH
6, over 24 hours, followed by two 1-liter changes of 200 mM Tris-Cl, pH 8 over five hours. This
enzyme could be stored at -20 oC for at least 7 months without losses in enzymatic activity. The
oxidized flavin content of choline oxidase as purified was determined from the ∆A452 after
treatment of the enzyme with 5 mM dithionite in air-saturated 200 mM Tris-Cl, pH 8, using an
ε452 value of 8.4 mM-1cm-1, which corresponds to the difference between the extinction
coefficients for the enzyme-bound oxidized flavin (ε452 = 8.4 mM-1cm-1) and semiquinone flavin
(ε452 = 3 mM-1cm-1). Reduction of choline oxidase with sodium dithionite was conducted
aerobically in 200 mM Tris-Cl, pH 8, at 15 oC. Dithionite was either prepared just before use in
the same buffer or added to the enzyme solution as a powder. For reactions with sodium sulfite,
the reagent was prepared just prior to use as 1 M stock solution in 200 mM Tris-Cl, pH 8.
Different amounts of sodium sulfite ranging from 0.5 to 25 mM were added to the enzyme
solution in 200 mM Tris-Cl, pH 8, at 15 oC, and UV-visible absorbance spectra were recorded at
different interval periods. Reversibility of the flavin-sulfite complex was determined by
following the increase in absorbance at 452 nm following removal of the unbound sulfite by gel
filtration using a Sephadex G-25 column (PD-10 column, Amersham-Pharmacia Biotech)
equilibrated with 200 mM Tris-Cl, pH 8. For treatment of choline oxidase with an oxidizing
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agent under non-denaturing conditions, the enzyme was incubated with 10 mM potassium
ferricyanide for 30 min on ice in 10% glycerol, 1 mM EDTA, 20 mM Tris-Cl, pH 8, before
removing ferricyanide by gel filtration using a Sephadex G-25 column equilibrated with 20 mM
Tris-Cl, pH 8.
ESR spectral data were recorded in 3-mm quartz tubes at 141 K using a Bruker ER200D
spectrophotometer equipped with an Oxford cryostat. Samples were prepared for ESR analysis
by gel filtration through a Sephadex G-25 column equilibrated in 50 mM HEPES, pH 8,
followed by freezing in liquid nitrogen. The following conditions and instruments settings were
used: microwave power, 2 mW; modulation amplitude, 2 G; and microwave frequency, 9.4 GHz.
Data Analysis. Kinetic data were fit with the KaleidaGraph software (Adalbeck

Software, Reading, PA) and the Enzfitter software (Biosoft, Cambridge, UK). Apparent kinetic
parameters in atmospheric oxygen were determined by fitting initial reaction rates at different
substrate concentrations to the Michaelis-Menten equation for one substrate. Initial rates
determined by varying the concentration of both choline or betaine aldehyde and oxygen were fit
to equations 1 and 2, respectively. Equation 1 describes a sequential steady state kinetic
mechanism, whereas equation 2 describes a sequential mechanism in which Ka «Kia (37). Ka and
Kb are the Michaelis constants for choline (or betaine aldehyde) (A) and oxygen (B), respectively,
and kcat is the turnover number of the enzyme (e).
k cat AB
v
=
e K a B + K b A + AB + K ia K b

(1)

k cat AB
v
=
e K b A + AB + K ia K b

(2)

The pH dependences of steady state kinetic parameters were determined by fitting initial
rate data to equation 3, which describes a curve with slope of +1 and a plateau region at high pH.
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The pH dependence of inhibition by glycine betaine was determined by fitting the initial rate
data to equation 4, which describes a curve with slope of -1 and a plateau region at low pH. C is
the pH-independent value of the kinetic parameter of interest.
⎛
⎜
C
log Y = log⎜
⎜
10− pH
⎜ 1 + − pK a
⎝ 10

⎞
⎟
⎟
⎟
⎟
⎠

(3)

⎛
⎜
C
log Y = log⎜
⎜ 10− pK a
⎜ 1 + − pH
10
⎝

⎞
⎟
⎟
⎟
⎟
⎠

(4)

Product inhibition studies were performed by varying the concentrations of both glycine
betaine and choline (or betaine aldehyde) at a fixed concentration of oxygen. The data were fit to
equations 5 to 7, which describe competitive, uncompetitive, and noncompetitive inhibition
patterns of the product and the organic substrate, respectively. P is the concentration of glycine
betaine, Kis and Kii are the inhibition constants for the slope and intercept term, respectively.
v
=
e

k cat A
⎡ ⎛ P
K a ⎢1 + ⎜⎜
⎣ ⎝ K is

(5)

⎞⎤
⎟⎟⎥ + A
⎠⎦

v
=
e

k cat A
⎡ ⎛ P
K a + A⎢1 + ⎜⎜
⎣ ⎝ K ii

v
=
e

k cat A
⎡ ⎛ P
⎡ ⎛ P ⎞⎤
⎟⎟⎥ + A⎢1 + ⎜⎜
K a ⎢1 + ⎜⎜
⎣ ⎝ K ii
⎣ ⎝ K is ⎠⎦

(6)

⎞⎤
⎟⎟⎥
⎠⎦

⎞⎤
⎟⎟⎥
⎠⎦

(7)
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Results
Choline Oxidase as Purified (E-FADox/sq). As shown in Figure 4.1, the UV-visible

absorbance spectrum of recombinant choline oxidase as purified at pH 8 suggests that the
enzyme-bound FAD is present as a mixture of oxidized and anionic semiquinone states (EFADox/sq) (6). Upon treatment of the enzyme with 10 mM potassium ferricyanide at pH 8
followed by gel filtration to remove the oxidizing agent, no significant spectral changes in the
near-UV and visible regions of the absorbance spectrum were observed (data not shown). These
results indicate that the addition of an oxidant under non-denaturing conditions had no effect on
the enzyme-bound flavin semiquinone.
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Figure 4.1. Reaction of recombinant choline oxidase with sodium dithionite.
Dashed line, the UV-visible absorbance spectrum of choline oxidase as purified was recorded at
a concentration of 60 µM in 200 mM Tris-Cl, pH 8; solid line, air-stable flavin semiquinonecontaining enzyme prepared by treatment with 5 mM sodium dithionite in aerobiosis and gel
filtration onto a Sephadex G-25 column equilibrated with the same buffer; dotted line, after
treatment of the flavin semiquinone-containing enzyme with 4 M urea at 40 oC for 40 min. Inset,
fluorescence emission spectrum of flavin semiquinone-containing choline oxidase at a
concentration of 8 µM in 200 mM Tris-Cl, pH 8 and 15 oC. The excitation wavelength was at
372 nm.
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Spectral Properties of Flavin Semiquinone-Containing Choline Oxidase (E-FADsq).

When the enzyme was incubated aerobically with 5 mM dithionite, a bleaching of the peak at
454 nm was observed in the visible absorbance spectrum of the enzyme and a spectrum with
maxima at 372 and 495 nm was obtained (data not shown). The ∆A452 was used to determine the
FADox content per enzyme active site, by using the ε452 values determined for the enzyme-bound
flavin in the oxidized and semiquinone states (see below). Typically, the enzyme as purified
contained variable amounts of flavin in the oxidized state, ranging from 15 to 55% of the total
flavin content (data not shown). Removal of excess dithionite by gel filtration yielded a similar
absorbance spectrum (Figure 4.1), indicating that the enzyme is capable of stabilizing the anionic
semiquinone species of the flavin (FADsq.) in the presence of molecular oxygen. Upon
incubation of the FADsq-containing choline oxidase in the presence of 4 M urea, the visible
absorbance spectrum of oxidized FAD with the typical peaks centered at 350 and 452 nm was
observed (Figure 4.1), consistent with the FADsq being stabilized by the protein
microenvironment and the cofactor becoming fully oxidized by molecular oxygen upon
unfolding the protein. An extinction coefficient of 19.95 mM-1cm-1 was calculated at 372 nm for
the enzyme-bound semiquinone of choline oxidase based upon the ε450 nm value of 11.3 mM-1cm1

for FAD 1 after denaturation of the enzyme by treatment with urea (38). At pH 8 and 15 oC, the

enzyme-bound anionic semiquinone emitted light at 454 nm upon excitation at 372 nm (Figure
4.1). As for the case of the visible absorbance spectrum, the typical fluorescence properties of
oxidized FAD with maximal emission at 530 nm (with λmax at 450 nm) were observed upon
denaturation of the FADsq-containing enzyme by treatment with urea (data not shown). The
1

It is assumed here that the ε450 nm for 8α-N(1)-histidyl FAD is the same as that for free FAD in solution, with a
value of 11.3 mM-1cm-1.
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circular dichroism spectrum of the E-FADsq form of choline oxidase showed a negative band at
370 nm, a sharp positive band at 406 nm, and a broad negative dichroic signal spanning from
450 to 650 nm (Figure 4.2). Such a spectrum is in agreement with previously reported circular
dichroic spectra of enzyme-bound anionic flavin semiquinones (39, 40).
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Figure 4.2. Circular dichroism spectrum of flavin semiquinone-containing choline oxidase.
Solid line, choline oxidase after treatment with 5 mM sodium dithionite in aerobiosis followed
by gel filtration onto a Sephadex G-25 column equilibrated with 200 mM Tris-Cl, pH 8; dotted
line, after treatment of the flavin semiquinone-containing enzyme with 4 M urea at 40 oC for 30
min. Spectra were recorded at 22 oC.
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As an independent approach to characterizing the enzyme-bound semiquinone flavin of
choline oxidase, ESR spectra of the enzyme as purified and of the semiquinone-containing
enzyme were determined. As shown in Figure 4.3, E-FADox/sq yielded an ESR signal at 2 G with
a peak-to-peak linewidth of 15.4 G, providing further evidence for the presence of an anionic
flavin semiquinone in the enzyme (41). A similar ESR spectrum with peak linewidth of 13.9 G
was observed when the enzyme was analyzed after treatment with dithionite and gel filtration to
remove the excess dithionite, further consistent with the formation of an air-stable anionic
semiquinone upon reduction of the enzyme by dithionite.
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Figure 4.3. Electron spin resonance spectrum of recombinant choline oxidase.
Spectra of choline oxidase were acquired at a concentration of 60 µM in 50 mM HEPES, pH 8.
The following spectral conditions were used: microwave power, 2 mW; modulation amplitude, 2
G; gain, 6.3 x 105; temperature, 141 K. Panel A, choline oxidase as purified; panel B, flavin
semiquinone-containing choline oxidase prepared freshly by addition of sodium dithionite and
gel filtration onto a Sephadex G-25 column.
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Spectral Properties of Oxidized FAD-Containing Choline Oxidase (E-FADox).

Treatment of choline oxidase at pH 6 and 15 oC resulted in the slow bleaching of the near-UV
band centered at 373 nm and concomitant increase of absorbance at 452 nm (Figure 4.4). The
resulting enzyme species showed absorbance maxima in the near-UV and visible regions
centered at 359 and 452 nm, as expected for an enzyme with the bound flavin in the oxidized
state (E-FADox). At 15 oC, a kobs value of 219 ± 1 x 10-6 s-1 was determined from the absorbance
changes at 452 nm for the complete conversion of E-FADox/sq to E-FADox (Figure 4.4, inset). To
minimize possible protein losses due to the prolonged incubation of the enzyme at pH 6, EFADox was also prepared by dialysis at 4 oC. When 1,300 units of choline oxidase as purified
were dialyzed at pH 6 for 24 hours 4,100 units of E-FADox were recovered, consistent with
formation of E-FADox being due to oxidation rather than denaturation of E-FADsq. As shown in
Figure 4.5, an extinction coefficient at 452 nm of 11.4 ± 0.6 mM-1cm-1 was calculated for EFADox from six independent experiments after denaturation of the enzyme by treatment with
urea. A fluorescence emission spectrum with a maximum at 530 nm (with λex at 452 nm) was
observed for E-FADox, providing further evidence for the presence of oxidized FAD. As for the
case of the E-FADox/sq species, a UV-visible absorbance spectrum identical to that of E-FADsq
was obtained upon aerobic addition of dithionite to E-FADox (data not shown).
Formation of a covalent N(5)-flavin adduct with sulfite is a feature that distinguishes
flavoprotein oxidases from dehydrogenases (42, 43). As shown in Figure 4.6, treatment of
FADox-containing choline oxidase with sodium sulfite resulted in the bleaching of the peak at
452 nm with the concomitant appearance of a peak centered at 320 nm, consistent with formation
of a sulfite N(5)-flavin adduct. At pH 7 and 15 oC, complex formation was slow and required
several hours for completion at concentrations of sulfite as high as 25 mM. Values for the rate of
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complex formation (kon) and dissociation (koff) of 0.035 ± 0.001 M-1s-1 and 4.9 ± 8.4 x 10-6 s-1
were calculated from a plot of kobs versus sulfite concentration, respectively (Figure 4.6, inset).
Although a koff value not significantly different from zero was observed, by using the upper
limiting koff value of 1.33 x 10-5 s-1 calculated from the sum of the y-intercept value in Figure 4.5
and the standard deviation associated with the measurement, an upper Kd value of ~40 µM could
be estimated from the ratio of the koff to kon values. From a plot of ∆A452 versus [sulfite], a Kd
value of 51 ± 10 µM was determined from the reaction at various concentrations of sulfite (data
not shown), in fairly good agreement with the value determined kinetically. Reversibility of the
flavin-sulfite adduct was established by following the increase in absorbance at 452 nm after
removing the excess sulfite by gel filtration (data not shown). However, an accurate
determination of the koff value could not be carried out due to instability of the enzyme over the
prolonged incubation times required for complete sulfite dissociation. Although the slow rates of
sulfite complex formation and dissociation observed with choline oxidase are atypical for
flavoprotein oxidases, similar results were recently observed for another flavin-linked enzyme,
N-methyltryptophan oxidase (44).
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Figure 4. 4. Conversion of E-FADox/sq to E-FADox.
Choline oxidase as purified at a concentration of 33 µM was incubated in air-saturated buffer at
pH 6 and 15 oC. Absorbance spectra were recorded at different times of incubation until no
further spectral changes were observed. Only selected spectra are shown: curve 1, absorbance
spectrum of choline oxidase recorded 1 min after gel filtration of the enzyme through a Sephadex
G-25 column equilibrated with 20 µM potassium phosphate, 20 mM sodium pyrophosphate, pH
6; curve 6, same sample after 15 h of incubation. Inset, time course of absorbance changes at 452
nm. The curve is a fit of the data to y = 0.420-0.071*e(0.79x) (R2=0.9997).
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Figure 4. 5. Reaction of FADox-containing choline oxidase with sodium dithionite.
Solid line, the UV-visible absorbance spectrum of FADox-containing choline oxidase was
recorded at a concentration of 75 µM in 200 mM Tris-Cl, pH 8; Dashed line, air-stable
semiquinone-containing enzyme prepared by treatment with 5 mM sodium dithionite in
aerobiosis and gel filtration onto a sephadex G-25 column equilibrated with the same buffer.
Inset, fluorescence emission spectrum of FADox-containing choline oxidase at a concentration of
15 µM in 200 mM Tris-Cl, pH 8 and 15 oC. The excitation wavelength was at 453 nm.
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Figure 4.6. Reaction of choline oxidase with sulfite.
FADox-containing choline oxidase at a concentration of 15 µM was incubated with 25 mM
sodium sulfite in air-saturated 100 mM potassium phosphate, pH 7 and 15 oC. Absorbance
spectra were recorded at different times of incubation until no further spectral changes were
observed. Only selected spectra are shown: curve 1, absorbance spectrum of choline oxidase
recorded 10 s after addition of sulfite; curve 20, same sample after 2 h of incubation. Inset, plot
of the observed rate of decrease in absorbance at 452 nm versus the concentration of sulfite. The
line is a fit of the data to y = 0.035x+0.0000049 (R2=0.999).
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Enzymatic Turnover of E-FADox/sq, E-FADsq and E-FADox with Choline. To determine

whether the flavin semiquinone of choline oxidase participates in catalysis, choline oxidase
containing either FADox/sq, FADsq, or FADox, was incubated with 4 mM choline in air-saturated
200 mM Tris-Cl, at pH 8 and 15 oC. As shown in Figure 4.7, a UV-visible absorbance spectrum
with maxima at 372 and 495 nm was observed with the FADox/sq-containing enzyme, suggesting
that the enzyme-bound oxidized flavin was fully reduced in the presence of the substrate, and
that the flavin semiquinone did not react with choline or oxygen under enzyme turnover. After
removal of the excess choline by gel filtration, a UV-visible absorbance spectrum substantially
identical to that of the resting state of E-FADox/sq was observed (Figure 4.7), further consistent
with the flavin semiquinone not participating in catalysis. When a freshly prepared sample of the
E-FADsq form of choline oxidase was subjected to the same treatment, no changes were observed
in the UV-visible absorbance spectra of both the enzyme under turnover and in the resting state
after removal of excess choline by gel filtration (Figure 4.7), in good agreement with the results
observed with the enzyme containing a mixture of oxidized and semiquinone flavins. Finally, a
peak centered at 356 nm was observed in the UV-visible absorbance spectrum of the FADoxcontaining enzyme in the presence of choline and oxygen, suggesting that this species of enzyme
was fully reduced under these conditions (Figure 4.7). After removing the excess choline by gel
filtration, an absorbance spectrum substantially identical to that of the initial E-FADox species in
the resting state was observed (Figure 4.7). Altogether, the results of these experiments are
consistent with the flavin semiquinone of choline oxidase being not catalytically competent and
with the enzyme-bound flavin cycling between fully oxidized and reduced states during catalytic
turnover of the enzyme with the substrates.
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Figure 4.7. UV-Visible absorbance spectra of choline oxidase during turnover with choline.
Choline oxidase containing different relative amounts of flavin semiquinone and oxidizied flavin
was incubated for 30 min with 4 mM choline in air-saturated 100 mM potassium phosphate, pH
7 and 15 oC, before stopping the reaction by gel filtration onto a Sephadex G-25 column
equilibrated with the same buffer. UV-Visible absorbance spectra were recorded for the enzyme
in the resting state before turnover (solid curve), under turnover (dashed curve), and in the
resting state after turnover (dotted curve). Panel A, 95 µM choline oxidase containing FADox/sq;
panel B, 50 µM choline oxidase containing FADsq; and panel C, 79 µM choline oxidase
containing FADox. Spectra for the resting enzyme after turnover were normalized to those of the
resting enzyme before turnover.
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Steady State Kinetics. The steady state kinetic parameters for recombinant choline

oxidase were determined for both the E-FADox and E-FADox/sq forms of choline oxidase, by
measuring the rate of oxygen consumption at varying concentrations of both the organic
substrate and oxygen at pH 7 and 25 oC. As expected based on previous studies on A. globiformis
choline oxidase (18), the kinetic data with choline and betaine aldehyde were fit best by
equations 1 and 2, which describe sequential kinetic mechanisms with finite and negligible Ka
values, respectively (37). As shown in Table 4.1, when the kinetic parameters were expressed per
active site oxidized flavin content, no significant differences were observed in the kcat and kcat/Km
values when enzyme forms with different FADox/FADtotal ratios were compared, providing
independent evidence that the flavin semiquinone of choline oxidase does not participate in
catalysis 2.
Product Inhibition Studies. As an independent approach to examining the steady state

kinetic mechanism of recombinant choline oxidase, the inhibition patterns of the product glycine
betaine with respect to either choline or betaine aldehyde were determined in air-saturated buffer
at pH 6.75. As shown in Table 4.2, the results were best fit by equation 5, consistent with glycine
betaine being competitive versus either choline or betaine aldehyde. Moreover, similar kinetic
parameters were obtained irrespective of the use of E-FADox/sq or E-FADox when the initial rates
were expressed per active site oxidized flavin (Table 4.2).

2

If the flavin semiquinone were as catalytically competent as the oxidized flavin in the reaction catalyzed by
choline oxidase, similar kcat and kcat/Km values should have been obtained by expressing the enzymatic activity per
active site total flavin content. Alternatively, if the flavin semiquinone were either less or more catalytically
competent than the oxidized flavin, due to the kinetic complexity of the reaction catalyzed by choline oxidase,
significantly different kcat, Km, Kia, and kcat/Km values should have been observed irrespective of whether the
enzymatic activity is expressed per active site oxidized flavin content or total flavin content. Within experimental
error, the kinetic results observed with enzyme forms containing different relative amounts of flavin semiquinone
and oxidized flavin are therefore consistent with the conclusion that the oxidized flavin is solely responsible for
catalytic activity.

185

Table 4.1. Steady-State Kinetic Parameters for Recombinant Choline Oxidase with Choline or Betaine Aldehyde as Substrate at pH
7a
KO2,
FADOX/
Ka,
Kia,
kcat,
kcat/Ka,
kcat/KO2,
b
-1 c
d
-1 -1 e
-1 -1
Substrate
FADtotal
s
mM
M s
M s
mM
eq.
R2
µM
Choline
1.00
61 ± 6 1.7 ± 0.3 36,000 ± 6,400
703 ± 102
87,100 ± 15,300 0.2 ± 0.05 1 0.998
Choline
0.37
60 ± 5 2.9 ± 0.3 21,000 ± 3,000
830 ± 90
72,400 ± 9,900
0.2 ± 0.03 1 0.999
betaine aldehyde
1.00
69 ± 1
1090 ± 30
64,000 ± 2,100
2.2 ± 0.09 2 0.998
betaine aldehyde
0.37
67 ± 1
970 ± 1
69,000 ± 100
2.3 ± 0.01 2 1.000
a
Enzyme activity was measured at varying concentrations of both organic substrate and oxygen in 50 mM potassium phosphate, pH
7 and 25oC. b Oxidized flavin content per total enzyme-bound flavin. c Rates are expressed per active site oxidized flavin content. d Ka
is the Km value for either choline or betaine aldehyde as substrate. e kcat/Ka is the kcat/Km value for either choline or betaine aldehyde
as substrate.
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Table 4.2. Product Inhibition Studies of Recombinant Choline Oxidase with Glycine Betainea
FADOX/
type of
kcat,
Km,
Kis,
Kii,
Substrate
FADtotalb
inhibitionc
s-1 d
mM
mM
mM
eq
R2
Choline
1.00
C
10.6 ± 0.2
0.8 ± 0.1
15 ± 1
5
0.999
UC
11.3 ± 0.2
1.1 ± 0.1
27 ± 1
6
0.929
8
14
7
0.995
NC
9.3 ± 0.4
0.6 ± 0.1
12 ± 2
10 ± 10
0.37
C
9.7 ± 0.1
0.8 ± 0.1
12 ± 0.3
5
0.993
UC
9.4 ± 0.1
0.7 ± 0.1
21 ± 0.1
6
0.941
7
0.993
NC
9.7 ± 0.1
0.8 ± 0.1
12 ± 0.1
108 ± 1011
betaine aldehyde
1.00
C
6.1 ± 0.1
2.0 ± 0.1
56 ± 2
5
0.991
UC
10.0 ± 0.1
5.0 ± 0.1
41 ± 2
6
0.971
7
0.960
NC
7.6 ± 0.7
2.8 ± 0.7
51 ± 26
103 ± 104
0.37
C
5.9 ± 0.1
2.6 ± 0.1
48 ± 4
5
0.996
UC
7.8 ± 0.1
4.0 ± 0.1
29 ± 1
6
0.982
NC
7.2 ± 0.3
3.3 ± 0.4
49 ± 11
755 ± 926
7
0.993
a
Enzyme activity was measured at varying concentrations of organic substrate and glycine betaine in air-saturated 50 mM potassium
phosphate, pH 6.75 and 25 ºC. b Oxidized flavin content per total enzyme-bound flavin. c C, competitive; UC, uncompetitive, NC,
noncompetitive. d Rates are expressed per active site oxidized flavin content.
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pH Dependence of the kcat and kcat/Km Values. The pH-dependence of the kinetic

parameters with choline as substrate was determined at varying concentrations of both choline
and oxygen in the pH range 6 to 10. As shown in Figure 4.8, both the kcat/Km and kcat values for
choline increased with increasing pH, reaching limiting values above pH 8. Apparent pKa values
of 7.6 ± 0.2 and 7.1 ± 0.2 were determined for a group that must be unprotonated for catalysis
from the kcat/Km and kcat pH-profiles, respectively. In contrast, the kcat/Km values for oxygen were
independent of pH, with values in the 104 M-1s-1 range (Figure 4.9).
To establish whether a measurable Km value could be determined with betaine aldehyde
as substrate for the enzyme, initial rates of reaction were measured at pH 6.5 and 10 by varying
the concentrations of both betaine aldehyde and oxygen. At both pH values the data were fit best
to equation 2 (data not shown), consistent with kcat being independent of the concentration of
betaine aldehyde (37). The kcat values with betaine aldehyde were 42 ± 2 at pH 6.5 and 70 ± 1 s-1
at pH 10. As for the case of choline, the kcat/Km values for oxygen determined with betaine
aldehyde as the organic substrate were independent of the pH (Figure 4.9).
As an approach to establishing whether some changes in the kinetic properties of the
enzyme take place in the conversion of E-FADox/sq to E-FADox, the pH dependences of the
kinetic parameters with choline as substrate for both enzyme species were determined in airsaturated buffer in the pH range from 5 to 10. As shown in Figure 4.10, both the kcat/Km and kcat
values yielded similar pH profiles irrespective of whether the E-FADox or the E-FADox/sq species
was used, indicating that no changes other than oxidation of E-FADsq occur in the preparation of
E-FADox by treatment at pH 6. The pKa values were 7.4 ± 0.1 and 7.3 ± 0.1 in the kcat/Km pH
profiles, and 6.4 ± 0.1 and 6.6 ± 0.1 in the kcat pH profiles with E-FADox and E-FADox/sq,
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respectively, in agreement with the values of 7.2 ± 0.2 and 6.4 ± 0.1 recently determined for
choline oxidase from A. globiformis (19).
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Figure 4.8. pH Dependence of the kcat/Km and kcat values for choline as substrate for recombinant
choline oxidase.
Choline oxidase activity was measured at varying concentration of both choline and oxygen at 25
o
C as described in the Experimental Procedures section. The lines are fits of the data to equation
3. Panel A, pH dependence of the kcat/Km values; panel B, pH dependence of the kcat values.
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Figure 4.9. pH Dependence of the kcat/Km values for oxygen with choline or betaine aldehyde as
substrate for recombinant choline oxidase.
Choline oxidase activity was measured at varying concentration of both choline (or betaine
aldehyde) and oxygen at 25 oC as described in the Experimental Procedures section. (T) Values
determined with choline; (U) values determined with betaine aldehyde. The line represents the
average pH-independent kcat/Km value with choline as substrate.
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Figure 4.10. pH Dependence of the apparent kinetic parameters of E-FADox/sq and E-FADox with
choline as substrate.
Choline oxidase activity was measured in air-saturated buffer at 25 oC. (z) Values determined
with E-FADox; ({) values determined with E-FADox/sq. The lines are fits of the data to equation
3. Panel A, pH dependence of the kcat/Km values; panel B, pH dependence of the kcat values.
pH Dependence of Inhibition by Glycine Betaine. The pH dependence of the inhibition

by glycine betaine was determined in atmospheric oxygen using choline as substrate for EFADox. As shown in Figure 4.11, the data were fit best by equation 4, consistent with a single
ionizable group with a pKa value of 7.5 ± 0.1 that must be protonated for inhibition.
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Figure 4.11. pH Dependence of inhibition by glycine betaine.
At each pH value, choline oxidase activity was measured at varying concentrations of both
choline and glycine betaine in air-saturated buffer at 25 oC. The Kis values for glycine betaine
were determined by fitting the initial rate data to equation 5. The line is a fit of the data to
equation 4.
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Discussion

Recombinant choline oxidase expressed in E. coli cells contains between 35 and 85% of
bound flavin in an anionic semiquinone form that requires the protein microenvironment to be
stabilized. At pH 8, this enzyme-bound flavosemiquinone is unusually insensitive to both
molecular oxygen 3 and the oxidizing agent ferricyanide, suggesting that the unpaired electron is
localized in a region of the flavin that is not accessible for reaction. Earlier studies on native
choline oxidase from Alcaligenes sp. showed that an anionic semiquinone that was poorly
reactive towards oxygen is stabilized by the enzyme (45), suggesting that this property does not
arise from the expression of the recombinant enzyme in the heterologous system used in our
study. A rationale for the unusual air-stability of the flavin semiquinone can be proposed based
on recent ab initio theoretical calculations, showing that most of the spin density in anionic
flavin semiquinones is distributed on either the benzene ring or the N(5) position of the flavin
(46, 47). The flavin N(5) locus is expected to be freely accessible to oxygen, because of the role
it plays in catalysis by accepting the hydride equivalent generated in the oxidation of the
substrate. In contrast, the benzene ring of FAD is involved in a 8α-N(1)-histidyl linkage with the
protein (4) and is likely to be hindered by the protein moiety. Stabilization of the spin density on
the benzene ring of the anionic semiquinone might further be contributed by the inductive effect
of the flavin 8α-N(1)-histidyl linkage with the protein moiety.
The choline oxidase-bound semiquinone undergoes a slow conversion to the fully
oxidized state at pH 6, indicating that a hundred fold increase in proton concentration
significantly destabilizes the flavin radical. Although not investigated further in this study, a
3

The rate of reaction with oxygen of anionic flavin semiquinones in solution is almost diffusion-controlled, with
second order rate constant values of 108 M-1s-1 (69, 70). That for enzyme-bound anionic semiquinones has been
reported for glucose oxidase to be in the 104 M-1s-1 range (49).
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possible rationale for the oxidation of the flavin semiquinone in choline oxidase is that at low pH
a limited fraction of the enzyme-bound semiquinone becomes protonated to yield the neutral
species of the semiquinone, which would be readily oxidized by molecular oxygen because of
localization of the unpaired electron on the highly oxygen-reactive C(4a) locus of the flavin (43).
pH-Dependent stabilization of both anionic and neutral flavin semiquinones by the same enzyme
was previously shown in another member of the GMC oxidoreductase superfamily, glucose
oxidase (42, 48), for which it was shown that the neutral semiquinone reacts with oxygen with a
second order rate constant of 1.4 x 104 M-1s-1 at 25 oC (49). Unusual stabilization of neutral
semiquinones by flavoprotein oxidases was also reported for nitroalkane oxidase (50) and Damino acid oxidase in the presence of benzoic acid (51).
The spectral studies of the enzyme under turnover establish that the flavin semiquinone
of choline oxidase is not catalytically relevant and that the enzyme under turnover cycles
between its fully oxidized and fully reduced states. This conclusion is further supported by
kinetic data, showing a good correlation between the turnover numbers of the enzyme with
choline and betaine aldehyde as substrate and the content of oxidized flavin per active site.
Consistent with the lack of catalytic role for the flavin semiquinone, variable FADox/FADsq ratios
for the enzyme-bound flavin are observed among different preparations of enzyme (6). Thus,
choline oxidase appears to be similar to methanol oxidase, which was shown in earlier studies to
contain a mixture of oxidized FAD and an air-stable anionic semiquinone that is not required for
catalysis (52). In contrast, air-stable flavin semiquinones for which a catalytic role of the flavin
radical was proposed (53, 54) were reported in the resting state of monoamine oxidase B (55-57)
and E. coli DNA photolyase (58, 59).

192
A weak positive charge is located in the active site of choline oxidase in proximity of the
N(1)-C(2)=O locus of FAD, as suggested by both the stabilization of the anionic semiquinone
and the high affinity of the enzyme for sulfite (43). By analogy with other members of the GMC
oxidoreductase superfamily whose three-dimensional structure is available, such as glucose
oxidase (60, 61), cholesterol oxidase (62, 63), and cellobiose dehydrogenase (64), it is likely that
the positive charge in choline oxidase is provided by the dipole of an α-helix.
A steady state kinetic analysis of choline oxidase from A. globiformis was recently
reported at pH 7 (18). The results of the kinetic studies reported here indicate that recombinant
and native choline oxidase share identical steady state sequential mechanisms in which the
products are released from the oxidized enzyme (Scheme 4.2) and, most importantly, that the
order of the kinetic steps involving substrate binding and product release is not affected by pH.
Independent evidence for product release occurring after reaction of the reduced enzyme with
oxygen is provided by the competitive inhibition patterns observed with glycine betaine versus
both choline and betaine aldehyde. The product inhibition patterns observed in this study also
rule out possible kinetically relevant conformational changes occurring after release of the
product from the enzyme active site, such as those observed with nitroalkane oxidase (65).
His-466 with a pKa value of 7.5 was recently proposed to participate in catalysis by
accepting the hydroxyl proton of choline, based on pH dependence studies in atmospheric
oxygen with choline oxidase from A. globiformis and sequence alignment comparison with other
members of the GMC enzyme superfamily (19). Consistent with those results, an amino acid
residue with pKa value of 7.6 is seen in the kcat/Km pH-profile of recombinant choline oxidase
determined at varying concentrations of choline and oxygen. In the kinetic mechanism of
Scheme 4.2, the kcat/Km value for choline is a combination of rate constants reflecting substrate
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binding, k1 and k2, the catalytic step in which choline is oxidized to betaine aldehyde, k3 and k4,
and the kinetic step in which the reduced enzyme-product complex is oxidized by oxygen, k5, as
illustrated by equation 8. This raises the possibility that the catalytic base may be involved in
oxygen reduction rather than in substrate oxidation. However, the observation that the kcat/Km
values for oxygen are independent of pH unequivocally establishes the involvement of the
catalytic base in the oxidation of choline to betaine aldehyde.
k cat
k1k 3 k 5 [O2 ]
=
K m k 2 k 4 + k 2 k 5 [O2 ] + k 3 k 5 [O2 ]

(8)

The pKa value of 7.5 seen in the pH profile of glycine betaine inhibition is due to an
amino acid residue that must be protonated for product binding, as expected if this residue is
involved in binding the caboxylate moiety of glycine betaine. This amino acid group is likely to
be the same histidine residue that must be unprotonated for catalysis and is responsible for the
pKa value of 7.6 observed in the kcat/Km pH profile. Since pKa values determined with
competitive inhibitors are expected to reflect true equilibrium dissociation constants, these
results establish choline as a slow substrate with little if any external forward commitment to
catalysis (66). This conclusion does not agree with that recently reported for choline oxidase
from A. globiformis based on pH and kinetic isotope effects studies using [1,2-2H4]-choline in
atmospheric oxygen, showing a decrease in the Dkcat/Km values with increasing pH (19). A
reasonable explanation that accounts for all the available data is that the decrease in the apparent
D

kcat/Km values with increasing pH when the concentration of oxygen is well below saturation is

not due to choline being a fast substrate for the enzyme as originally proposed (19), but to the

194
reverse catalytic step (k4 in Scheme 4.2) becoming significantly fast as compared to the kinetic
step in which the enzyme-bound reduced flavin is oxidized (k5 in Scheme 4.2) 4.
No ionizable groups with pKa value in the pH range from 6 to 10 are required for oxygen
reduction in the betaine aldehyde- or glycine betaine-choline oxidase complexes, as suggested by
the pH independence of the kcat/Km values for oxygen with either choline or betaine aldehyde as
substrate. These data are consistent with a hydrophobic environment being required for flavin
activation in the reduced enzyme-product complexes. In this respect, a hydrophobic channel that
may serve as an entrance for oxygen to the active site was recently proposed for another member
of the GMC oxidoreductase superfamily, cholesterol oxidase (67). Oxygen reactivity in choline
oxidase therefore appears to be different from that of glucose oxidase, for which protonation of
the active site His-516 residue was recently shown to increase the reactivity of the reduced
enzyme towards oxygen by about 4 orders of magnitude (68).
In summary, the results of the studies on choline oxidase presented herein have
established that the enzyme is a typical flavoprotein oxidase, showing formation of an anionic
flavin semiquinone and reactivity with sulfite. However, stabilization of the flavin semiquinone
by the enzyme is unusual in that it occurs in the presence of molecular oxygen. Such a lack of
4

In the kinetic mechanism of Scheme 4.2, the observed isotope effect on the kcat/Km value is given by
D
D

kcat
=
Km

k3
k
+ 1.24 4
k2
k5 [O2 ]
(66), where 1.24 is the value for the equilibrium kinetic isotope effect for the
k
k4
1+ + 3 +
k2 k5[O2 ]

k3 +

conversion of an alcohol to an aldehyde (71). If the forward commitment to catalysis k3/k2 is negligible, any
decrease in the observed kinetic isotope effect must be due to the reverse commitment to catalysis k4/k5[O2], which
depends on the concentration of oxygen. Since choline oxidase from A. globiformis has a Km value for oxygen of 0.6
mM at pH 7 and 19 oC (18), and the concentration of oxygen in air-saturated buffers at 19 oC is ~0.3 mM, it follows
that under these conditions the rate of oxidation of the enzyme-bound reduced flavin becomes signhificantly slow.
Consequently, a significant increase in the reverse commitment to catalysis is expected at concentrations of oxygen
well below saturation in the enzyme-catalyzed oxidation of choline.
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reactivity towards oxygen has allowed a spectroscopic characterization of the enzyme-bound
anionic flavin semiquinone and to establish that the flavin semiquinone does not participate in
catalysis. From a mechanistic standpoint, the kinetic data presented here have indicated that the
recently proposed catalytic base of choline oxidase, His-466, participates in the oxidation of the
organic substrate but not in the reduction of molecular oxygen.
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CHAPTER V
On the Catalytic Role of the Conserved Active Site Residue His466 of Choline Oxidase

(This chapter was published in verbatim in Ghanem, M., and Gadda, G., (2005), Biochemistry
44, 893-904. © 2005 American Chemical Society. All rights reserved.)

Abstract

The oxidation of alcohols to aldehydes is catalyzed by a number of flavin-dependent
enzymes, which have been grouped in the Glucose-Methanol-Choline oxidoreductase enzyme
superfamily. These enzymes exhibit little sequence similarity in their substrates binding
domains, but share a highly conserved catalytic site, suggesting a similar activation mechanism
for the oxidation of their substrates. In this study, the fully conserved histidine residue at position
466 of choline oxidase was replaced with an alanine residue by site-directed mutagenesis and the
biochemical, spectroscopic, and mechanistic properties of the resulting CHO-H466A mutant
enzyme were characterized. CHO-H466A showed kcat and kcat/Km values with choline as
substrate that were 60- and 1000-fold lower than the wild-type enzyme, while the kcat/Km value
for oxygen was unaffected, suggesting the involvement of His466 in the oxidation of the alcohol
substrate but not in the reduction of oxygen. Replacement of His466 with alanine significantly
affected the microenvironment of the flavin, as indicated by the altered behavior of CHO-H466A
with sulfite and dithionite. In agreement with this conclusion, a midpoint reduction potential of
+106 mV for the two-electron transfer in the catalytically competent enzyme-product complex
was determined at pH 7 for CHO-H466A, which was ~25 mV more negative than that of the
wild-type enzyme. Enzymatic activity in CHO-H466A could be partially rescued with exogenous
imidazolium, but not imidazole, consistent with the protonated form of histidine exerting a
catalytic role. pH profiles for glycine betaine inhibition, the deprotonation of the N(3)-flavin
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locus, and the kcat/Km value for choline all showed a significant shift upward in their pKa values,
consistent with a change in the polarity of the active site. Finally, kinetic isotope effects with
isotopically labeled substrate and solvent indicated that the histidine to alanine substitution
affected the timing of substrate OH and CH bond cleavages, consistent with removal of the
hydroxyl proton being concerted with hydride transfer in the mutant enzyme. All taken together,
the results presented in this study suggest that in choline oxidase, His466 modulates the
electrophilicity of the enzyme-bound flavin and the polarity of the active site, and contributes to
the stabilization of the transition state for the oxidation of choline to betaine aldehyde.
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Introduction

The oxidation of alcohols to aldehydes is catalyzed by a number of flavin-dependent enzymes,
among which are choline oxidase (1, 2), choline dehydrogenase (3), glucose oxidase (4, 5),
cholesterol oxidase (6), and cellobiose dehydrogenase (7). These enzymes all utilize FAD as a
cofactor for catalysis and have been grouped in the Glucose-Methanol-Choline (GMC1)
oxidoreductase enzyme superfamily (8). Although GMC enzymes exhibit little sequence
similarity in their substrate binding domains, the crystal structure of glucose oxidase (9, 10),
cholesterol oxidase (11-13), and the flavin domain of cellobiose dehydrogenase (14), show that
they all share a highly conserved catalytic site (Figure 5.1), suggesting a similar activation
mechanism for the oxidation of their substrates. Recent mechanistic studies on choline oxidase
with the use of isotopically labeled substrate and solvent indicated that alcohol oxidation occurs
through a base-catalyzed formation of an alkoxide species that precedes the transfer of a hydride
from the substrate α-carbon to the isoalloxazine system of the FAD cofactor (Scheme 5.1) (15).
To date, the nature of both the catalytic base that abstracts the hydroxyl proton from the substrate
and the amino acid residue(s) that provide the necessary stabilization of the ensuing alkoxide
species in catalysis remains elusive. Earlier mechanistic studies on cholesterol oxidase (16, 17),
cellobiose dehydrogenase (18), and glucose oxidase (10, 19, 20), suggested that an histidine
residue, which is fully conserved within the GMC family and corresponds to His466 of choline
oxidase, might act as the specific base that participates in the oxidation of the alcohol substrate

1

Abbreviations: CHO-H466A, mutant form of choline oxidase with His466 replaced with Ala; CHO-WT, wild-type
choline oxidase; GMC, Glucose-Methanol-Choline oxidoreductase enzyme superfamily; Dkcat/Km and Dkcat/Km(D2O)
indicate substrate kinetic isotope effects determined with 1,2-[2H4]-choline in aqueous and deuterated solvent,
respectively; D2Okcat/Km and D2Okcat/Km(D) represent solvent kinetic isotope effects determined with choline and
deuterated choline, respectively; D,D2Okcat/Km is multiple kinetic isotope effect determined with choline in H2O and
deuterated choline in D2O.
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(Figure 5.1). However, the recent availability of a crystal structure of an unliganded form of
cholesterol oxidase at sub-atomic resolution, in which it was shown that the Nε2 position of the
active site His447 residue pointing at the substrate hydroxyl group is protonated (13), clearly does
not support this histidine residue acting as a specific base in catalysis. These structural
observations prompted the authors to suggest that the conserved histidine residue might act as a
hydrogen bond donor to the hydroxyl oxygen of the substrate, which would assist in positioning
the substrate with respect to the flavin for efficient catalysis (13).

A

B
E370

Q329
H516

H310 H466

C

H559

E412

N510
D

H689
N517

H447
E361
D530

N731

N485

Figure 5.1. The conserved active site residues in the GMC oxidoreductase superfamily.
Panel A, hypothetical structure of choline oxidase generated by using SWISS-MODEL software
and energy minimization by using SYBIL 6.9 software and the structure of glucose oxidase as
template; panel B, glucose oxidase (PDB code 1CF3); panel C, cholesterol oxidase (PDB code
1COY); panel D, cellobiose dehydrogenase (PDB code 1NAA).
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Our group recently cloned and overexpressed the gene coding for choline oxidase (E.C.
1.1.3.17) from Arthrobacter globiformis strain ATCC 8010 (21), and showed that the resulting
enzyme maintains biochemical and kinetic properties similar to those of the native choline
oxidase (21-23). The enzyme is a homodimer of 120 kDa, with each subunit containing
covalently bound FAD in a 8α-N(1)-histidyl linkage (21, 23, 24), and it catalyzes the oxidation
of choline to glycine betaine through two sequential flavin-linked hydride transfers from choline
and the ensuing betaine aldehyde intermediate to molecular oxygen (Scheme 5.2) (21-23). This
reaction is of considerable interest for medical and biotechnological applications, since
accumulation of glycine betaine in many pathogens and plants enables their stress-resistance
towards hyperosmotic environments (25, 26). Consequently, the study of choline oxidase has
potential for the development of therapeutic agents that inhibit the biosynthesis of glycine
betaine and render pathogenic bacteria susceptible to either conventional treatments or the innate
immune system, and for the improvement of water stress resistance in genetically engineered
crops lacking efficient glycine betaine biosynthetic systems.
In the present study, a mutant choline oxidase in which the active site residue His466 was
replaced with alanine was prepared by site-directed mutagenesis and the biochemical,
spectroscopic, and mechanistic properties of the resulting CHO-H466A mutant enzyme were
characterized in order to obtain insights on the catalytic role played by this conserved histidine
residue. The results of the studies presented herein provide new insights into the chemical
mechanism of choline oxidase and, by extension, of the GMC oxidoreductase enzyme
superfamily.
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Experimental Procedures
Materials. Escherichia coli strain Rosetta(DE3)pLysS were from Novagen (Madison,

WI). The QuikChange Site-Directed Mutagenesis kit was from Stratagene (La Jolla, CA). The
QIAprep Spin Miniprep kit was from Qiagen (Valencia, CA). Oligonucleotides used for sitedirected mutagenesis and for sequencing of the mutant gene were custom synthesized by the
DNA Core Facility of the Department of Biology of Georgia State University or by Sigma
Genosys (The Woodlands, TX). Oligonucleotides, bovine serum albumin, chloramphenicol,
tetracycline, isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite
(dithionite), sodium sulfite, betaine aldehyde, glycine betaine, Luria-Bertani agar and broth, and
PMSF were from Sigma (St. Louis, MO). Choline chloride and ampicillin were from ICN
(Aurora, OH). 1,2-[2H4]-Choline bromide was from Isotec Inc. (Miamisburg, OH). Deuterium
oxide (D2O) was from Cambridge Isotope Laboratories Inc. (Andover, MA). Wild-type choline
oxidase (CHO-WT) from Arthrobacter globiformis strain ATCC 8010 was expressed from
pET/codA1 and purified to homogeneity as previously described (21). The fully oxidized FADcontaining CHO-WT was prepared as described in ref. (27). All other reagents were of the
highest purity commercially available.
Instruments. UV-visible absorbance spectra were recorded using an Agilent

Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated water
bath. Fluorescence emission spectra were recorded with a Shimadzu Spectrofluorometer model
RF-5301 PC thermostated at 15 °C. Circular dichroism spectra were acquired using a Jasco J-810
spectropolarimeter at 5 °C.
Site-Directed Mutagenesis. A QuikChange kit was used to prepare the mutant enzyme

choline oxidase-H466A (CHO-H466A). The method used was essentially according to the
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manufacturer’s instructions, using pET/codA1 plasmid (21) as a template and Cho-H466Af
(5′CAACACCGTCTACGCCCCCGTGGGCACCGTGC

3′)

and

Cho-H466Ar

(5′CACGGTGCCCACGGGGGCGTAGACGGTGTTGTGC 3′) oligonucleotides as forward and
reverse primers (underlined letters indicate mismatches), respectively. DNA was sequenced at
the DNA Core Facility at Georgia State University using an Applied Biosystems Big Dye Kit on
an Applied Biosystems model ABI 377 DNA sequencer. Sequencing confirmed the presence of
the mutant gene in the correct orientation. E. coli strain Rosetta(DE3)pLysS competent cells
were transformed with plasmid pET/codA1-H466A by electroporation.
Expression and Purification of CHO-H466A. Permanent frozen stocks of E. coli cells

Rosetta(DE3)pLysS harboring plasmid pET/codA1-H466A were used to inoculate 4.5 liters of
Luria-Bertani broth medium containing 50 µg/ml ampicillin and 34 µg/ml chloramphenicol, and
liquid cultures were grown overnight at 37 °C. The cultures were induced for protein expression
by adding 0.1 mM IPTG and then incubated for an additional 5 h at 22 °C. A 100 µl aliquot was
taken 5 h after induction with IPTG to be used for visualization of the expressed protein using
sodium dodecyl sulfate polyacrylamide gel electrophoresis following the Laemmli method (28).
The gel was stained with Commassie Brilliant Blue G-250. The mutant enzyme CHO-H466A
was purified to homogeneity using the same procedure used previously for the purification of the
wild-type enzyme (21).
Spectral Studies. The extinction coefficient of CHO-H466A was determined in Tris-Cl,

pH 8, after denaturation of the enzyme by treatment with 0.1% SDS at 100 °C for 5 min, based
upon the ε450 value of 11.3 mM-1 cm-1 for free FAD (29). The spectral properties of CHO-WT
and CHO-H466A before and after the addition of 200 mM of glycine betaine were determined at
15 °C in 100 mM sodium pyrophosphate buffer, pH 6.5. All spectra were normalized to the
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molar extinction of the uncomplexed enzyme and corrected for dilution. For reactions with
sodium sulfite, the reagent was prepared freshly as 1 M stock solution in 100 mM sodium
pyrophosphate, pH 6.5. Different amounts of sodium sulfite at final concentrations ranging from
25 to 100 mM were added to the enzyme solution in 100 mM sodium pyrophosphate, pH 6.5, at
15 °C, and the UV-visible absorbance spectra were recorded at different times. Since previous
studies on wild type choline oxidase showed that the enzyme is reduced by treatment with
dithionite in the presence of oxygen (23), reduction of CHO-H466A with dithionite was carried
out aerobically in 20 mM Tris-Cl, pH 8, at 15 °C, by adding dithionite to the enzyme solution as
a powder. The excess amount of dithionite was removed by gel filtration using a Sephadex G-25
column equilibrated with 20 mM Tris-Cl, pH 8. The pH dependence of the absorbance spectra
for both wild-type and mutant enzymes at concentrations of ~20 µM in 20 mM sodium
phosphate, 20 mM sodium pyrophosphate, pH 6, and 15 °C, were determined by titrating with
sodium hydroxide.
The CD spectra of CHO-WT and CHO-H466A were recorded at 5 °C in 20 mM Tris-Cl,
pH 8, at concentrations of enzyme of 5 and 15 µM for the far and the near UV, respectively. The
fluorescence emission spectra of CHO-WT and CHO-H466A were acquired in 20 mM Tris-Cl
buffer, pH 8 at 15 °C. The excitation wavelengths for CHO-WT and CHO-H466A were 453 nm
and 458 nm, respectively.
Enzyme Assays. The enzymatic activity of CHO-H466A was measured by the method of

initial rates as described for the wild-type enzyme (21, 23) using a computer-interfaced Oxy-32
oxygen-monitoring system (Hansatech Instrument Ltd.). The kinetic parameters of CHO-H466A
were determined by varying the concentrations of both choline, in the range between 2.5 and 35
mM, and oxygen, in the range between 24 and 460 µM, as substrates, in 50 mM potassium
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phosphate, pH 7, at 25 °C. The effect of pH on the kinetic parameters of CHO-H466A were
determined over a pH range from 5.5 to 11 by a series of enzyme activity assays at varying
choline concentrations ranging from 0.025 to 45 mM in air-saturated 50 mM sodium
pyrophosphate at 25 °C. The kinetic isotope effects of CHO-H466A were obtained by
determining the kinetic parameters of the enzyme using either choline or 1,2-[2H4]-choline as
substrate in either aqueous or deuterated solvent, in air-saturated 50 mM sodium pyrophosphate
at 25 °C and pL 10. For the determinations of solvent isotope effects, buffers were prepared
using 99.9% deuterium oxide by adjusting the pD value with NaOD. The pD values were
determined by adding 0.4 to the pH electrode readings (30). For all steady state kinetic isotope
effects, activity assays were carried out by alternating substrate or solvent isoptomers. Product
inhibition studies were carried out by varying the concentrations of both glycine betaine, in the
range between zero and 60 mM, and choline, in the range between 0.02 and 20 mM, in airsaturated 50 mM sodium pyrophosphate at 25 °C, over a pH range from 7 to 11. The effect of
imidazole on the turnover number of CHO-H466A was determined by measuring the enzymatic
activity with 10 mM choline as substrate for the enzyme in the presence of varying
concentrations of imidazole in the range from 0 to 250 mM in air-saturated 50 mM potassium
phosphate, pH 7, or 50 mM sodium pyrophosphate for other pH values.
Potentiometric Titrations. All redox titrations of wild-type and H466A CHO were

carried out on the glycine betaine-liganded enzyme at 15 °C in a cell similar to the one described
by Edmondson (1985). Potentials were measured by using a Pt electrode relative to an Ag/AgCl
double junction reference electrode with an Orion Model 701A pH/mV meter (31). The reference
electrode was calibrated prior to each titration as described by Edmondson (31), using a
deoxygenated, saturated quinhydrone solution in 0.09 M KCl and 0.01 M HCl at 25 °C. In a
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typical titration, 2.5 ml of ~20-30 µM choline oxidase containing glycine betaine at a
concentration of 1.5 M in 20 mM Tris-Cl, pH 7, was scrubbed free of oxygen by at least 15
cycles of alternate degassing under vacuum and flushing with O2-free argon. The following
redox mediators were added to ensure complete redox equilibration: 2 µM methyl viologen (-440
mV), 0.5 µM dichlorophenolindophenol (+217 mV), 0.5 µM phenazine methosulfate (+80mV),
0.5 µM thionin (+60 mV), 0.5 µM duroquinone (-5 to +5 mV), 0.5 µM resorufin (-50 mV), and
0.5 µM indigo carmine (-125 mV) (32, 33). The ligand-bound enzyme solutions were titrated
electrochemically as described by Dutton (34), using freshly prepared sodium dithionite as
reductant and potassium ferricyanide as oxidant in 20 mM Tris-Cl, pH 7 (34). Adequate time
was permitted for electronic equilibration after each addition of sodium dithionite or potassium
ferricyanide prior to the spectrum being recorded; equilibrium of the system was considered to
be obtained when the measured potential drift was less than 1 mV in 5 min, which was typically
achieved after 30 to 60 min. UV-visible absorbance spectra were recorded using an Agilent
Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated cell
holder and a magnetic stirrer beneath the cell holder. All spectra were corrected for any drift in
the baseline by subtracting the absorbance at 800 nm.
Data Analysis. Kinetic data were fit with the KaleidaGraph software (Synergy Software,

Reading, PA) and the Enzfitter software (Biosoft, Cambridge, UK). Apparent kinetic parameters
in atmospheric oxygen were determined by fitting initial reaction rates at different substrate
concentrations to the Michaelis-Menten equation for one substrate. Initial rates determined by
varying the concentration of both choline and oxygen were fit to eq 1, which describes a
sequential steady-state kinetic mechanism. Ka and Kb are the Michaelis constants for choline (A)
and oxygen (B), respectively, and kcat is the turnover number of the enzyme (e). Product
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inhibition studies data were fit to eq 2, which describes competitive inhibition pattern of the
product and the organic substrate. P is the concentration of glycine betaine, and Kis is the
inhibition constant for the slope effect. The pH dependencies of steady-state kinetic parameters
were determined by fitting initial rate data to eq 3, which describes a curve with a slope of +1
and a plateau region at high pH. The pH dependence of inhibition by glycine betaine was
determined by fitting the initial rate data to eq 4, which describes a curve with a slope of -1 and a
plateau region at low pH. C is the pH-independent value of the kinetic parameter of interest. Data
of the pH dependencies of the absorbance spectra for both wild-type and mutant enzymes were
fit to eq 5, which describes a curve with a slope of -1 and plateau regions at low and high pH,
where A and B represent the absorbance values at 500 nm at low and high pH, respectively. The
mid-point reduction potentials of the enzymes were determined by fitting the data to the Nernst
equation (eq 6), where Eh is the measured electrode potential at equilibrium at each point in the
titration; Em is the mid-point redox potential; R is the gas constant, with a value of 8.31 J mol-1 at
15 °C; T is the temperature in Kelvin; n is the number of electron transferred; F is Faraday’s
constant, with a value of 96.48 kJ V-1 mol-1.
k cat AB
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Results
Expression and Purification of CHO-H466A. CHO-H466A was expressed and purified

to homogeneity as judged by SDS-PAGE using the same protocol developed for the wild-type
enzyme (data not shown). As for the case of the wild-type enzyme, about 150 mg of pure mutant
enzyme could be typically obtained from 4.5 liters of Luria-Bertani culture medium. The specific
activity of the H466A form of choline oxidase was ~45-times lower than that of the wild-type
enzyme [0.12 vs. 5.3 µmol O2 min-1 mg-1 (21)], suggesting that His466 plays a role in catalysis in
choline oxidase.
Spectral Properties. In order to verify that the mutant enzyme maintains an overall fold

similar to that of the wild-type enzyme, the structural properties of CHO-H466A were examined
using CD and fluorescence spectroscopy. The near- and the far-UV CD spectra of CHO-H466A
were found to be similar to those of the wild-type enzyme (Figure 5.2), suggesting an overall
fold of the mutant enzyme similar to that of the wild-type enzyme. As shown in Figure 5.2, the
protein fluorescence emission spectrum of CHO-H466A obtained upon excitation at 285 nm
yielded a peak at 340 nm, as for the case of the wild-type enzyme, but with increased intensity.
Such an increase in fluorescence intensity is consistent with either a decrease in the polarity of
the microenvironment surrounding nearby aromatic residues (35) or the removal of a quenching
effect upon substituting the active site histidine with an alanine residue, both effects attributable
to the presence of a tyrosine residue, Tyr465, adjacent to the site of mutation in the amino acid
sequence of the enzyme (21).
The UV-visible absorbance spectrum of CHO-H466A at pH 8 showed the typical flavin
peaks in the near-UV and visible region of the absorbance spectrum (Figure 5.2), indicating that
the enzyme-bound flavin cofactor in the mutant enzyme as purified is in the oxidized state. As
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expected for an enzyme containing covalently bound FAD, the soluble fraction prepared upon
treatment of CHO-H466A with 10% trichloroacetic acid followed by centrifugation to remove
the denatured protein was devoid of absorbance (data not shown). A stoichiometry of 0.32 ± 0.05
FAD per monomer of protein was calculated for CHO-H466A, indicating that the flavin content
of the mutant enzyme was significantly less than that of the wild-type choline oxidase, for which
a stoichiometry close to unity was previously reported2 (21). The enzyme-bound flavin of CHOH466A showed an extinction coefficient at 458 nm of 12 mM-1 cm-1, in agreement with the value
of 11.4 mM-1 cm-1 at 452 nm previously determined with the wild-type form of the enzyme (23).
The flavin fluorescence emission spectrum of CHO-H466A had a maximum at ~530 (λex at 458
nm), with a relative intensity of ~50% of that seen for the wild-type enzyme (Figure 5.2),
consistent with an altered flavin microenvironment in the mutant protein.
The absence of a flavin semiquinone in the UV-visible absorbance spectrum of CHOH466A as purified (Figure 5.2) is in stark contrast to the observation recently reported for the
wild-type form of choline oxidase, for which the enzyme-bound cofactor was found as a mixture
of oxidized and air-stable anionic semiquinone flavin species (21, 23). Treatment of the mutant
enzyme under aerobic conditions with dithionite at pH 8 resulted in the rapid bleaching of the
peak at 458 nm and the appearance of a spectrum with maxima at 372 and 495 nm (data not
shown), consistent with reduction of the enzyme-bound flavin to the semiquinone state, as for the
case of wild-type enzyme (23).
2

A lower flavin to protein stoichiometry was reported in earlier studies on mutant forms of trimethylamine
dehydrogenase and p-cresol methylhydroxylase, in which a positively charged arginine residue in the proximity of
the N(1)-C(2)=O locus of the flavin cofactor was selectively replaced (36, 37). Although the low degree of enzyme
flavinylation in CHO-H466A was not investigated further in this study, it is reasonable that the low flavin content in
the mutated enzyme might be due to the removal of the positively charged His466 (vide infra) from the active site of
the enzyme, which results in an altered flavin microenvironment in CHO-H466A. In this context, an effect of the
alanine replacement of His466 on the flavin microenvironment of choline oxidase is supported by several
observations presented herein.
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Figure 5.2. Comparison of the spectral properties of CHO-H466A (solid curves) and CHO-WT
(dotted curves).
Panels A and B, circular dichroism spectra of CHO-H466A and CHO-WT in 20 mM Tris-Cl, pH
8, at 5 °C. Enzyme concentrations were 15 and 5 µM for the near-UV and far-UV
determinations, respectively; panel C, protein fluorescence emission spectra of CHO-H466A and
CHO-WT in 20 mM Tris-Cl, pH 8, at 15 °C, the excitation wavelength was 285 nm for both
enzymes; panel D, UV-visible absorbance and fluorescence emission spectra of CHO-H466A
and CHO-WT in 20 mM Tris-Cl, pH 8, at 15 °C, the excitation wavelengths for CHO-WT and
CHO-H466A were 453 nm and 458 nm, respectively.

However, while no spectral changes were observed with the wild-type enzyme upon
aerobic incubation at pH 8 of the semiquinone-containing enzyme after removal of the excess
dithionite by gel filtration (23), complete reoxidation of the enzyme-bound anionic flavin
semiquinone was observed with CHO-H466A as indicated by the increase in absorbance at 458
nm (data not shown). These data clearly indicate that the lack of flavin semiquinone in the CHOH466A protein as purified is due to an impaired ability of this mutant enzyme to stabilize the
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anionic flavin semiquinone rather than to promote its formation. In contrast to wild type choline
oxidase, which was recently shown to form a tight reversible N(5)-flavin sulfite adduct with a Kd
value of ~50 µM at 15 °C (23), no significant absorbance changes were observed upon treatment
of CHO-H466A with either 25 or 100 mM sodium sulfite at pH 6.5 over 3.5 h of incubation
(Figure 5.3). All taken together, these data further suggest a change in the flavin
microenvironment upon replacing His466 with alanine.
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Figure 5.3. Reaction of CHO-H466A with sulfite.
UV-visible absorbance spectra of CHO-H466A after 3.5 hours of incubation with 100 mM
sodium sulfite in the absence (solid curve) or the presence (dotted curve) of 100 mM imidazole.
Enzyme concentrations were 50 µM in 100 mM sodium pyrophosphate, pH 6.5, at 15 °C.

Effect of pH on the Spectral Properties of CHO-H466A and Wild-type Choline
Oxidase. The effect of pH on the spectral properties of the histidine mutant was determined and

compared to that of wild-type enzyme. At pH 6, CHO-H466A exhibited absorbance maxima at
458 and 369 nm, whereas the wild-type enzyme showed maxima at 455 and 357 nm (data not
shown). As the pH is increased, a decrease in absorbance in the near-UV and visible regions of
the spectra associated with increased resolution in the 430-500 nm region were observed with
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both CHO-H466A and the wild-type enzymes (Figure 5.4). Such spectral perturbations are
consistent with deprotonation of the FAD at the N(3)-H position occurring as the pH is increased
(38). From the spectral changes at 500 nm, a pKa value of 9.3 ± 0.2 was determined for the
ionization of the N(3)-H locus of the enzyme-bound 8α-N(1)-histidyl-FAD in CHO-H466A
(Figure 5.4). Such a value compares well with the value of 9.7 that is observed for 8α-Nimidazoyl-riboflavin in solution (31). In contrast, a pKa value of 8.2 ± 0.1 was determined for the
wild-type enzyme (Figure 5.4). These data are consistent with His466 significantly affecting the
ionization of the oxidized flavin at the N(3)-H locus in choline oxidase, and with a change in the
flavin microenvironment upon replacing His466 with alanine.
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Figure 5.4. Effect of pH on the spectral properties of CHO-H466A and CHO-WT.
Absorbance spectra were recorded at an enzyme concentration of 21 µM in 20 mM sodium
phosphate, 20 mM sodium pyrophosphate, at 15 °C. Only selected difference absorbance spectra
in the pH range between 6 (curve 1) to 12 (curve 7) are shown for CHO-H466A. Insets, UVvisible absorbance values at 500 nm of CHO-H466A (•) and CHO-WT (○) as a function of pH;
the curves are fits of the data to eq (5).
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Redox Potentiometry. The mid-point reduction-oxidation potential of CHO-H466A in

complex with glycine betaine was determined through the reductive titration of the enzyme with
sodium dithionite as a reductant, and was compared to that for the wild-type form of the enzyme.
This determination was carried out on the glycine betaine-enzyme complex rather than the
unliganded enzyme because the catalytic transfers of hydride equivalents from choline and the
aldehyde intermediate to molecular oxygen via the flavin cofactor occur when the active site of
the enzyme is occupied by either the substrate or the product of the reaction (22, 23). As shown
in Figure 5.5, the oxidized flavin bound to CHO-H466A was reduced to the hydroquinone with
no significant formation of semiquinone species, as expected based on previous data indicating
that the enzyme under turnover cycles between the oxidized and reduced states3 (23). At pH 7, a
mid-point reduction-oxidation potential (Em,7) of +106 ± 0.5 mV was determined in two
independent experiments for CHO-H466A by fitting the data to Nernst equation (eq 6). A value
of 24 mV was calculated from the slope in a plot of the reduction-oxidation potential as a
function of the logarithm of [oxidized]/[reduced] flavin (Figure 5.5), in good agreement with the
theoretical value of 28.5 mV for a two-electron transfer reaction at 15 °C. A similar analysis of
the wild-type enzyme yielded an Em,7 value of +132 ± 1 mV for the two-electron transfer in the
glycine betaine-enzyme complex (data not shown), a value that is in keeping with previously
reported values for other flavoenzymes whose cofactor is covalently linked to the protein, such
3

Attempts to determine the Em,7 through the oxidative titration of the enzyme using potassium ferricyanide as an
oxidant failed with both the mutant and wild-type enzymes, mainly due to instability of the enzyme in the reduced
state over the prolonged times required for equilibration of the system after each addition of oxidant. Nonetheless,
we are confident of the quality of the data reported herein since with both the mutant and wild-type enzymes the Em,7
values determined in two independent experiments were in excellent agreement with each other. Furthermore, the
Em,7 values for both enzymes differed by less than 2% when the data where analyzed by using
(E m,7 − E)/ 28.5
, where a and b are component absorbance values contributed by the flavin in
A458 = a + b × 10
(E m,7 - E)/ 28.5

1 + 10

the oxidized and reduced states, respectively, and E and Em,7 are the electrode potential and the midpoint reductionoxidation potential for a two-electron transfer process, respectively (34, 39).
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as p-cresol methylhydroxylase (Em,7 = 84 mV) (40) or vanillyl alcohol oxidase (Em,7 = 55 mV)
(41). Consequently, a ~25 mV decrease in the reduction-oxidation potential of the enzyme-bound
flavin is effected by the replacement of the active site histidine with an alanine residue.
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Figure 5.5. Potentiometric redox titration of CHO-H466A in complex with glycine betaine.
Curve 1, UV-absorbance spectrum of the fully oxidized CHO-H466A at a concentration of ~23
µM in the presence of 1.5 M glycine betaine, in 20 mM Tris-Cl, pH 7 at 15 °C; curves 2-19, are
selected intermediate spectra recorded during the reduction of the ligand bound CHO-H466A
after each addition of sodium dithionite; curve 20, UV-absorbance spectrum of the fully reduced
ligand bound CHO-H466A. Inset, Nernst plot of the potentiometric data for the reduction of the
enzyme-bound flavin in CHO-H466A. The line is a fit of the data to eq 6.
Steady-State Kinetics. The steady-state kinetic parameters for wild-type choline oxidase

with choline as substrate were recently reported (23). Here, the steady-state kinetic parameters of
CHO-H466A were determined by monitoring the rate of oxygen consumption at varying
concentrations of both choline and oxygen at pH 7 and 25 °C. As expected from previous data
with the wild-type enzyme, the best fit of the data was observed to a sequential steady-state
kinetic mechanism (eq 1), consistent with the order of the kinetic steps involving substrate
binding and product release being not changed by the substitution of His466 with alanine. When
the kinetic parameters for CHO-H466A were compared to those of the wild-type enzyme (Table

222
5.1), a 60- and 1000-fold decrease in both the kcat and kcat/Km values for choline were observed,
respectively, indicating a direct participation of His466 in the oxidation of choline. In contrast, the
kcat/Km value for oxygen was only 1.5-times lower in CHO-H466A as compared to the wild-type

enzyme (Table 5.1), suggesting a minimal involvement of the histidine residue in the oxidation
of the enzyme-bound reduced flavin by molecular oxygen.
Rescuing Effects of Imidazole. From a structural standpoint, the histidine to alanine

mutation in the active site of choline oxidase is equivalent to the removal of an imidazole moiety
from the side chain of the amino acid residue at position 466. In principle, both the kinetic and
biochemical properties that have been affected by such a mutation should be at least partially
restored in the enzyme in the presence of exogenous imidazole. At pH 7, the kcat value with
choline as substrate increased in a concentration-dependent pattern with increasing amounts of
exogenous imidazole in the assay reaction mixture (Table 5.2), indicating that CHO-H466A
activity can be rescued by imidazole. In contrast, no significant effect was observed with the
wild-type enzyme under the same conditions. Although the effect of imidazole accounted for
only a limited rescue of the enzymatic activity of CHO-H466A when compared to that of the
wild-type enzyme, i.e., less than 10% at pH 7, it was nonetheless significant and allowed the
determination of the effect of pH on the imidazole effect in order to establish whether the
protonated or the unprotonated form of imidazole is responsible for the effect.
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Table 5.1. Steady State Kinetic Parameters of CHO-H466A and CHO-WT
with Choline as Substrate at pH 7a

CHO-H466A

CHO-WTb

1.1 ± 0.1

61 ± 6

Ka, mMc

29 ± 1

1.7 ± 0.3

kcat/Ka, M-1s-1 c

38 ± 2

36000 ± 6400

KO2, µM

21 ± 2

703 ± 102

55000 ± 5000

87100 ± 15300

8.5 ± 2.9

0.20 ± 0.05

0.997

0.998

kinetic parameters
kcat, s-1

kcat/KO2, M-1s-1
Kia, mM
R2
a

Enzymatic activity was measured by varying the concentrations of both
choline and oxygen in 50 mM potassium phosphate, pH 7, at 25 °C.
b
From ref. (23).
c
Ka and kcat/Ka are the Km and kcat/Km values for choline, respectively.

Table 5.2. The Effect of Imidazole on the Turnover Number of CHO-H466A at Different
pH Values a

PH

kcat, s-1b

kcat (Imidazole), s-1b

KImidazole, mMc

R2

5.5

0.03

0.21 ± 0.05

52 ± 6

0.998

6

0.07

0.32 ± 0.02

71 ±15

0.985

7

0.37

0.52 ± 0.06

18 ± 3

0.992

8

0.72

0.67d

ndf

Nd

10

0.73

0.70e

nd

Nd

a

Enzymatic activity was measured in the presence of imidazole (0-250 mM) with 10 mM
choline as a substrate in 50 mM air-saturated buffer at 25 °C.
b
kcat and kcat (Imidazole) are the turnover numbers of the enzyme in the absence and the
presence of saturated imidazole, respectively.
c
KImidazole is the concentration of imidazole at which half the maximal turnover number is
observed.
d,e
Turnover number in the presence of 80 mM and 100 mM imidazole, respectively.
f
nd, not determined.
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As summarized in Table 5.2, no changes on kcat with choline were observed in the
presence of imidazole at both pH 8 and 10, whereas 5- and 10-fold increases in the kcat values
were seen at pH 6 and 5.5, respectively. When the relative increase in the kcat values due to
exogenous imidazole was analyzed as a function of pH (Figure 5.6), the data could be fit to a
curve with a slope of -1 (eq 5), indicating a pH effect on the rescuing of the enzymatic activity of
CHO-H466A. These results clearly indicate that the protonated form of imidazole is the
catalytically relevant species responsible for the partial rescue of enzymatic activity in CHOH466A, thereby providing strong evidence against His466 acting as a the specific base in choline
oxidase.
Addition of exogenous imidazole was also effective in restoring the ability of CHOH466A to stabilize an N(5)-flavin adduct with sulfite, as indicated by the bleaching of the flavin
peak at 458 nm upon incubating the enzyme with 100 mM sodium sulfite at pH 6.5 in the
presence of 100 mM imidazole (Figure 5.3).
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Figure 5.6. pH dependence of the imidazole-rescued activity of CHO-H466A.
The percentage of increase in kcat values of CHO-H466A as a function of pH, calculated from the
ratio of the kcat value with choline measured in the presence of saturating imidazole to the kcat
value measured in the absence of imidazole. The curve is a fit of the data to eq 5.
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pH Dependence of the kcat and kcat/Km Values. Previous pH dependence studies with

choline oxidase established the requirement of a catalytic base with pKa value of ~7.5 in the
oxidation of choline but not in the subsequent oxidation of the reduced enzyme-bound flavin
(23). Here, the kinetic parameters of CHO-H466A were measured as a function of pH by varying
the concentration of choline in air-saturated buffer since, as previously shown, with wild-type
choline oxidase the pKa value determined in the kcat/Km pH profile for the organic substrate is
independent of the concentration of oxygen (21, 23, 27). With CHO-H466A, both the kcat/Km and
kcat values for choline increased with increasing pH and reached limiting values at high pH

(Figure 5.7), consistent with the requirement for an unprotonated group in catalysis with the
mutant enzyme. A pKa value of 9.0 ± 0.1 was determined in the pH profile for the kcat/Km value,
consistent with replacement of the histidine with an alanine at position 466 affecting the
electrostatic properties of the active site and with His466 not being the active site catalytic base in
choline oxidase4. A pKa value of 6.0 ± 0.1 was also determined in the pH profile of the kcat value
for CHO-H466A.
Substrate and Solvent Kinetic Isotope Effects. Substrate and solvent kinetic isotope

effects on the kcat/Km value with 1,2-[2H4]-choline as substrate for wild-type choline oxidase
were recently reported and are summarized in Table 5.3 (21). With that enzyme, the observed
D

kcat/Km value corresponds to the true kinetic isotope effect and can be used to probe the status of

the CH bond in catalysis, since at saturating oxygen concentrations both the forward and reverse
4

In principle, the results of the pH dependence studies of CHO-H466A are also consistent with the histidine residue
being the catalytic base in the wild-type enzyme, and with some amino acid residues other than His466 becoming the
catalytic base in the mutant enzyme devoid of histidine, as originally suggested for H447 of cholesterol oxidase (17).
If this were the case, the increase in the enzymatic activity of the CHO-H466A mutant protein in the presence of
imidazole should show pH dependence with maximal effects above pH 7, i.e., above the pKa value of imidazole, at
which the fraction of unprotonated imidazole that might act as a base is higher. The data presented in Figure 6
clearly do not support this alternative interpretation of the pH profile data.
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commitments to catalysis are negligible (21). Here, the effect of isotopically substituted choline
on the kcat/Km value with CHO-H466A was determined in air-saturated 50 mM sodium
pyrophosphate at pH 10 and 25 oC, at which the true kinetic isotope effects could be measured5.
With CHO-H466A there was a significant decrease in the Dkcat/Km value with respect to the wildtype enzyme (Table 5.3), consistent with either a nonlinear transition state in which the
stretching vibration of the hydride in motion is not completely lost in the transition state (42-44),
or with the kinetic step in which the substrate CH bond is cleaved becoming partially masked by
some other slow kinetic steps in the mutant enzyme. The effect of deuterated solvent, which was
previously used to establish that OH bond cleavage of the choline substrate is kinetically fast in
the reaction catalyzed by the wild-type enzyme (21), was also determined at a pL value of 10. As
shown in Table 5.3, a significant

D2O

kcat/Km value was observed with CHO-H466A, suggesting

that OH bond cleavage has become partially rate-limiting in the mutant enzyme. No significant
changes in the Dkcat/Km value were observed upon substituting H2O with D2O. Similarly, the
D2O

kcat/Km value was the same irrespective of the isotopic composition of the substrate. Finally, a

multiple kinetic isotope effect on the kcat/Km value that was equal to the product of the substrate
and the solvent isotope effects was determined. These kinetic data are consistent with removal of
the hydroxyl proton being concerted with hydride transfer to the flavin in CHO-H466A (45).
From a mechanistic standpoint, these data indicate that in choline oxidase the replacement of the
histidine at position 466 with an alanine residue results in a significant perturbation of the timing
of substrate bond cleavage in the oxidation of the choline substrate.

5

Under atmospheric oxygen conditions at 25 oC (i.e., with a concentration of dissolved oxygen of 0.25 mM), due to
the low Km value for oxygen with a value of 5 ± 2 µM at pH 10 (Ghanem, M., and Gadda, G.; unpublished data),
CHO-H466A is > 97% saturated with oxygen. Therefore, with CHO-H466A the true kinetic isotope effect could be
determined from the Dkcat/Km value under atmospheric conditions.

m

4

pK = 9.0 ± 0.1
a

2

2

cat

cat

4

pKa = 6.0 ± 0.1

0

6

8

pH

10

12

-1

0

-2
4

log k , s

log k /K , M s

-1 -1

227
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Figure 5.7. pH dependence of kcat/Km (•) and kcat (○) values of CHO-H466A for choline as
substrate.
Enzymatic activity was measured at varying concentrations of choline in air-saturated buffer
between pH 5.5 and 11, at 25 °C. The curves are fits of the data to eq 3.

Table 5.3. Substrate and Solvent Isotope Effects on the Oxidation of Choline
Catalyzed by CHO-H466A

CHO-H466Aa

CHO-WTb

D

6.3 ± 0.8

10.7 ± 2.6

D

6.0 ± 0.7

ndc

D2O

2.2 ± 0.3

1.1 ± 0.2

D2O

2.0 ± 0.2

nd

13.2 ± 1.3

10.4 ± 1.8

kinetic parameters
kcat/Km
kcat/Km(D2O)
kcat/Km
kcat/Km(D)

D, D2O

kcat/Km

a

Enzymatic activity was measured by varying the concentrations of either
choline or 1,2-[2H4]-choline in air-saturated 50 mM sodium pyrophosphate, pL
10, at 25 °C. Values shown are the average of two independent experiments.
b
From ref. (21).
c
nd, not determined.
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Binding of Glycine Betaine. Recent kinetic data showed that glycine betaine inhibits

choline oxidase by binding at the active site of the enzyme, resulting in spectral perturbations of
the UV-visible absorbance spectrum (23, 27). Here, the effect of glycine betaine binding on the
spectral properties of CHO-H466A was determined and compared to that of the wild-type
enzyme by recording the absorbance spectrum for the enzyme before and after the addition of
200 mM glycine betaine, at pH 6.5 and 15 °C. As shown in Figure 5.8, binding of the inhibitor to
the enzyme resulted in significant spectral perturbations in the 300 to 500 nm region of the
absorbance spectrum, with a maximal increase in absorbance at ~496 nm. In contrast, the wildtype enzyme produced a maximal increase in absorbance at ~450 nm upon binding glycine
betaine (Figure 5.8). The pH dependence of the inhibition by glycine betaine was determined in
atmospheric oxygen using choline as substrate for CHO-H466A. As shown in Figure 8, the data
were consistent with a single ionizable group that must be protonated for inhibition, as expected
from previous studies on the wild-type enzyme (23). Although the pKa value for such a
protonated group was poorly defined due to instability of the CHO-H466A enzyme at high pH
values, a pKa value ≥ 9 could be estimated from the visual inspection of the data in Figure 8.
Such a value is at least 1.5 pH units higher than the value of 7.5 previously determined for wildtype choline oxidase (23, 27, 46). Interestingly, glycine betaine binding was slightly tighter with
CHO-H466A than with the wild-type enzyme, as suggested by the limiting Kis values of 5.2 ±
0.5 and 12.5 ± 1.1 determined at low pH for the two enzymes (Figure 5.8), suggesting that His466
does not directly participate in product binding.
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Figure 5.8. Binding of glycine betaine to CHO-H466A.
Panel A, the UV-visible absorbance spectra of CHO-H466A at a concentration of 51 µM were
recorded in 100 mM sodium pyrophosphate, pH 6.5 and 15 °C, before (solid curve) and after
(dotted curve) the addition of 200 mM glycine betaine. Inset, comparison of the difference
spectrum of CHO-H466A (solid curve) with that of CHO-WT (dotted curve) under the same
conditions. Panel B, comparison between the pH dependence of the product inhibition of CHOH466A (•) and wild-type enzyme (○) from ref. (23), using glycine betaine. Enzymatic activity
was measured at varying concentrations of choline and glycine betaine in air-saturated buffer
between pH 7 and 11 for CHO-H466A, and between pH 5.5 to 9 for wild-type enzyme, at 25 °C.
The lines are fits of the data to eq 4. The Kis values for glycine betaine were determined by fitting
the initial rate data to eq 2.
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Discussion

The mutant form of choline oxidase in which the active site histidine at position 466 was
replaced by an alanine residue maintains structural and kinetic properties that are similar to those
of the wild-type enzyme, as indicated by both the spectroscopic and the steady-state kinetics data
presented in this study. Consequently, the mechanistic properties that allow the elucidation of the
role this amino acid residue plays in the reaction catalyzed by choline oxidase could be
investigated by using a combination of biochemical, spectroscopic, and mechanistic probes.
The active site residue His466 is involved in the oxidation of the choline substrate, but not
in the following reduction of molecular oxygen catalyzed by choline oxidase. Evidence
supporting this conclusion comes from the steady-state kinetic data with CHO-H466A as
compared to those with the wild-type enzyme, showing that the kcat/Km value for choline
decreases by three orders of magnitude whereas that for oxygen is not significantly changed in
the mutant enzyme. The lack of involvement of His466 in the oxidative half-reaction agrees well
with previous kinetic data on choline oxidase as a function of pH, showing that no ionizable
groups with pKa values between 6 and 10 are required for oxidation of the enzyme-bound
reduced flavin in catalysis (23).
His466 is likely not the specific base with pKa of ~7.5 that abstracts the hydroxyl proton of
the substrate in the reductive half-reaction in which choline is oxidized to betaine aldehyde.
Strong evidence supporting this conclusion comes from the pH dependence of the imidazole
effect with CHO-H466A, showing that imidazolium, but not imidazole, is the catalytically
relevant species responsible for the partial rescue of the enzymatic activity of the mutant
enzyme. These data are clearly difficult to reconcile with the assumption that His466 is the
catalytic base participating in the oxidation of choline since, if that were the case, maximal
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rescue of the enzymatic activity of the mutant enzyme would have been observed at increasing
pH. Consistent with His466 not being the catalytic base in choline oxidase, the limiting kcat/Km
value with choline at high pH is only ~20-fold lower in CHO-H466A as compared to the wildtype enzyme (23). In this respect, recent structural data at sub-atomic resolution showed that the
Nε2 atom of the equivalent histidine residue in the active site of cholesterol oxidase, His447, is
protonated, suggesting that this conserved residue in the GMC oxidoreductase superfamily may
play a role other than acting as a specific base in catalysis (13). In this context, a number of
observations presented in this study suggest that in choline oxidase His466 contributes to catalysis
by modulating the electrophilicity of the flavin cofactor and the polarity of the active site, and by
stabilizing the negative charge that is formed in the transition state for the oxidation of choline to
betaine aldehyde.
A significant contribution to the electrophilicity of the FAD cofactor, which accounts for
a fraction of the decreased rate of choline oxidation, is provided by the side chain of His466, as
indicated by the decrease of ~25 mV in the midpoint reduction potential of the enzyme-bound
flavin in CHO-H466A with respect to the wild-type choline oxidase. A direct electrostatic
interaction of the imidazole side chain, through its Nε2 locus, and the N(1)-locus of the flavin
cofactor was previously proposed in glucose oxidase based on X-ray crystallographic data (9),
suggesting that an analogous interaction might occur in choline oxidase (Figure 5.9). Evidence
supporting the presence of such an interaction in choline oxidase is provided by the lack of
stabilization of the anionic flavin semiquinone and of the sulfite N(5)-flavin adduct that were
observed with CHO-H466A, which is consistent with a change in the protein microenvironment
surrounding the N(1)-C(2)=O region of the flavin (36, 47-52). From the ∆Em,7 value of -25 mV
determined upon replacing H466 with alanine in choline oxidase one can calculate an energetic
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contribution of ~4.2 kJ mol-1, which accounts for a five-fold decrease in the rate of hydride
transfer to the flavin in the mutant enzyme as compared to the wild-type form of choline oxidase.
Since mechanistic investigations on wild-type choline oxidase are consistent with the kcat/Km
value for choline reflecting the kinetic step of choline oxidation (21), a ~20-fold decrease in the
rate of choline oxidation can be estimated from the ratio of the limiting kcat/Km values for choline
at high pH determined in this study with CHO-H466A and the wild-type enzyme (23).
Consequently, while His466 contributes to the electrophilicity of the enzyme-bound flavin for
efficient substrate oxidation, such an effect cannot fully explain the decreased catalytic activity
observed with the mutant enzyme, consistent with His466 contributing to catalysis by using also
other strategies (vide infra). The modulation of the redox potential of the flavin does not appear
to correlate with the rate of electron transfer from the reduced flavin to molecular oxygen, as
indicated by the similar kcat/Km values for oxygen of CHO-H466A and the wild-type enzyme.
Thus, it is likely that other factors, such as steric or solvation effects, are important in the
activation of the reduced flavin for reaction with molecular oxygen.
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Figure 5.9. Proposed interaction of His466 with the flavin N(5)-sulfite adduct.
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His466 provides stabilization to the transition state that is formed in the oxidation of
choline to betaine aldehyde, thereby facilitating the activation of the alcohol substrate for facile
hydride transfer to the flavin cofactor (Scheme 5.3). Such a transition state in the mechanism of
choline oxidase is supported by mechanistic studies on the wild-type form of choline oxidase
using substrate and solvent deuterium kinetic isotope effects. (21) Evidence for stabilization of
the alkoxide species by His466 comes from the effects of histidine replacement on the relative
timing for bond cleavage in the mutant enzyme, showing that the hydroxyl proton is in flight in
the transition state for CH bond cleavage. Indeed, the loss of stabilization of the alkoxide species
would make its formation energetically unfavorable, resulting in the loss of the "chelating effect"
provided by the electrostatic interaction in the wild-type enzyme. In the absence of such a
"chelating effect" catalysis would still occur, but it would be significantly slower because it
requires that the vibrational motions of the pairs of atoms involved in bond breaking and making,
i.e., the hydroxyl proton and the catalytic base along with the flavin N(5) and the α-carbon
hydrogen, be in phase to allow both proton and hydride transfer to occur. Alternatively, initiation
of the hydride transfer would decrease the pKa of the oxygen sufficiently for proton transfer to
the catalytic base. In either case, removal of the hydroxyl proton would be concerted with
hydride transfer, as was observed with CHO-H466A. Independent evidence for stabilization of
the alkoxide species comes from the complete loss of the ability of CHO-H466A to form an
N(5)-flavin adduct with sulfite, which is restored in the presence of exogenous imidazole.
Although following the seminal work of Massey (49-51), the ability of flavoenzymes to stabilize
a tight flavin adduct with sulfite has been mainly used as a probe of the electrophilicity of the
flavin, N(5)-flavin adducts with sulfite depend also on steric factors as well as stabilizing
interactions in the active site. With choline oxidase, it is likely that the negatively charged
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oxygen atom of the sulfite N(5)-flavin adduct is stabilized by a direct interaction with the side
chain of His466 (Figure 5.9). In the absence of this interaction, such as in the case of CHOH466A, the N(5)-flavin adduct with sulfite would not be stabilized; exogenous imidazole would
restore such an interaction in the mutant enzyme by bridging the methyl side chain of the alanine
residue at position 466 to the oxygen atom of the sulfite-flavin adduct. Such a direct interaction
between the sulfite oxygen and an active site amino acid residue was previously observed in the
three-dimensional structures of flavocytochrome b2 (53) and glycolate oxidase (52), providing
direct structural support for an analogous interaction in choline oxidase. The stabilization of the
transition state is likely provided by the protonated form of His466, as suggested by the pH
studies on the rescuing effect of the activity of CHO-H466A by exogenous imidazole, showing
that the enzymatic activity of the mutant enzyme can be partially restored by imidazolium, but
not imidazole. A stabilization of an alkoxide species by an active site tyrosine residue similar to
that proposed here for His466 of choline oxidase was recently proposed in flavocytochrome b2
(54), suggesting that this might be a common strategy utilized by flavin-dependent enzymes for
the oxidation of inactivated as well activated alcohols, such as α-hydroxy acids.
The polarity of the active site, which is essential for efficient proton transfer of the
hydroxyl proton from the alcohol substrate to the active site proton acceptor, is modulated by
His466. Evidence supporting this conclusion comes from the pH profiles of the absorbance
spectra of CHO-H466A and the wild-type enzyme, showing that the pKa value for the ionization
of the N(3) locus of FAD increases by one pH unit upon substituting His466 with alanine. Such an
increase in the pKa value is consistent with a decreased polarity in the protein microenvironment
surrounding the flavin N(3) locus (38). Consistent with a less polar active site, an increase in
both the protein fluorescence of the unliganded enzyme and the absorbance at 496 nm of the
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enzyme in complex with glycine betaine is seen with CHO-H466A with respect to the wild-type
enzyme (35, 38). The decrease in polarity of the active site of CHO-H466A results in the
perturbation of equilibria for ionization of groups that participate in catalysis, among which the
amino acid group that accepts the hydroxyl proton from the substrate. Indeed, in CHO-H466A
the pKa value for the catalytic base in the active site is raised from 7.5 to ~9, as indicated by the
pH profile of the kcat/Km values for choline. In agreement with previous studies on wild-type
choline oxidase (23), the same pKa value of ~9 is seen in the pH-profile of glycine betaine
inhibition with CHO-H466A. Thus, His466 appears to be important for regulating the reactivity
of the catalytic base that accepts the hydroxyl proton of the substrate for efficient catalysis.
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Scheme 5.3. Proposed role of His466 in stabilizing the transition state during the oxidation of
choline catalyzed by choline oxidase.

236
On the basis of the results of the rescuing experiments with imidazole, showing that the
activity of CHO-H466A can be partially rescued by imidazolium, one would expect His466 to
interact with the carboxylate moiety of the glycine betaine product of the reaction. This
expectation would be reinforced by the proposed role for His466 in the stabilization of the
alkoxide intermediate, since both the alkoxide and the carboxylate bear negatively charged
oxygen. If this were the case, a significant increase to the extent of 2 to 3 orders of magnitude
should be observed in the inhibition constant for glycine betaine with the CHO-H466A enzyme,
as in the case of mutant forms of D-amino acid oxidase (48) or sarcosine oxidase (55), where
positively charged groups on the enzyme that ion pair the carboxylate moieties of the product
were replaced. However, the results of the product inhibition studies show that binding of
glycine betaine to CHO-H466A is unaffected, if not slightly tighter, with respect to the wild-type
enzyme. In this respect, recent studies with a number of substituted product analogs indicated
that in choline oxidase the acetate moiety of glycine betaine does not contribute to binding, but
that the trimethylammonium headgroup is a major determinant instead (27). This apparent
discrepancy of His466 interacting with the negatively charged oxygen of the transient alkoxide
species but not with that of the carboxylate product is readily dissipated when one considers the
spatial location of their respective oxygen atoms with respect to the histidine residue. Indeed,
while the positioning of both the alkoxide and the product is dictated by the interactions
established in the active site by the trimethylammonium headgroup (27), the alkoxide oxygen is
linked to an sp3-hybridized carbon whereas the carboxylate oxygen is attached to an sp2hybridized carbon. The change from the tetrahedral configuration of the alkoxide to the planar
configuration of the carboxylate-containing product results in the carboxylate oxygen moving ~1
Å away from the side chain of His466, thereby abating the electrostatic interaction between the
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two charges. Although the results presented here do not allow us to draw any conclusion
concerning the binding of the substrate in choline oxidase, it is expected that due to the lack of a
negatively charged oxygen, binding of choline is somewhat weaker than that of the alkoxide. A
similar result where substitution of an active site histidine residue resulted in differential binding
of the substrate and the transition state was recently reported for (S)-mandelate dehydrogenase
(56).
In summary, the results presented herein using a combination of biochemical,
spectroscopic, and mechanistic approaches support evidence for the conserved His466 playing
multiple, but equally important, roles in the oxidation of the alcohol substrate catalyzed by
choline oxidase. This residue modulates the electrophilicity of the enzyme-bound FAD for
efficient hydride transfer from the substrate; it contributes to the polarity of the active site for
efficient proton transfer from the substrate hydroxyl oxygen; and, it stabilizes the choline
alkoxide transient species to facilitate hydride transfer from the substrate to the flavin. In light of
the structural similarities among the members of the GMC oxidoreductase superfamily, the
present results strongly suggest that those enzymes that catalyze the oxidation of unpolarized
alcohols are likely to use similar catalytic strategies. Finally, the conclusions presented herein
provide an example of the difficulty in developing a comprehensive description of the role
carried out by amino acid residues located at the active site of enzymes, which arises from the
complex nature of enzyme function to which individual residues are likely to contribute through
multiple strategies. Current studies in our laboratory are aimed at the elucidation of the nature of
the catalytic base that abstracts the hydroxyl proton from the alcohol substrate in the active site
of choline oxidase.
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CHAPTER VI
Effects of Reversing the Protein Positive Charge in Proximity of the N(1)-Flavin Locus of
Choline Oxidase

(This chapter was published in verbatim in Ghanem, M., and Gadda, G., (2006), Biochemistry
45, 3437-47. © 2006 American Chemical Society. All rights reserved.)

Abstract

A protein positive charge near the flavin N(1) locus is a distinguishing feature in common
to most flavoprotein oxidases, with mechanistic implications for the modulation of flavin
reactivity. A recent study showed that in the active site of choline oxidase the protein positive
charge is provided by His466. Here, we have reversed the charge by substitution with aspartate
(CHO-H466D), and for the first instance characterized a flavoprotein oxidase with a negative
charge near the flavin N(1) locus. CHO-H466D formed a stable complex with choline, but lost
the ability to oxidize the substrate. In contrast to the wild type enzyme, which binds FAD
covalently in a 1:1 ratio, CHO-H466D contained ~0.3 FAD per protein, of which 75% was not
covalently bound to the enzyme. Anaerobic reduction of CHO-H466D resulted in the formation
of neutral hydroquinone, with no stabilization of flavin semiquinone; in contrast, the anionic
semiquinone and hydroquinone species were observed with the wild type and a H466A variant of
the enzyme. The midpoint reduction potential for the oxidized/reduced couple in CHO-H466D
was ~160 mV lower than that of the wild type enzyme. Finally, CHO-H466D lost the ability to
form complexes with glycine betaine or sulfite. Thus, upon reversing the protein charge near the
FAD N(1) locus, choline oxidase lost the ability to stabilize negative charges in the active site,
irrespective of whether they develop on the flavin or are borne on ligands, resulting in defective
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flavinylation of the protein, decreased electrophilicity of the flavin, and consequent loss of
catalytic activity.
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Introduction

The presence of a protein positive charge proximal to the N(1) locus of the flavin has
been proposed in flavoprotein oxidases long before the three dimensional structures of a number
of flavin-dependent oxidases have become available (1-5). Indeed, most flavoprotein oxidases
stabilize thermodynamically the anionic flavin semiquinone (6-11), form a stable reversible
N(5)-flavin adduct with sulfite (1-4, 6, 7, 11-13), and stabilize the benzoquinoid anion forms of
6-hydroxy-, 8-hydroxy-, 6-mercapto-, and 8-mercapto-flavin analogs (4, 14-17), all features that
require the stabilization of a negative charge localized in the N(1)-C(2)=O region of the flavin.
The mechanistic implications for a protein positive charge stabilizing a negative charge on the
N(1) locus of the flavin are: i) to render flavin reduction thermodynamically favorable by
elevating the midpoint reduction-oxidation potential of the bound flavin (1, 4, 15, 17-19); ii) to
preferentially stabilize the anionic form of the reduced flavin that readily reacts with oxygen (14, 18, 19); iii) to facilitate the flavinylation process for those enzymes in which the flavin is

covalently linked to the protein moiety (20). To date, the X-ray crystallographic structures of
glucose oxidase from Aspergillus niger (21) and Penicillium amagasakiense (22), cholesterol
oxidase from Brevibacterium sterolicum (23) and Streptomyces sp. (24, 25), pyranose 2-oxidase
from Peniophora sp. (26) and Trametes multicolor (27), cellobiose dehydrogenase from
Phanerochaete chrysosporium (28), baker's yeast flavocytochrome b2 (29), spinach glycolate

oxidase (30), pig kidney D-amino acid oxidase (31), and bacterial sarcosine oxidase (32),
trimethylamine dehydrogenase (33), and dihydroorotate dehydrogenase (34), have shown that
either a positively charged amino acid residue or a dipole of an α-helix is oriented toward the
N(1)-C(2)=O region of the enzyme-bound flavin. While the effects of replacing the positive
charge with a neutral amino acid on the flavin properties have been investigated for lactate
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monooxygenase (35), no studies have addressed the characterization of the flavin properties of
an oxidase in which the positive charge close to the flavin N(1) was reversed.
Choline oxidase (E.C. 1.1.3.17) is a flavin-dependent enzyme that oxidizes choline to
glycine betaine via an enzyme-bound aldehyde intermediate (Scheme 1). This reaction is of
considerable interest for medical and biotechnological applications, since accumulation of
glycine betaine in many pathogens and plants enables their stress-resistance towards
hyperosmotic environments (36, 37). Choline oxidase has been characterized in its biophysical,
structural, and mechanistic properties. The enzyme is a homodimer with a mass of 120 kDa (38),
contains covalently linked FAD in a 1:1 stoichiometry (38), and under turnover cycles between
its fully oxidized and reduced states (39, 40). A detailed picture of the catalytic mechanism of
choline oxidase has emerged from pH, kinetic isotope, and temperature effects studies (39-43),
as well as mechanistic studies with substrate and product analogs (44) and site-directed mutants
(45). Briefly, in catalysis an unidentified active site base with pKa of 7.5 activates the alcohol
substrate with formation of an alkoxide species (species 1 in Scheme 2) (39), which is transiently
stabilized in the active site through electrostatic interaction with the imidazolium side chain of
His466 (45) (species 2 and 3 Scheme 2). Hydride transfer from the α-carbon of the substrate to
the enzyme-bound flavin occurs quantum mechanically from the activated choline alkoxide
species (species 3 in Scheme 2) (41). Substrate binding is mainly dictated by interactions
involving the trimethylammoniun headgroup of the alcohol, with little participation of the ethyl
moiety (44). In a recent study in which His466 was replaced with alanine, our group showed that
in catalysis His466 is protonated and that, besides stabilizing the transient alkoxide species that is
formed in catalysis, this protein group modulates the electrophilicity of the enzyme-bound FAD
and the polarity of the active site (species 3 in Scheme 2) (45). Consistent with the proposed
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roles, the recent determination of the X-ray structure of choline oxidase showed that His466 is
located at distance of ~3.3 Å from the N(1) locus of the enzyme-bound flavin (Figure 1) (George
Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished results).
In the present study, we have prepared by site-directed mutagenesis a choline oxidase variant in
which His466 was replaced with aspartate, and characterized the biochemical and biophysical
properties of the enzyme-bound flavin in the mutant enzyme bearing a negative charge at
position 466. The results presented show that the protein positive charge proximal to the flavin
N(1) locus is important for correct flavinylation of the enzyme, modulation of flavin reactivity
and, consequently, the catalytic activity of the enzyme.
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Figure 6.1. Line draw showing the interaction of His466 with the N(1)−C(2)═O locus of FAD
and the choline alkoxide species in the transition state for the oxidation of choline catalyzed by
choline oxidase.
The positioning of His466 relative to the flavin is from the X-ray crystallographic structure of the
enzyme recently determined at 1.86 Å resolution (George Lountos, Fan Fan, Giovanni Gadda,
and Allen M. Orville; unpublished results), the positioning of choline is arbitrary.
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Experimental Procedures
Materials. Escherichia coli strain Rosetta(DE3)pLysS was from Novagen (Madison,

WI). The QuikChange Site-Directed Mutagenesis kit was from Stratagene (La Jolla, CA). The
QIAprep Spin Miniprep kit was from Qiagen (Valencia, CA). Oligonucleotides used for sitedirected mutagenesis and for sequencing of the mutant gene were custom synthesized by the
DNA Core Facility of the Department of Biology of Georgia State University or by Sigma
Genosys (The Woodlands, TX). Nucleotides, bovine serum albumin, chloramphenicol,
tetracycline, isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite
(dithionite), sodium sulfite, betaine aldehyde, glycine betaine, xanthine, xanthine oxidase, LuriaBertani agar and broth, and PMSF were from Sigma (St. Louis, MO). Choline chloride and
ampicillin were from ICN (Aurora, OH). Recombinant choline oxidase (CHO-WT)1 from
Arthrobacter globiformis strain ATCC 8010 was expressed in E. coli strain Rosetta(DE3)pLysS

from plasmid pET/codA1 and purified to homogeneity as previously described (38). Fully
oxidized FAD-containing CHO-WT was prepared as described in ref. (44). The mutant form of
choline oxidase with histidine 466 replaced with alanine (CHO-H466A) was prepared, expressed
and purified to homogeneity according to ref. (45). All other reagents were of the highest purity
commercially available.
Instruments. UV-visible absorbance spectra were recorded using an Agilent

Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated water
bath. Fluorescence spectra were recorded with a Shimadzu Spectrofluorometer model RF-5301

1

CHO-WT, wild type choline oxidase; CHO-H466D, mutant form of choline oxidase with histidine 466 replaced
with aspartate; CHO-H466A, mutant form of choline oxidase with histidine 466 replaced with alanine; E'1 and E'2,
midpoint reduction-oxidation potential of the oxidized/semiquinone and semiquinone/reduced FAD redox couples;
E'm, 7, midpoint reduction-oxidation potential of the oxidized/reduced FAD redox couple determined at pH 7.
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PC thermostated at 15 °C. Enzymatic activity of choline oxidase was measured polarographically
using a computer-interfaced Oxy-32 oxygen-monitoring system (Hansatech Instrument Ltd.).
Site-Directed Mutagenesis. A QuikChange kit was used to prepare CHO-H466D, in

which histidine 466 was replaced with aspartate. The method used was essentially according to
the manufacturer’s instructions, using the pET/codA1 plasmid (38) as a template and ChoH466Df (5′-CAACACCGTCTACGACCCCGTGGGCACCGTGC-3′) and Cho-H466Dr (5′CACGGTGCCCACGGGGTCGTAGACGGTGTTGTGC-3′) oligonucleotides as forward and
reverse primers, respectively (underlined letters indicate mismatches). DNA was sequenced at
the DNA Core Facility at Georgia State University using an Applied Biosystems Big Dye Kit on
an Applied Biosystems model ABI 377 DNA sequencer. Sequencing confirmed the presence of
the correct mutation. E. coli strain Rosetta(DE3)pLysS competent cells were transformed with
plasmid pET/codA1-H466D by electroporation.
Expression and Purification of CHO-H466D. CHO-H466D was expressed and purified

to homogeneity as judged by SDS-PAGE using the same procedure used previously for the
purification of CHO-WT and CHO-H466A (38, 45). Glycerol at a final concentration of 10%
was incorporated in the buffers throughout the purification procedure to increase the stability of
the enzyme.
Spectrophotometric Studies. The UV-visible absorbance and fluorescence emission or

excitation spectra of CHO-H466D, CHO-WT and CHO-H466A, were acquired in 20 mM
sodium phosphate, 20 mM sodium pyrophosphate and 10% glycerol, pH 6 at 15 °C. The UVvisible absorbance spectra of the reduced form of enzymes were acquired using an anaerobic
cuvette in 50 mM sodium phosphate, 50 mM sodium pyrophosphate and 10% glycerol, pH 6 at
15 °C. The cuvette contained one ml final volume of enzyme at a final concentration between 20
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and 30 µM, 300 µM xanthine, and 10 µM methyl viologen. A sidearm attached to the cuvette
contained xanthine oxidase at a final concentration of ~0.5 µM. The cuvette and contents were
made anaerobic by at least 15 cycles of alternate degassing under vacuum and flushing with O2free argon. The enzyme solution was then mixed with xanthine oxidase in the side arm, and the
reduction of the enzyme-bound flavin was monitored spectrophotometrically. Spectra of the
reduced enzymes reported in this study were recorded prior to the accumulation of significant
amounts of viologen radical.
The extinction coefficient of CHO-H466D was determined in 20 mM Tris-Cl, pH 8, after
denaturation of the enzyme by incubation at 40 °C for one hour in the presence of urea at a final
concentration of 4 M, based upon the ε450 value of 11.3 mM-1 cm-1 for free FAD (46). A value of
12 mM-1 cm-1 was determined at 450 nm, which was similar to the values of 11.4 mM-1 cm-1 at
452 nm for CHO-WT and 12 mM-1 cm-1 at 458 nm for CHO-H466A (40, 45). For the
quantitation of covalently bound flavin, ~20 µM CHO-H466D was incubated on ice for 30 min
after the addition of 10 % trichloroacetic acid, followed by removal of precipitated protein by
centrifugation. The concentration of FAD was then determined in both the supernatant and the
pellet dissolved in 4 M urea solution as described above. Identification of the flavin cofactor
released by acid treatment was carried out through MALDI-TOF mass spectrometry in both
positive and negative ion modes using a 50:50 methanol/acetonitrile matrix. Anaerobic
incubation of CHO-H466D with choline was carried out in 20 mM Tris-Cl, pH 8, after
anaerobiosis was established by repeated cycles of alternate degassing under vacuum and
flushing with ultra-pure O2-free argon in an anaerobic cell equipped with two side arms. Choline,
at a final concentration of 10 mM, was initially loaded into a side arm and subsequently mixed
with CHO-H466D under anaerobiosis. Few grains of sodium dithionite were loaded into the
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second side arm and mixed with CHO-H466D in complex with choline after an hour of
anaerobic incubation to ensure the functionality of the enzyme-bound flavin. Binding of glycine
betaine and sulfite to the enzymes was carried out as previously described (40, 45). The pH
dependence of the UV-visible absorbance spectra of oxidized CHO-H466D was determined in
20 mM sodium phosphate, 20 mM sodium pyrophosphate, 10% glycerol, at 15 °C, by titrating
sodium hydroxide into the enzyme solution at pH 6. The pH dependences of the UV-visible
absorbance spectra of the reduced enzymes were determined in a custom made anaerobic cuvette
(Lillie Glassblowers, Smyrna, GA) that was fitted with a pH micro-electrode through a glass
joint and an anaerobic syringe containing sodium hydroxide. The cuvette contained 3 ml of
enzyme at a final concentration between 20 and 30 µM in 50 mM sodium phosphate, 50 mM
sodium pyrophosphate, and 10 % glycerol, pH 6. A sidearm attached to the cuvette was loaded
with choline at a final concentration of 150 mM. The cuvette and contents were made anaerobic
by at least 15 cycles of alternate degassing under vacuum and flushing with O2-free argon. The
enzyme solution was then mixed with choline in the side arm in order to reduce the enzymebound flavin. With CHO-H466D, which could not be reduced anaerobically with choline, a
syringe filled with anaerobic ~2 mM dithionite was inserted firstly into the cuvette under positive
argon

pressure,

and

the

reduction

of

the

enzyme-bound

flavin

was

monitored

spectrophotometrically until completion. In all the cases, once the UV-visible absorbance
spectrum of the hydroquinone species was observed, a pH micro-electrode and a syringe
containing anaerobic 3 M sodium hydroxide were mounted onto the anaerobic cuvette under
positive argon pressure. The pH of the anaerobic enzyme solution was then changed stepwise by
addition of the base, and both the pH and the UV-visible absorbance spectra were recorded after
each step.
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Potentiometric Titrations. The midpoint reduction-oxidation potentials of unliganded

CHO-H466D, CHO-H466A, and CHO-WT, were determined through the reductive titration of
the enzyme with sodium dithionite as a reductant as previously described for CHO-WT and
CHO-H466A in complex with glycine betaine (45).
Enzyme Assays. The enzymatic activity of CHO-H466D was measured polarographically

with choline by measuring the rate of oxygen consumption as described for the wild type enzyme
(38, 40).
Data Analysis. Data of the spectrophotometric titrations for complex formation between

choline oxidase and various ligands were fit to eq 1, where Y and A are the observed and
maximal absorbance changes at the selected wavelength, respectively, X is the concentration of
the varied ligand, and K is the complex dissociation constant. Data of the pH dependencies of the
absorbance spectra were fit to eq 2, which describes a curve with a slope of +1 and plateau
regions at low and high pH, where A and B represent the absorbance values at 500 nm at low and
high pH, respectively. The midpoint reduction-oxidation potentials of the enzymes were
determined by fitting the data to eq 3, where Eh is the observed electrode potential at equilibrium
at each point in the titration, E′m is the midpoint reduction-oxidation potential, R is the gas
constant, with a value of 8.31 J mol-1 K-1, T is the temperature in Kelvin, n is the number of
electrons transferred, and F is Faraday’s constant, with a value of 96.48 kJ V-1 mol-1.

Y=

AX
X +K

(1)
− pK a

Y = A ×10 −pH + B−×pK10
a
10 + 10

− pH

(2)
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E h = E' m + 2.303 RT
nF

log

[FAD Ox or Sq ]
[FADSq or Red ]

(3)
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Results
Expression and Purification of CHO-H466D. CHO-H466D was expressed and purified

at pH 8 to high level as judged by SDS-PAGE using the same protocol used for the wild type
enzyme (Figure 6.2). About 100-150 mg of pure CHO-H466D could be typically obtained from
4.5 liters of Luria-Bertani culture medium. In contrast to the wild type enzyme, for which 35 to
85% of the bound flavin exists at pH 8 in an air-stable anionic semiquinone state (38, 40) that
can be oxidized by extended incubation at pH 6 (40), the flavin in CHO-H466D was in the
oxidized state throughout the purification procedure. In this respect, CHO-H466D is similar to
CHO-H466A, for which no flavin semiquinone was observed in the UV-visible absorbance
spectrum of the purified enzyme (45). Purified CHO-H466D at final concentrations as high as 20
µM showed no oxygen consumption when assayed with 30 mM choline as a substrate at pH 7

and 25 oC. In comparison, the CHO-WT at a final concentration of 0.1 µM typically shows a
catalytic activity of ~15 s-1 with 10 mM choline (38), suggesting that replacement of the histidine
at position 466 with aspartate results in the complete loss of catalytic activity in choline oxidase.
1

2

3

4
60 kDa

Figure 6.2. Purification of CHO-H466D.
Lane 1, molecular weight marker proteins; lane 2, cell-free extract of Escherichia coli strain
Rosetta(DE3)pLysS harboring plasmid pET/codA-H466D induced with 0.05 mM IPTG for 5 h at
23 °C; lane 3, sample treated with 30 and 65% ammonium sulfate saturation; lane 4, purified
CHO-H466D in 20 mM Tris-Cl and 10% glycerol, pH 8, after DEAE-Sepharose column
chromatography. The molecular mass of the purified CHO-H466D is indicated.
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Spectral Properties of Oxidized CHO-H466D. The UV-visible absorbance spectrum of

oxidized CHO-H466D at pH 62 showed a 10 nm hypsochromic shift of the visible peak centered
at ~450 nm and a 10% decrease in the intensity of the 372 nm peak with respect to both CHOWT and CHO-H466A (Figure 6.3A), suggesting an altered protein microenvironment in the
protein containing aspartate at position 466. Accordingly, the relative intensity of the flavin
fluorescence emission at ~525 nm (with λex at 447 nm) was 5 and 10 times larger than that
observed with CHO-WT and CHO-H466A, respectively (Figure 6.3B). Similarly, the flavin
fluorescence excitation spectrum of CHO-H466D had maxima at 376 and 460 nm (with λem at
530 nm), with 5- and 10-fold the intensities seen with the CHO-WT and CHO-H466A (Figure
6.3C). In contrast, no significant differences were seen in the intensities of the protein
fluorescence emission peaks at 340 nm among the three different forms of enzyme (Figure
6.3D), suggesting that the overall folds of the mutant enzymes were similar to that of the wild
type enzyme. The spectral properties of oxidized CHO-H466D, CHO-WT and CHO-H466A, are
summarized in Table 6.1.

2

The spectral properties of the oxidized forms of CHO-WT, CHO-H466A, and CHO-H466D, were compared at pH
6 to avoid artifactual contributions on the UV-visible absorbance spectra due to pH, since the three enzyme variants
showed pH effects on the UV-visible absorbance spectra of the oxidized enzymes with pKa ≥ 8.2 (this study and ref.
(45).
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Figure 6.3. Comparison of the spectral properties of CHO-H466D, CHO-WT and CHO-H466A.
Comparison of the spectral properties of CHO-H466D (thick solid curves), CHO-WT (thin solid
curves) and CHO-H466A (dotted curves) in 20 mM sodium phosphate, 20 mM sodium
pyrophosphate and 10% glycerol, pH 6 at 15 °C. Panel A, UV-visible absorbance spectra of the
oxidized and reduced species of enzymes after treatment with xanthine (300 µM) and xanthine
oxidase (~0.5 µM). Inset, difference absorbance spectrum of oxidized CHO-H466D (thick solid
curve) minus that of CHO-WT as a reference; panel B, flavin fluorescence emission spectra, the
excitation wavelengths were 447, 457 and 457 nm for CHO-H466D, CHO-WT and CHOH466A, respectively; panel C, flavin fluorescence excitation spectra, the emission wavelength
was 530 nm for all forms of enzyme; panel D, protein fluorescence emission spectra, the
excitation wavelengths were 285 nm.
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Table 6.1. Comparison of the Spectral Properties Parameters of CHO-H466D, CHO-H466A, and
CHO-WT, at pH 6
CHO-H466D
CHO-H466A
CHO-WT
E-FADOx
UV-visible absorbance (λmax, nm)
276, 372, 447
267, 361, 457
279, 366, 457
ε (mM-1 cm-1)
210, 10, 12
272, 11.8, 13
154, 11.3, 12.4
Stoichiometry (FAD/protein)
0.29 ± 0.03
0.32 ± 0.05 a
0.88 ± 0.12 b
% of FAD covalently bound
~25%
100% a
100% b
Fluorescence emission (λmax, nm)
524
524
525
λex = 447 or 457 nm
522
519
524
λex = 372, 361 or 366 nm
335
342
339
λex = 285 nm
Fluorescence excitation (λmax, nm)
λem = 530 nm
376, 460
371, 475
361, 470
a
pKa (N(3)−H)
9.3 ± 0.2
8.2 ± 0.1 a
10.3 ± 0.1
E-FADRed
UV-visible absorbance (λmax, nm)
~340, ~400
~350, ~400
347
ε (mM-1 cm-1)
~6.7, ~2.9
~5.8, ~3.3
4.2
E-FADOx-glycine betaine
UV-visible absorbance (λmax, nm)
nd c
361, 459
358, 455
Kd, mM
nd
15 ± 2
4.2 ± 0.4
Kis, mM d
nd
5.2 ± 0.5
13 ± 1
a
b
c
d
From ref (45). From ref (38). Not determined. Limiting inhibition constant determined
kinetically with choline as substrate at low pH; from ref (45).

Flavin Stoichiometry and Content of CHO-H466D. Previous studies showed that

choline oxidase contains covalently linked FAD in a 1:1 stoichiometry (38). In contrast, upon
denaturation of the CHO-H466D variant by treatment with urea, a stoichiometry of 0.29 ± 0.03
FAD per monomer of enzyme could be determined from two independent experiments. Similar
flavin content was previously reported for the CHO-H466A variant (Table 6.1) (45), suggesting
that the flavin content in choline oxidase is significantly affected by replacement of the active
site histidine with either a neutral or anionic amino acid residue. Interestingly, treatment of
CHO-H466D with 10% cold trichloroacetic acid followed by centrifugation to remove the
denatured protein yielded a UV-visible absorbance spectrum of the soluble fraction with peaks at
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370 and 450 nm, suggesting that at least part of the flavin in CHO-H466D is not covalently
bound (Figure 6.4). A MALDI-TOF mass spectrometric analysis of the flavin released from
CHO-H466D yielded a m/z− ratio of 784.1 (Figure 6.4), consistent with the non-covalently bound
flavin in CHO-H466D being FAD. From the intensities of the peaks at 450 nm in the supernatant
and pellet dissolved in 4 M urea obtained upon acid treatment of CHO-H466D, it was estimated
that ~75% of the flavin in CHO-H466D is tightly but not covalently bound to the enzyme. These
data clearly suggest that reversing the positive charge in proximity of the FAD N(1) locus affects
not only the flavin content in the protein but also the extent of protein flavinylation.
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Figure 6.4. Stoichiometry and flavin content of CHO-H466D.
Thick solid curve, UV-visible absorbance spectrum of CHO-H466D in 20 mM Tris-Cl and 10%
glycerol, pH 8; dotted curve, UV-visible absorbance spectrum of the soluble fraction after
treatment of CHO-H466D with 10% of trichloroacetic acid for 30 min on ice and centrifugation
to remove denatured protein; thin solid curve, UV-visible absorbance spectrum of the denatured
precipitated fraction after solubilization in 4 M urea. Inset, MALDI-TOF mass spectrometric
analysis of the soluble fraction after treatment of CHO-H466D with 10% of trichloroacetic acid.
The spectrum was recorded in negative ion mode with a 50:50 methanol/acetonitrile matrix.
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Spectrophotometric Properties of Reduced CHO-H466D. The UV-visible absorbance

spectrum of the fully reduced form of CHO-H466D was obtained by anaerobic incubation of the
enzyme with xanthine and xanthine oxidase, at pH 6. As shown in Figure 6.3A, an indistinct
shoulder with no well-defined peaks was observed in the 400 to 450 nm region of the absorbance
spectrum of CHO-H466D hydroquinone, suggesting that at pH 6 the flavin hydroquinone bound
to this enzyme variant was present in the neutral form (47-49). During the reduction process, no
flavin semiquinone intermediate was observed (data not shown). A similar reduction of CHOWT yielded a UV-visible absorbance spectrum with a well-defined peak at 347 nm (Figure
6.3A), consistent with previous data on anaerobic substrate reduction of the wild type enzyme
that suggested the presence of the reduced flavin in the anionic state (40). In the case of CHOH466A, anaerobic reduction of the enzyme at pH 6 resulted in a UV-visible absorbance spectrum
with features that were intermediate between those of CHO-H466D and CHO-WT, i.e., both a
poorly defined peak at ~350 nm and a shoulder in the 400 nm region (Figure 6.3A). Thus, at pH
6 the reduced flavin in CHO-H466A is likely present as a mixture of anionic and neutral
hydroquinones. The spectral properties of the three enzyme variants in the reduced state are
summarized in Table 6.1.
Effect of pH on the Spectrophotometric Properties of CHO-H466D. The effects of pH

on the UV-visible absorbance spectra of CHO-H466D were determined on the oxidized and
reduced enzymes. As shown in Figure 6.5, the absorbance at 500 nm increased between limiting
values upon increasing pH, yielding a pKa value of 10.3 ± 0.1, which could be assigned to the
ionization of the N(3) locus of the oxidized enzyme-bound FAD (50). Previous data on CHOH466A and CHO-WT yielded pKa values of ~9.3 and ~8.2, respectively (45), consistent with
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significant changes in the microenvironment surrounding the FAD N(3) locus upon replacing
His466 with a neutral or anionic amino acid.
No significant spectral changes were observed in the UV-visible absorbance spectrum of
CHO-H466D hydroquinone upon raising the pH from 6 to 10, consistent with the neutral species
of the reduced flavin being stabilized in this pH range (data not shown). Similarly, no spectral
changes were observed in the same pH range with CHO-WT hydroquinone, suggesting that
ionization of the N(1) position of FAD has a pKa significantly lower than 6 or that the N(1)
position of FAD is not solvent accessible in the wild type reduced enzyme (data not shown). In
contrast, the UV-visible absorbance spectrum of CHO-H466A hydroquinone at pH 8 showed
features that are typically associated with the anionic reduced flavin, i.e., a distinct peak at 356
nm (Figure 6.6). Thus, in CHO-H466A the relative amount of anionic versus neutral
hydroquinone increased significantly upon increasing the pH from 6 to 8, suggesting that the
flavin N(1) locus in this enzyme variant is both solvent accessible and ionizable in this pH range.
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Figure 6.5. Effect of pH on the spectral properties of CHO-H466D.
UV-visible absorbance spectra were recorded at an enzyme concentration of ~20 µM in 20 mM
sodium phosphate, 20 mM sodium pyrophosphate and 10% glycerol, at 15 °C. Only selected
spectra are shown for the enzyme at pH 6 (thick solid curve), pH 10 (dotted curve), and pH 12
(thin solid curve). Inset, Absorbance values at 500 nm as a function of pH; data were fit to eq (2).

263

-1

ε, mM cm

-1

20
15
1

10
356 nm

5
0
300

20

400

500

600

700

800

Wavelength, nm
Figure 6.6. Anaerobic reduction of CHO-H466A using xanthine and xanthine oxidase.
Anaerobic reduction of CHO-H466A with 300 µM xanthine and ~0.5 µM xanthine oxidase in 50
mM sodium phosphate, 50 mM sodium pyrophosphate and 10% glycerol, at pH 8 and 15 °C.
Curve 1: UV-visible absorbance spectrum of the fully oxidized species of the enzyme.
Unnumbered curves: selected intermediate spectra recorded during the reduction of the enzyme
showing the formation of anionic flavin semiquinone. Curve 20: UV-visible absorbance
spectrum of the hydroquinone form of enzyme.
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Figure 6.7. Potentiometric reduction titration of CHO-H466D in complex with choline.
Curve 1: UV-visible absorbance spectrum of the fully oxidized CHO-H466D at an ambient
redox potential of +267 mV at a concentration of ~20 µM in the presence of 10 mM choline, in
20 mM Tris-Cl and 10% glycerol, pH 7, at 15 °C. Curves 2-4: selected intermediate spectra
recorded during reduction of the ligand-bound CHO-H466D after each addition of sodium
dithionite at ambient redox potentials of +40, –77, and –130 mV, respectively. Curve 5: UVvisible absorbance spectrum of the fully reduced ligand-bound CHO-H466D at ambient redox
potential of -217 mV, showing significant turbidity of the reduced enzyme solution.
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Redox Potentiometry of Unliganded CHO-H466D, CHO-H466A, and CHO-WT.

Previous studies established that with choline oxidase in complex with glycine betaine the
replacement of His466 with alanine resulted in a decrease of the midpoint reduction-oxidation
potential for the oxidized-reduced flavin couple from +132 mV to +106 mV at pH 7 (45). Since
CHO-H466D does not bind glycine betaine, but forms a stable complex without reacting with
choline (vide infra), here we have attempted to determine the reduction-oxidation potential of
CHO-H466D in the presence of 10 mM choline at pH 7 and 15 oC. However, significant
turbidity of the enzyme solution developed during the course of the reduction (Figure 6.7),
preventing the determination of the reduction-oxidation potential of CHO-H466D in complex
with a ligand. Consequently, the midpoint reduction-oxidation potential of CHO-H466D, and
those for CHO-WT and CHO-H466A for comparison, were determined on the free enzymes in
the absence of ligands at pH 7. With both CHO-WT and CHO-H466A, the midpoint reductionoxidation potentials for the first and second reducing equivalents were well separated, resulting
in the thermodynamic stabilization of the flavin anionic semiquinone species (Figure 6.8A-D). In
agreement with the observed potentials for the first and second electron transfer equilibria, 100%
and 90% of flavin semiquinones were seen with CHO-WT and CHO-H466A, respectively
(Figure 6.8E and Table 6.2). In contrast, with CHO-H466D no flavin semiquinone was observed
during reduction of the enzyme at pH 7 resulting in the determination of the E'm, 7 values for the
oxidized-reduced enzyme couple (Figure 6.8F). In all cases, the analyses of the data according to
the Nernst formalism yielded lines in plots of Eh versus log ([oxidized or semiquinone
species]/[semiquinone or reduced species]) with slopes of ~59 and 35 for the one- and twoelectron transfers, respectively, in agreement with the expected values of 57 and 28.5 mV at 15
o

C (Figure 6.8 and Table 6.2). As illustrated in Table 6.2, the E'm, 7 for the transfer of the two
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electrons with CHO-H466D had a value that was ~130 mV and ~160 mV more negative than the
calculated midpoint potentials for the corresponding two-electron transfers in CHO-H466A and
CHO-WT. These data are consistent with a significant effect of the amino acid residue at
position 466 on the electrophilicity of the enzyme-bound flavin in choline oxidase. Interestingly,
the midpoint reduction-oxidation potential for the oxidized-semiquinone couple in wild type
choline oxidase was +211 mV, which is to our knowledge the highest value for such
thermodynamic equilibrium reported for a flavoprotein oxidase (9, 11, 51-56).

Table 6.2. Midpoint Reduction-Oxidation Potentials for the Enzyme-FAD of Unliganded CHOWT, CHO-H466A, and CHO-H466D, at pH 7a
Enzyme
E′1 (mV)b
E′2 (mV)c
E′m, 7 (mV)d
% Sq
[slope, mV]
[slope, mV]
[slope, mV]

CHO-WT
CHO-H466A
CHO-H466D
a

+211 ± 2

-65 ± 2

+91 ± 2

-6 ± 2

naf

[60 ± 3]
[57 ± 3]

100

+73e

[59 ± 3]

90

+42.5e

Na

0

[57 ± 4]

b

-89 ± 1
[35 ± 1]

Conducted in 20 mM Tris-Cl, pH 7, at 15 °C.
Midpoint potential (n =1) of
oxidized/semiquinone FAD redox couple. c Midpoint potential (n =1) of
semiquinone/hydroquinone FAD redox couple. d Midpoint potential (n =2) of
oxidized/hydroquinone FAD redox couple. e Calculated midpoint potential for CHO-WT
CHO-H466A (E′m, 7 = (E′1 + E′2)/2; (57)). f Not available.
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Figure 6.8. Potentiometric reduction-oxidation titration of CHO-WT, CHO-H466A, and CHOH466D.
Potentiometric reduction-oxidation titration of CHO-WT (Panel A and B), CHO-H466A (Panel
C and D), and CHO-H466D (Panel F) at concentrations of ~20 µM, in 20 mM Tris-Cl, pH 7 at
15 °C. Curves 1, UV-visible absorbance spectra of the oxidized species of enzymes; curves 2,
UV-visible absorbance spectra of the maximum red anionic semiquinone that formed during the
reductive titrations; curves 3, UV-visible absorbance spectra of the fully reduced species of
enzymes. Panel E, quantitation of the amount of flavin semiquinone formed with CHO-WT (left
panel) and CHO-H466A (right panel). Insets, determination of the midpoint reduction potentials:
Panel A, B, C, and D Nernst plots of the potentiometric data for the reduction of the enzymebound flavin in CHO-WT and CHO-H466A (panel A and C: OxÆSq; panel B and D: SqÆRed),
data were fit to eq (3); panel F, Nernst plot of the potentiometric data for the reduction of the
enzyme-bound flavin in CHO-H466D (OxÆRed), data were fit to eq (3).
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Binding of Choline, Glycine Betaine, and Sulfite to CHO-H466D. In agreement with

the lack of oxygen consumption of CHO-H466D when assayed polarographically with choline as
substrate, the anaerobic mixing of this mutant protein with 10 mM choline resulted in no
bleaching of the flavin peak at ~450 nm over 60 min of incubation, as shown in Figure 6.9A.
However, a 4 nm batochromic shift associated with an increase in absorbance at 375 nm was
observed in the UV-visible absorbance spectrum of CHO-H466D in the presence of choline
(Figure 6.9A). These spectral changes were similar to those seen for the CHO-H466A variant in
complex with glycine betaine (Figure 6.10B), suggesting that CHO-H466D retained the ability to
bind choline at the active site without subsequent oxidation of the substrate. The lack of
reactivity of CHO-H466D with choline was exploited for the determination of an equilibrium
constant for the dissociation of choline from the enzyme (Kd) of 0.45 ± 0.04 mM at pH 8, which
was carried out spectrophotometrically by following the UV-visible spectral changes of the
enzyme in the visible region at increasing concentrations of choline (Figure 6.9B). Such a Kd
value was four-times lower than the Kd value of ~1.8 mM that was recently determined through
rapid reaction studies of CHO-WT reacting with choline at pH 8 (58), suggesting that reversing
the charge at position 466 results in a slightly tighter binding of choline to the active site of the
enzyme.
The lack of enzymatic activity of CHO-H466D prevented a kinetic determination of the
inhibition constant for binding of glycine betaine to the enzyme, as was previously carried out
for both CHO-WT (40) and CHO-H466A (45). Consequently, the determination of the
dissociation constant for glycine betaine binding was carried out on the wild type and mutant
forms of choline oxidase by following the spectral changes associated with mixing of the enzyme
with increasing concentrations of ligand. With both CHO-WT and CHO-H466A, Kd values for

268
glycine betaine binding that were in good agreement with those previously determined using the
kinetic approach could be determined at pH 6 (Figure 6.10A-B and Table 6.1) (40, 45). In
contrast, no significant spectral changes could be observed with CHO-H466D at concentrations
of glycine betaine as high as 80 mM (Figure 6.10C), suggesting that choline oxidase lost the
ability to bind glycine betaine upon replacing the active site histidine with aspartate.
Wild type choline oxidase was shown previously to form a tight reversible N(5)-flavin
sulfite adduct with a Kd value of ~50 µM at pH 7 and 15 °C (40). In contrast, with CHO-H466A
an N(5)-flavin sulfite adduct could be obtained only in the presence of exogenous imidazole,
while in the absence of imidazole no adduct could be formed even after 3.5 h of incubation of
CHO-H466A with 100 mM sulfite (45). Similarly, no spectral changes could be detected here
when CHO-H466D was incubated for 3 h at pH 6 and 15 oC in the presence of 100 mM sodium
sulfite (Figure 6.11), consistent with lack of stabilization of the sulfite-flavin adduct in CHOH466D.
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Figure 6.9. Binding of choline to CHO-H466D.
Panel A, UV-visible absorbance spectra of CHO-H466D were recorded at a concentration of ~30
µM in 20 mM Tris-Cl, pH 8 and 15 °C, before (thick solid curve), after one hour of anaerobic
incubation of the enzyme with 10 mM choline (dotted curve) and after the addition of dithionite
powder (thin solid curve). Inset, difference spectrum of the enzyme bound choline to the free
enzyme; panel B, difference absorbance spectra of CHO-H466D at a concentration of ~20 µM in
20 mM Tris-Cl, pH 8 and 15 °C, during the aerobic titration of choline in the concentration range
between zero (curve 1) and 3.5 mM (curve 12). Inset, Absorbance values at 500 nm as a function
of choline concentration; data were fit to eq 1.
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Figure 6.10. Binding of glycine betaine to CHO-WT, CHO-H466A and CHO-H466D.
Difference spectra of CHO-WT (panel A) and CHO-H466A (panel B) during the aerobic
titration of glycine betaine in a concentration range between zero (curves 1, panel A and B) and
62 mM (curve 10, panel A) or 23 mM (curve 11, panel B). Insets, Absorbance values at 457 nm
(panel A) and 496 nm (panel B) as a function of glycine betaine concentration for CHO-WT and
CHO-H466A; the curves are fits of the data to eq 1. Panel C, UV-visible absorbance spectra of
CHO-H466D before (solid curve) and after aerobic titration of glycine betaine up to a final
concentration of ~80 mM (dotted curve). Absorbance spectra were recorded at enzymes
concentration of ~20 µM in 20 mM sodium phosphate, 20 mM sodium pyrophosphate and 10%
glycerol, pH 6.
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Figure 6.11. Reaction of CHO-H466D with sulfite.
UV-visible absorbance spectra of CHO-H466D before (solid curve) and after 3 h of aerobic
incubation with 100 mM sodium sulfite (dotted curve). Enzyme concentration was 15 µM in 100
mM sodium pyrophosphate, pH 6, at 15 °C.
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Discussion

A recent biochemical and mechanistic study on a mutant form of choline oxidase in
which the active site histidine at position 466 was replaced with alanine established the
involvement of His466 in the reductive half-reaction in which choline is oxidized to betaine
aldehyde, but not in the following oxidative half-reaction in which oxygen is reduced to
hydrogen peroxide (45). Of particular interest was the finding that in catalysis His466 is
protonated, as suggested by the observation that the enzymatic activity of CHO-H466A could be
partially rescued in the presence of exogenous imidazolium, but not imidazole (45). The
positively charged His466 was proposed to play multiple roles in the oxidation of choline
catalyzed by choline oxidase, by contributing to the polarity of the active site, stabilizing the
negatively charged transition state, and activating the flavin for the oxidation reaction (45). As
illustrated in Scheme 6.2, the contribution of His466 to the active site polarity would be required
for the efficient removal of the substrate hydroxyl proton that results in the activation of the
substrate (species 1 and 2). The stabilization of the resulting choline alkoxide species (species 2)
and the activation of the enzyme-bound flavin (species 3) would correctly position and facilitate
the quantum mechanical transfer of the hydride from the substrate α-carbon to the N(5) flavin
locus (species 3) (39, 45, 58). The recent determination of the crystal structure of choline oxidase
showed that His466 is located in the active site at ~3.3 Å from the N(1) locus of the flavin (Figure
6.1) (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished results),
consistent with the proposed roles for this residue in catalysis. In the present study, we have
prepared a second variant of choline oxidase in which His466 was replaced with an aspartate
residue by site-directed mutagenesis, and investigated the effects of reversing the charge in
proximity of the N(1) locus of the flavin by using biochemical and biophysical approaches.
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From a biophysical standpoint, reversing the protein positive charge at position 466 in
choline oxidase results in the lack of stabilization of the negative charge that is produced on the
N(1) locus of the enzyme-bound flavin in the one- and two-electron reduced forms of choline
oxidase. Evidence for this conclusion comes primarily from the UV-visible absorbance spectrum
of the two-electron reduced form of CHO-H466D at pH 6, which is consistent with the enzymebound flavin hydroquinone being in the neutral state (47-49). The lack of changes in the UVvisible absorbance spectrum of the reduced flavin upon raising the pH from 6 to 10 is further
consistent with stabilization of the neutral flavin hydroquinone in CHO-H466D being due to the
effect of the negatively charged aspartyl side chain, since such a residue is expected not to
change its ionization state above pH 6. In contrast, the wild type enzyme stabilizes the anionic
form of hydroquinone between pH 6 and 10, as shown by the well-resolved peak at 356 nm in
the UV-visible absorbance spectrum of the two-electron reduced enzyme. These data, in turn,
suggest that the histidyl side chain at position 466 either decreases the pKa value for the
ionization of the N(1) FAD locus in the reduced enzyme to values below 6 or hinders solvent
accessibility to the N(1) locus, thereby preventing its protonation during flavin reduction. In
agreement with these conclusions, the alanyl variant of the enzyme, which carries a small and
neutral side chain proximal to the FAD N(1) position, exists as a mixture of neutral and anionic
hydroquinones at pH 6 and as the anionic species at pH 8. Different stabilization of the negative
charge on the N(1) locus of the flavin in the hystidyl, alanyl, and aspartyl enzymes is
independently suggested by the observation that the anionic flavin semiquinone was stabilized at
pH 7 only in the wild type and H466A mutant enzymes, but not in CHO-H466D. These results
suggest that at least in choline oxidase the removal of the positive charge in proximity of the
N(1) locus of the flavin is not sufficient to destabilize the anionic flavin semiquinone, and that
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such a destabilization requires the presence of a protein negative charge. Finally, the lack of
changes in the UV-visible absorbance spectrum of oxidized CHO-H466D in the presence of
sodium sulfite, which was previously observed to form a tight reversible N(5)-flavin adduct with
the wild type enzyme (40), provides independent evidence that replacing the protein positive
charge at position 466 results in lack of stabilization of the negative charge on the N(1)-C(2)=O
flavin locus.
The most dramatic effect arising from the lack of stabilization of the negative charge on
the pyrimidine ring of the reduced flavin in CHO-H466D is that about 75% of the enzyme-bound
FAD is tightly, but not covalently, bound to the protein moiety. This conclusion is supported by
the analysis of the supernatant obtained upon acid treatment of the enzyme containing aspartate
at position 466 followed by centrifugation to remove the denatured protein. In contrast, both
CHO-WT and CHO-H466A have been recently reported to contain only covalently bound FAD
(38, 45), suggesting that replacing the protein positive charge close to the N(1) atom of the flavin
with a neutral residue is not sufficient to affect the flavinylation of the enzyme. With both the
aspartyl and alanyl mutant proteins the total FAD content was three- to four-fold lower than that
previously observed for the wild type enzyme, in which a 1:1 stoichiometry of FAD to protein
was established, further suggesting that the presence of a protein positive charge close to the
N(1) position of the flavin is important for the formation of the covalent linkage between FAD
and the protein in choline oxidase. These results are in keeping with other studies recently
reported on trimethylamine dehydrogenase, sarcosine oxidase, N-methyltryptophan oxidase, and
p-cresol methylhydroxylase (20, 59-62), suggesting that a positively charged microenvironment

close to the flavin N(1)-C(2)=O locus is important for the stabilization of negatively charged
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reduced flavin that is proposed to transiently form during the covalent attachment of the flavin to
either the 6- or 8-position of the isoalloxazine ring (62).
From a functional standpoint, the most notable effect of reversing the protein positive
charge on the side chain at position 466 in choline oxidase is a ~160 mV decrease in the
midpoint reduction-oxidation potential of the enzyme-bound flavin for the two-electron transfer
occurring between the oxidized and reduced enzyme-bound flavin. Such an effect arises from
both the lack of covalent linkage between the enzyme-bound flavin and the protein and the
presence of the negatively charged aspartyl side chain near the flavin N(1) locus. Earlier results
on a number of flavin-dependent enzymes containing covalently bound flavins, namely
cholesterol oxidase (63), vanillyl-alcohol oxidase (55), and p-cresol methylhydroxylase (54),
showed that, irrespective of the type of flavin linkage and protein, removing the covalent linkage
between the flavin and the enzyme results in a decrease of the E'm, 7 value of the bound flavin of
~100 mV. If one assumes a similar contribution to the E'm, 7 value of ~100 mV from the covalent
linkage in choline oxidase, the effect of the negative charge of the aspartyl side chain on the
midpoint reduction-oxidation potential of the flavin in CHO-H466D can be estimated at -60 mV.
Since a 30 mV decrease in the E'm, 7 value was observed in this study upon replacing His466 with
alanine, it can be concluded that the electrophilicity of the enzyme-bound flavin is increased by
~6 kJ mol-1 in the presence of a positive charge and decreased by a similar extent in the presence
of a negative charge near the N(1) locus of the flavin. A similar energetic contribution of a
protein positive charge near the flavin N(1) locus on the electrophilicity of the flavin was
previously reported for lactate monooxygenase, where substituting Lys266 with a methionine
residue resulted in a decrease of 30 mV in the midpoint reduction-oxidation potential of the
flavin (35). Although replacement of a histidine with either an aspartate or glutamate residue was
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previously reported in cholesterol oxidase from Brevibacterium sterolicum, no potentiometric
data were reported in that study (64). Consequently, this is the first instance in which the effect
of reversing the charge near the flavin N(1) locus on the electrophilicity of the enzyme-bound
flavin has been investigated in a flavin-dependent oxidase.
Reversing the positive charge of His466 with aspartate in choline oxidase results in the
complete loss of enzymatic activity, as suggested by the lack of both oxygen consumption and
bleaching of the enzyme-bound flavin upon mixing CHO-H466D with choline. The loss of
enzymatic activity correlates well with the ∆E'm, 7 value of ~160 mV observed between CHOH466D and CHO-WT, which accounts for a ~250,000-fold decrease in the rate of hydride
transfer to the flavin in the H466D mutant enzyme as compared to the wild type enzyme3.
However, the 30 mV decrease in the E'm, 7 value observed here for CHO-H466A, which agrees
well with the previously reported value of ~25 mV (45), cannot fully explain the 20-fold
decrease in the rate of choline oxidation that was previously reported for CHO-H466A as
compared to the wild type enzyme (45). With CHO-H466A, the decrease in catalytic activity was
explained by both a decrease in the flavin electrophilicity, which is reflected in the E'm, 7 value,
and the lack of stabilization of the negatively charged alkoxide species that is transiently formed
in the oxidation of choline (45). The data presented here with CHO-H466D, which could not
bind glycine betaine or sulfite, suggest that also the H466D variant likely lost the ability to
stabilize extra negative charges in the active site4. Similar results in which the enzyme did not
3

A more rigorous approach for the correlation of the loss of enzymatic activity of CHO-H466D with the change in
the midpoint oxidation-reduction potential of the enzyme-bound flavin would entail a study of the linear free energy
relationship of the rate of flavin reduction using choline oxidase reconstituted with a number of flavin analogues.
Such an analyses was beyond the purpose of the current study.
4
The denaturation of the enzyme that ensues upon anaerobic reduction of CHO-H466D in complex with saturating
concentrations of choline is also consistent with inability of CHO-H466D to accommodate an extra negative charge
in the active site. Indeed, while the anaerobic reduction of the free unliganded enzyme results in the stabilization of
the neutral hydroquinone, it is likely that the presence of choline in the active site hinders solvent access to the N(1)
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show catalytic activity upon replacing the protein positive charge near the flavin N(1) locus were
previously reported for active site mutant forms of cholesterol oxidase in which His447, which is
the residue equivalent to His466 of choline oxidase, was replaced by either a glutamate or
aspartate residue. However, in that study the characterization of the enzyme-bound flavin was
not reported.
Our recent study on the H466A mutant protein of choline oxidase showed that the
enzymatic activity of the enzyme is only 20-times lower than that of the wild type enzyme and
that, most importantly, the enzymatic activity could be partially rescued in the presence of
exogenous imidazolium but not imidazole in the assay reaction mixture (45). Although these data
are consistent with H466 acting as an electrostatic catalyst by stabilizing the transient alkoxide
species that forms in the oxidation of choline (species 2 and 3 in Scheme 6.2), they do not
unequivocally rule out His466 as being the general base catalyst that removes the hydroxyl proton
of the substrate (species 1 in Scheme 6.2). Indeed, His466 would still be able to electrostatically
stabilize the anionic species of the substrate after removing the hydroxyl proton from the
substrate and acquiring a positive charge. If this were the case, substitution of His466 with
aspartate would be expected to generate a mutant enzyme with at least partial catalytic activity,
since the negatively charged aspartyl side chain at position 466 would be neutralized upon
abstracting the substrate hydroxyl proton, thereby allowing the transient formation of the
alkoxide species. However, the observation that CHO-H466D is completely devoid of enzymatic
activity with choline is not consistent with Asp466 acting as a base in the active site of the
aspartyl mutant of choline oxidase.

position of the bound flavin, thereby preventing its protonation during reduction with the consequent unfolding of
the protein due to charge repulsion between Asp466 and the negatively charged reduced flavin.
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In summary, the results of the biochemical and biophysical investigation of a choline
oxidase variant in which the protein charge near the flavin N(1) locus was reversed by sitedirected mutagenesis suggest that the enzyme has lost the ability to stabilize negative charges in
the active site, irrespective of whether they develop on the flavin or are borne on active site
ligands. This effect results in the defective flavinylation of the protein, decreased electrophilicity
of the enzyme-bound flavin and, consequently, loss of catalytic activity in the enzyme. The latter
conclusion is further consistent with His466 in the wild type enzyme not acting as a general base
catalyst in the reductive half-reaction in which choline is initially activated to the alkoxide
species upon removal of its hydroxyl proton. Taken together, the data presented here provide
further evidence for the importance of a protein positive charge close to the N(1) flavin in
choline oxidase and, by extension, in flavoprotein oxidases, and indicate that the enzyme loses
its functionality upon reversing, but not neutralizing, such a positive charge.
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CHAPTER VII
On the Role of the Active Site Residue His310 of Choline Oxidase

Abstract

Choline oxidase (E.C. 1.1.3.17) from Arthrobacter globiformis is a member of the
Glucose-Methanol-Choline (GMC) oxidoreductase enzyme superfamily. The enzyme catalyzes
the oxidation of choline to glycine betaine through two sequential flavin-linked hydride transfers
from choline and the ensuing betaine aldehyde intermediate to molecular oxygen. The presence
of a protein positive charge close to the N(1) locus of the bound flavin is a common
characteristic feature of flavoprotein oxidases. Recent studies revealed that in the active site of
choline oxidase the protein positive charge is provided by His466, which is located at a distance
of ~3.3 Å from the N(1) locus of the enzyme-bound flavin (His466Nε2-N(1)-FAD). The X-ray
crystal structure of choline oxidase also showed that another histidine residue, His310, is located
at a distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1). To assess the contribution made by
His310 in catalysis, a mutant form of the enzyme was prepared in which the active site residue
His310 was substituted with alanine. Polarographic preliminary results on the enzyme obtained by
substituting His310 by an alanine residue showed that the purified mutant enzyme completely lost
its catalytic activity with choline as substrate, suggesting the involvement of His310 in catalysis.
However, spectrophotometrically, CHO-H310A was still able to bind choline with the
subsequent reduction of the enzyme-bound flavin, which happened significantly slower than with
the wild-type form of choline oxidase (16 h vs 1 s) and in a biphasic way. The results obtained
herein also indicated the involvement of His310 in the flavinylation process and the binding of the
coenzyme to the polypeptide chain of the protein as the removal of this residue resulted in a
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significant alteration of the stoichiometric amount of the flavin. Therefore, these results together
with the structural information suggest an important role of His310 in catalysis and the
modulation of the enzyme-bound flavin.
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Introduction

Choline oxidase (E.C. 1.1.3.17) is a flavin-dependent cytosolic enzyme that catalyzes the
oxidation of choline to glycine betaine via an enzyme-bound aldehyde intermediate (Scheme
7.1). This reaction is of considerable interest for medical and biotechnological applications, since
accumulation of glycine betaine in many pathogens and plants enables their stress-resistance
towards hyperosmotic environments (1, 2). Therefore, the study of choline oxidase has potential
for the development of therapeutic agents that inhibit the biosynthesis of glycine betaine and
render pathogenic bacteria susceptible to either conventional treatments or the innate immune
system, and for the improvement of water stress resistance in genetically engineered crops
lacking efficient glycine betaine biosynthetic systems. Choline oxidase has been characterized in
its biophysical, structural, and mechanistic properties. The enzyme is a homodimer with a mass
of 120 kDa (3), contains covalently linked FAD in a 1:1 stoichiometry (3), and under turnover
cycles between its fully oxidized and reduced states (4, 5). A detailed picture of the mechanism
of the reaction catalyzed by choline oxidase was obtained from the biophysical, kinetic,
structural and mechanistic studies of the wild-type Arthrobacter globiformis choline oxidase as
well as selected mutant forms of the enzyme (4-11). In summary, during the reductive halfreaction, the alcohol substrate, choline, is activated through the proton abstraction of its hydroxyl
group by an unidentified active site base with pKa of 7.5 with the subsequent formation of an
alkoxide species (4). This choline alkoxide intermediate species is transiently stabilized in the
active site through an electrostatic interaction with the N(3) atom of the protonated imidazole
side chain of His466 (Figure 7.1) (10). Hydride transfer from the α-carbon of the substrate to the
N(5) locus of the isoalloxazine nucleus of the enzyme-bound FAD occurs quantum mechanically
from the activated choline alkoxide species (6). The trimethylammoniun headgroup of the
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substrate alcohol is the major determinant for substrate binding and specificity, with little
participation of the ethyl moiety (9).
The presence of a protein positive charge close to the N(1) locus of the bound flavin is a
common characteristic feature of flavoprotein oxidases. In recent studies our group showed that
in the active site of choline oxidase the protein positive charge is provided by His466 (10, 11),
which is located at a distance of ~3.3 Å from the N(1) locus of the enzyme-bound flavin
(His466Nε2-N(1)-FAD) (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville;
unpublished results). The X-ray crystal structure of choline oxidase also showed that another
histidine residue, His310, is at a distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1) (Figure 7.2).
In addition, the X-ray crystallographic data of the enzyme also showed that the N(3) atom of
His310 is located at a distance of ~2.8 Å from the carbonyl main chain oxygen atoms of Thr380
and Val507 (Figure 7.2). These structural data, along with our previous studies on the role of the
conserved active site His466 residue suggest that His466 is hydrogen bonded to both N(1)-FAD
and His310Nδ1 through its N(3) and N(1) atoms, respectively. Moreover, these data also suggest
that His310 is hydrogen bonded to the carbonyl oxygen atoms of Thr380 and Val507 through its
N(3) atom (Figure 7.2). Accordingly, one would expect the existence a proton-transfer network
between the protonated conserved active site residue His466 and His310.
In the present study, to assess the contribution made by His310 in catalysis, a mutant form
of choline oxidase was prepared in which His310 was substituted with alanine.
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Scheme 7.1. Reaction catalyzed by choline oxidase.
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Figure 7.1. Line draw showing the interaction of His466 with the N(1)−C(2)═O locus of FAD
and the choline alkoxide species in the transition state for the oxidation of choline catalyzed by
choline oxidase.
The positioning of His466 relative to the flavin is from the X-ray crystallographic structure of the
enzyme recently determined at 1.86 Å resolution (George Lountos, Fan Fan, Giovanni Gadda,
and Allen M. Orville; unpublished results), the positioning of choline is arbitrary.
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Figure 7.2. Crystal structure of choline oxidase.
X-ray crystallographic structure of the active site of choline oxidase determined at 1.86 Å
resolution (George Lountos, Fan Fan, Giovanni Gadda, and Allen M. Orville; unpublished
results).
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Experimental Procedures
Materials. Escherichia coli strain Rosetta(DE3)pLysS was from Novagen (Madison,

WI). The QuikChange Site-Directed Mutagenesis kit was from Stratagene (La Jolla, CA). The
QIAprep Spin Miniprep kit was from Qiagen (Valencia, CA). Oligonucleotides used for sitedirected mutagenesis and for sequencing of the mutant gene were custom synthesized by the
DNA Core Facility of the Department of Biology of Georgia State University or by Sigma
Genosys (The Woodlands, TX). Oligonucleotides, bovine serum albumin, chloramphenicol,
tetracycline, isopropyl-β-D-thiogalactopyranoside (IPTG), lysozyme, sodium hydrosulfite
(dithionite), sodium sulfite, betaine aldehyde, glycine betaine, Luria-Bertani agar and broth, and
PMSF were from Sigma (St. Louis, MO). Choline chloride and ampicillin were from ICN
(Aurora, OH). Wild-type choline oxidase (CHO-WT) from Arthrobacter globiformis strain
ATCC 8010 was expressed from pET/codA1 and purified to homogeneity as previously
described (3). The fully oxidized FAD-containing CHO-WT was prepared as described in ref.(9).
All other reagents were of the highest purity commercially available.
Instruments. UV-visible absorbance spectra were recorded using an Agilent

Technologies diode-array spectrophotometer model HP 8453 equipped with a thermostated water
bath. Rapid kinetics was carried out on a Hi-Tech SF-61 stopped-flow spectrophotometer
thermostated at 15

C.

Site-Directed Mutagenesis. A QuikChange kit was used to prepare the mutant forms of

choline oxidase (CHO-H310A; CHO-H310D; and CHO-H310N). The method used was
essentially according to the manufacturer’s instructions, using pET/codA1 plasmid (3) as a
template and Cho-H310Af (5′ CGAGCACCTGCAGGACGCCCCGGAAGGCGTGG 3′); ChoH310Df (5′ GGGCGAGCACCTGCAGGACGACCCGGAAGGCGTGGTGC 3′); Cho-H310Nf
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(5′ GGGCGAGCACCTGCAGGACAACCCGGAAGGCGTGGTGC 3′) and Cho-H310Ar (5′
GCACCACGCCTTCCGGGGCGTCCTGCAGGTGCTCGCC

3′);

ChoH310Dr

(5′

GCACCACGCCTTCCGGGTCGTCCTGCAGGTGCTCGCC

3′);

Cho-H310Nr

(5′

GCACCACGCCTTCCGGGTTGTCCTGCAGGTGCTCGCC 3′) oligonucleotides as forward
and reverse primers, respectively (underlined letters indicate mismatches). DNA was sequenced
at the DNA Core Facility at Georgia State University using an Applied Biosystems Big Dye Kit
on an Applied Biosystems model ABI 377 DNA sequencer. Sequencing confirmed the presence
of the mutant genes in the correct orientation. E. coli strain Rosetta(DE3)pLysS competent cells
were transformed with pET plasmids harboring the mutant genes by electroporation.
Expression and Purification of CHO-H310A. CHO-H310A was expressed and purified

to homogeneity as judged by SDS-PAGE using the same procedure used previously for the
purification of CHO-WT and CHO-H466A (3, 10). The enzyme as purified was stored at -20 °C
in 20 mM Tris-Cl and 10% glycerol (to increase the solubility and stability of the purified
enzyme), pH 8.
Spectrophotometric Studies. The UV-visible absorbance spectra of CHO-H310A were

acquired in 20 mM Tris-Cl and 10% glycerol, pH 8, at 15 °C. The extinction coefficient of CHOH310A was determined in 20 mM Tris-Cl, pH 8, after denaturation of the enzyme by incubation
at 40 °C for 3.5 h in the presence of urea at a final concentration of 4 M, based upon the ε450
value of 11.3 mM-1 cm-1 for free FAD (12). For the quantitation of the ratio of the covalently to
the uncovalently bound flavin to the enzyme, ~ 20 µM of enzyme was incubated on ice for 30
min after the addition of 10 % trichloroacetate, followed by removal of precipitated protein by
centrifugation, and the determination of the concentration of FAD in the supernatant solution.
For the anaerobic reaction of CHO-H310A with its organic substrate, choline, CHO-H310A in
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20 mM Tris-Cl and 10% glycerol, pH 8, was made anaerobic by repeated cycles of alternate
degassing under vacuum and flushing with ultra-pure O2-free argon in an anaerobic cell
equipped with two side arms. The organic substrate, choline was loaded into one side arm and
was mixed with CHO-H310A at final concentrations ranging from 0.5 to 20 mM and incubated
for 16-40 h.
Enzyme Assays. The enzymatic activity of CHO-H310A was measured by the method of

initial rates as described for the wild-type enzyme (3, 5) using a computer-interfaced Oxy-32
oxygen-monitoring system (Hansatech Instrument Ltd.). The effect of imidazole on the turnover
number of CHO-H310A was determined by measuring the enzymatic activity with 10 mM
choline as substrate for the enzyme in the presence of 100 mM of imidazole in air-saturated 50
mM sodium pyrophosphate, pH 6 or 10.
Data Analysis. Spectroscopic data points of the anaerobic incubation of CHO-H310A

with its organic substrate choline were fit into eq 1 that describes a case of double-exponential
decay, in which k1 and k2 represent the first-order rate constants for the fast and the slow phase of
the reductive half reaction, respectively, t is time, At is the value of absorbance at 456 nm, A1 and
A2 are the amplitude of the total change in the fast and the slow phase of the reductive half

reaction, respectively, and A∞ is the absorbance at infinite time. Data points obtained for the
observe rate of the slow phase of flavin reduction were fit to eq 2, where kobs is the observed rate
for the reduction of enzyme bound flavin, kred is the limiting rate of flavin reduction at saturated
substrate concentration, Kd is the dissociation constant, and A is the substrate concentration.
At = A1 exp( −k1t ) + A2 exp( −k 2 t ) + A∞
k obs =

k red A
Kd + A

(1)
(2)
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Results
Expression and Purification of CHO-H310A. CHO-H310A was expressed and purified

to high purity and quantity using the same protocol established for the CHO-WT (Figure 7.3).
Similar to wild-type enzyme, about 100-150 mg of pure CHO-H310A could be typically
obtained from 4.5 liters of Luria-Bertani culture medium. Polarographically, CHO-H310A as
purified at final concentrations as high as 20 µM did not show any catalytic activity toward its
organic substrate choline at final concentration of 20-30 mM at pH 7, at 25 °C. In comparison,
the CHO-WT at a final concentration of 0.1 µM typically shows a catalytic activity of ~15 s-1
with 10 mM choline (3), suggesting that histidine at position 310 is essential for the catalytic
activity in choline oxidase.
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A
Figure 7.3. Expression and purification of CHO-H310A.
Figure A: lane 1, molecular weight marker proteins; lane 2, total cell proteins before induction;
lane 3, total cell proteins after induction with 0.1 mM IPTG for 5 hours at 23 oC. Figure B: lane
1, molecular weight marker proteins; lane 2-10, pooled purified fractions of CHO-H310A in 200
mM Tris-Cl, pH 8, after DEAE column chromatography.
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Spectral Properties. The UV-visible absorbance spectrum of oxidized CHO-H310A at

pH 8 showed the typical spectrum of the oxidized flavin with peaks centered at 272, 356 and 458
nm in the near-UV and visible regions (Figure 7.4), suggesting that the enzyme-bound flavin
cofactor in the mutant enzyme as purified is in the oxidized redox state. The enzyme-bound
flavin of CHO-H310A showed an extinction coefficient at 458 nm of 11.6 mM-1 cm-1 (Figure
7.4), consistent with the values of 11.4 mM-1 cm-1 at 452 nm, 12 mM-1 cm-1 at 458 nm, and 12
mM-1 cm-1 at 450 nm that were previously determined for the wild-type, CHO-H466A, and
CHO-H466D enzymes, respectively (5, 10, 11). Similar to wild-type or CHO-H466A forms of
choline oxidase, CHO-H310A bound FAD covalently. A stoichiometry of ~0.11 FAD per
monomer of protein was calculated for CHO-H310A, indicating that the flavin content of CHOH310A was significantly less than that of the wild-type choline oxidase, for which a
stoichiometry close to unity was previously reported (3). A stoichiometry of ~0.3 FAD per
monomer of protein was previously determined for both CHO-H466A and CHO-H466D mutant
forms of choline oxidase (10, 11). This result suggests that histidine residue at position 310
significantly affects the flavinylation and the coenzyme binding of choline oxidase.

Absobance

0.20
0.15
0.10
0.05
0.00
300 400 500

600 700

800

Wavelength, nm

Figure 7.4. Spectral properties of CHO-H310A.
Solid curve, UV-visible absorbance spectrum of CHO-H310A in 20 mM Tris-Cl and 10%
glycerol, pH 8; dashed curve, after incubation with 4 M urea at 40 ºC for 3.5 h.
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Reaction of CHO-H310A with Choline. Purified CHO-H310A at final concentrations as

high as 20 µM showed no oxygen consumption when assayed with 20-30 mM choline as a
substrate at pH 7 and 25 °C. Nevertheless, the anaerobic incubation of CHO-H310A with choline
at a final concentration ranging from 0.75 to 20 mM resulted in a biphasic reduction of the
oxidized enzyme-bound flavin, with a fast phase that started right after mixing the enzyme with
its organic substrate and lasted for ~30 min, and a slow phase that lasted for ~16-40 h until the
full reduction of the bound flavin (Figure 7.5 and 7.6). This result clearly suggests that although
CHO-H310A does not show any catalytic activity toward its organic substrate choline as
measured polarographically, as assessed spectrophotometrically, CHO-H310A is still capable to
bind and oxidize its organic substrate choline but with a significantly slower rate compared to
that of CHO-WT or even CHO-H466A. The data points obtained for the observed rate of the fast
phase of flavin reduction after the anaerobic incubation of CHO-H310A with different
concentrations of choline (0.75-20 mM), were scattered and did not allow the determination of
the kred and the Kd for such fast phase (Figure 7.7A). However, the data points obtained for the
observed rate of the slow phase of flavin reduction, with the exception of the point at the highest
concentration of choline (20 mM), fit to eq 2 (data not shown). The value obtained for kred by
fitting those data points to eq 2 was ~200,000-fold lower than that for wild-type enzyme (4.37
×10-4 s-1 vs 93 s-1), and the value determined for Kd was at least 2-fold higher than that of wildtype enzyme (0.65 mM vs 0.29 mM) (4). Alternatively, the data points for the observed rate of
the slow phase of flavin reduction fit to substrate inhibition equation (Figure 7.7B). However,
due to the lack of the data points at the inhibitory phase it did not allow the determination of the
kred, Ki and Km. The scattering of the data points that have been observed during the fast phase of

CHO-H310A reaction with choline could be attributed either to the independence of the reaction
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to the substrate concentration, or due to a conformational change of the enzyme upon the
substitution of the active site residue His310 to alanine. This conformational change could be
studied in the future by examining the overall fold of the mutant enzyme and compare it with
that of the wild type choline oxidase using either tryptophan fluorescence or CDspectrophotometer.
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Figure 7.5. Anaerobic reaction of CHO-H310A with choline (1).
Solid curves, UV-visible absorbance spectra of CHO-H310A before incubation with choline;
dashed curves, UV-visible absorbance spectra of CHO-H310A after anaerobic incubation with
0.75 mM of choline for 40 h (panel A), 1 mM choline for 16 h (panel B), 1.5 mM choline for 16
h (panel C), 2 mM choline for 16 h (panel D), 5 mM choline for 16 h (panel E), and 10 mM
choline for 5.5 h (panel F). Enzyme concentrations were 10-20 µM in 20 mM Tris-Cl and 10%
glycerol, pH 8, at 15 °C.
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Figure 7.6. Anaerobic reaction of CHO-H310A with choline (2).
UV-visible absorbance values (•) at 456 nm as a function of time after the anaerobic incubation
of CHO-H310A with 0.75 mM of choline for 40 h (panel A), 1 mM choline for 16 h (panel B),
1.5 mM choline for 16 h (panel C), 2 mM choline for 16 h (panel D), 5 mM choline for 16 h
(panel E), and 10 mM choline for 5.5 h (panel F). The curves are fits of the data to eq 1.
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Figure 7.7. Anaerobic reaction of CHO-H310A with choline (3).
Observed rate (•) of the decrease of absorbance at 456 nm as a function of choline concentration
for CHO-H310A during the fast phase (panel A) and the slow phase (panel B).

Table 7.1. Anaerobic Spectral Incubation of CHO-H310A with
Cholinea
Slow phase
Fast phase
[Choline], mM
kobs, min-1
kobs × 103, min-1

0.75

0.061 ± 0.001

1.0 ± 0.1

1

0.063 ± 0.001

2.0 ± 0.3

1.5

0.187 ± 0.002

4.0 ± 0.1

2

0.35 ± 0.005

7.0 ± 0.2

5

0.23 ± 0.005

10 ± 0.3

10

0.26 ± 0.01

11 ± 0.2

20

0.13 ± 0.005

6.0 ± 0.5

a

Enzyme concentrations were 10-20 µM in 20 mM Tri-Cl and 10
% glycerol, pH 8, at 15 °C.
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Discussion
A proton-transfer network in the active site of choline oxidase. In a recent study in

which His466 was replaced with alanine, our group showed that His466 is protonated and that,
besides stabilizing the transient alkoxide species that is formed in catalysis, this protein group
modulates the electrophilicity of the enzyme-bound flavin and the polarity of the active site
(species 3 in Scheme 7.2) (10). In another recent study in which His466 was replaced with
aspartate, our group was able to show that His466, which is located at a distance of ~3.3Å from
the N(1) locus of the bound FAD, is responsible for stabilizing the negative charge that develops
in the enzyme active site (species 3,4, and 5 in Scheme 7.2) (11). The X-ray crystal structure of
choline oxidase showed that His310 is located at a distance of ~2.9 Å from His466 (His466Nδ1His310Nδ1) (Figure 7.2). The X-ray crystal structure of the enzyme along with our previous studies
on the role of the conserved active site His466 residue suggest the existence of a proton-transfer
network between the protonated conserved active site residue His466 and His310; the latter residue
is hydrogen bonded to the carbonyl oxygen atoms of Thr380 and Val507 through its N(3) atom
(Figure 7.2).
The preliminary results obtained herein by substituting the active site residue His310 of
choline oxidase show that the resulting enzyme is completely devoid of any catalytic activity
with choline as substrate, suggesting that His310 plays an essential role in the active site of
choline oxidase. As shown in Scheme 7.2, our proposed model of the mechanism of reaction for
the oxidation of choline catalyzed by choline oxidase in which a proton-transfer network
between His466 and His310 is proposed can be summarized as follows. 1) During the reductive
half-reaction, an unidentified active site base with a pKa of 7.5 activates the alcohol substrate
with formation of an alkoxide species (species 1 and 2 in Scheme 7.2) (4, 5). 2) This alkoxide
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intermediate is transiently stabilized in the active site through electrostatic interaction with the
Nε2 atom of the protonated side chain of His466 (species 3 in Scheme 7.2) (10). 3) The protonated
His466 also stabilizes electrostatically the negative charge that develops at N(1)-C(2)=O locus of
the reduced flavin (anionic species) through its Nε2 atom (species 3 in Scheme 7.2) (11). 4) The
hydride transfer from the α-carbon of the substrate to the N(5) locus of the bound occurs
quantum mechanically from the activated choline alkoxide species (species 3 in scheme 7.2) (6).
5) His466 is hydrogen bonded to His310 (His466Nδ1-His310Nδ1); the latter residue is hydrogen bonded

to the main chain carbonyl oxygen atoms of Thr380 and Val507. The main proposed role of such a
proton-transfer network is to prevent the protonated His466 from losing its proton during the
oxidative half-reaction. This proton-transfer network serves to transfer this proton from His466 to
His310 before the reaction of molecular oxygen. As a result of such proton transfer, the negative
charge at the N(1)-C(2)=O locus of the anionic hydroquinone is stabilized through hydrogen
bonding with Nε2 atom of the imidazole side chain of His466 (species 4 in Scheme 7.2). 6)
During the oxidative half-reaction, and after the transfer of the proton from His466 to His310, the
electron delocalization from the N(1) locus of the anionic hydroquinone along with the proton
transfer from an unidentified catalytic base results in the formation of the C(4a)-hydroperoxoflavin (species 5 in Scheme 7.2); 7) the highly unstable C(4a)-hydroperoxo-flavin abstracts the
second proton from the hydride at N(5) locus of the FAD with the subsequent release of H2O2
and the formation of oxidized enzyme-bound FAD (species 6 and 7 in Scheme 7.2); 8 ) finally,
the oxidation of the hydrated betaine aldehyde occurs through a base catalyzed transfer of a
hydride ion from the organic substrate to the enzyme-bound FAD, with a mechanism that is
similar to that proposed for the oxidation of choline as proposed recently in a study by our group
on the mechanism of aldehyde oxidation (13).
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In summary, the previously obtained results on the CHO-H466A and CHO-H466D
mutants (10, 11) suggested that His466 plays an important role in the transient stabilization of
choline alkoxide intermediate, in stabilization of the negative charge that develops on the N(1)C(2)=O locus of the bound flavin, and in modulation of the electrophilicity of the bound FAD
and the polarity of the active site. The preliminary results obtained herein on the CHO-H310A
mutant form of choline oxidase suggested that His310 plays an essential role in the active site of
choline oxidase because its substitution with alanine resulted in a complete loss of its catalytic
activity toward choline as a substrate. One would expect that CHO-H310A is completely devoid
of activity with choline due to the fact that the substitution of His310 with alanine resulted in
alteration of the position of His466 and in turn resulted in an completely inactive enzyme or at
least 200,000-time slower than CHO-WT. In addition, the substitution of His310 with alanine
would disrupt the proposed proton-transfer network between His466 and His310. In that sense,
further site-directed mutagenesis studies (H310D and H310N) are currently underway in order to
gain insights into the role played by such a proton-transfer network involving His310 and His466 in
the reaction catalyzed by choline oxidase.
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CHAPTER VIII
General Discussion

Choline oxidase from Arthrobacter globiformis catalyzes the oxidation of choline to
glycine betaine (1-3). This reaction is of considerable interest for biotechnological and
biomedical applications. The biotechnological and biomedical importance come from the
reaction product glycine betaine, which is one of the most commonly used compatible solutes
that is accumulated in the cytoplasm of many plants and microorganisms to counteract
hyperosmotic environments (4). The accumulation of glycine betaine was observed in many
human pathogenic bacteria, allowing their growth and survival under hyperosmotic conditions
that are frequently encountered at human infectious sites (5-7). The development of efficient
specific inhibitors targeting glycine betaine synthetic pathway therefore has potential for the
microbial treatment. Similarly, in transgenic plants, glycine betaine serves a similar function,
enabling bioengineering of economically relevant crop plants with enhanced stress resistances
(8-11). From a chemical standpoint, the oxidation reaction catalyzed by choline oxidase is of
particular interest in that the cleavage of the substrate CH bond is energetically unfavorable due
to the high pKa value of the CH group (12). In this study, the biophysical, biochemical,
structural, and mechanistic properties of wild-type as well as selected mutant forms of choline
oxidase are presented, providing a solid background for the medical and biotechnological
applications of choline oxidase. In addition, the results obtained in this study have also shed light
on other structurally and mechanistically related flavoprotein oxidases.
The correct nucleotide sequence of the codA gene encoding for choline oxidase was
established in this study. The codA gene contains large amount of GC (~70%), resulting in
difficulties in PCR amplification. Addition of 2% of DMSO into the PCR reaction mixture
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increased the efficiency of denaturation for the double stranded DNA and yielded a full-length
PCR product. Sequence analysis was performed independently with two forms of the codA gene:
the cloned codA gene directly from the genomic DNA of A. globiformis strain ATCC 8010; and
the subcloned codA gene (a gift kindly provided by Dr. Norio Murata, National Institute for
Basic Biology, Okazaki, Japan), which has been prepared by F. Fan. Similar sequencing results
were obtained, both of which showed that the previously reported nucleotide sequence of codA
in GenBank (13) contained seven flaws. These seven flaws resulted in a translated protein with a
significantly altered amino acid sequence between position 298 and 410. The correct newly
determined amino acid sequence of choline oxidase corresponds to the mass of the enzyme with
one linked FAD (60.612 kDa), consistent with the experimental mass spectral determination
(60.614 kDa). For comparison, the calculation of the incorrect previously reported amino acid
sequence of the enzyme yields a molecular mass of 59.648 kDa. A significant increase in
homology between choline oxidase and other members of the GMC oxidoreductase superfamily
was also observed when the newly reported amino acid sequence was used (Figure 3.4 in
Chapter III), which further strengthens our sequence analysis. Importantly, the recently solved
X-ray crystal structure of choline oxidase clearly showed a covalent linkage between the
His99Nε2 and FADC8M atoms, in contrast to the previously proposed His87Nε1 determined by
mass spectroscopic studies which was based on the previously reported incorrect amino acid
sequence of the enzyme (14). The previously reported incorrect nucleotide sequence of A.
globiformis codA gene was recently replaced with a newer version in the GenBank (accession

number X84895.2) that is identical to our sequence.
In this study, our group has established an efficient protocol to express and purify the
recombinant choline oxidase to high purity and quantity, allowing detailed biochemical and
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mechanistic studies of this enzyme. The same protocol was also applied to express and purify
different mutant forms of the enzyme. The cloned codA gene from A. globiformis was expressed
to high quantity in Escherichia coli strain Rosetta(DE3)pLysS, which provides tRNAs for rare
codons. The codA gene contains 27 of such rare codons due to its high GC content. The enzyme
was then purified to homogeneity using 30 to 65% ammonium sulfate followed by anion
exchange chromatography onto a DEAE-Sepharose Fast Flow column. Typically ~150-200 mg
pure choline oxidase could be obtained from 4.5 liters liquid LB culture medium (Table 3.2 in
Chapter III).
The recombinant choline oxidase as purified was found to contain large amounts of
anionic flavin semiquinone species (35-85%). At pH 8, enzyme-bound flavosemiquinone
remains unusually stable when subjected to the treatments with molecular oxygen or oxidizing
agents such as ferricyanide, suggesting that the unpaired electron resides in a solvent inaccessible
region of the flavin (Figure 4.1 in Chapter IV). The enzyme-bound semiquinone undergoes a
slow conversion to the fully oxidized form at pH 6 (Figure 4.4 in Chapter IV), indicating that an
increase in proton concentration significantly destabilizes the flavin radical. The spectral studies
of the enzyme under turnover showed only two states, i.e., the fully oxidized and reduced forms,
indicating that the flavin semiquinone of choline oxidase is catalytically inactive (Figure 4.7 in
Chapter IV). The kinetic data further support this conclusion by showing a good correlation
between the turnover numbers of the enzyme with choline and betaine aldehyde as substrate and
the content of oxidized flavin per active site (Table 4.2 in Chapter IV). The conversion of the
kinetically inactive inert semiquinone form of flavin to the active oxidized form increases the
specific activity of the purified enzyme at least by 2-folds. The unusual stabilization of
flavosemiquinone along with the formation of a tight reversible flavin-N(5)-sulfite adduct in
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wild-type choline oxidase was explained as a result of the stabilization of the negative charge
that develops on N(1) locus of the flavin by a protein positive charge close to that region. Such
protein positive charge was firstly assigned to the dipole of an adjacent α-helix, which is fully
conserved among the GMC oxidoreductase superfamily (15-19). Our recent studies on the active
site residue His466 clearly suggest that the protonated form His466 stabilizes the negative charge
that develops on the N(1) locus of the bound flavin as well as the negative charge of the transient
alkoxide intermediate during catalysis (Chapter V and VI) (20, 21). Interestingly, the midpoint
reduction-oxidation potential for the oxidized-semiquinone couple in wild-type choline oxidase
was 211 mV (Figure 6.8 and Table 6.2 in Chapter VI) (20), which is exceptionally the highest
value for such thermodynamic equilibrium reported for a flavoprotein oxidase (22-27), consistent
with the unusual stabilization of flavosemiquinone in choline oxidase. In addition, the mutant
form of choline oxidase in which the positively charged histidine residue at position 466 was
reversed (H466D) lost its ability to either stabilizes the semiquinone species of the bound flavin
or the formation of flavin-N(5)-sulfite adduct, consistent with the proposed role of His466 in
stabilizing the negative charge that develops on the N(1) locus of the bound FAD. Furthermore,
the midpoint potential for the transfer of the two electrons with CHO-H466D showed a value
that was ~130 mV and ~160 mV more negative than the calculated midpoint potentials for the
corresponding two-electron transfers in CHO-H466A and CHO-WT, respectively (Figure 6.8
and Table 6.2 in Chapter VI) (20). These data are consistent with a significant effect of the
amino acid residue at position 466 on the electrophilicity of the enzyme-bound flavin in choline
oxidase (20).
Steady state kinetic studies suggested a sequential mechanism with either choline or
betaine aldehyde as substrate over a pH range of 6.5 to 10. The pH dependence of the kinetic
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parameters at varying concentrations of both choline and oxygen indicated that a catalytic base
with a pKa value of 7.5 is required during the reductive-half reaction of both choline and betaine
aldehyde oxidation. Based on the amino acid sequence alignment comparison of choline oxidase
with other members of the GMC enzyme superfamily, the fully conserved His466 was firstly
proposed to be the catalytic base (28). However, pH-dependent studies with H466A showed
similar pH-dependences although the pKa value is shifted (Figure 5.7 in Chapter V) (21),
suggesting that His466 might not be the catalytic base. Strong evidence supporting this conclusion
comes from the pH dependence of the imidazole effect with CHO-H466A, showing that
imidazolium, but not imidazole, is the catalytically relevant species responsible for the partial
rescue of the enzymatic activity of the mutant enzyme (Figure 5.6 in Chapter V) (21). These data
are clearly difficult to reconcile with the assumption that His466 is the catalytic base since, if that
were the case, maximal rescue of the enzymatic activity of the mutant enzyme would have been
observed at increasing pH. In this respect, recent structural data showed that the Nε2 atom of the
equivalent histidine residue in the active site of cholesterol oxidase, His447, is protonated,
suggesting that this conserved residue in the GMC oxidoreductase superfamily may play a role
other than acting as a specific base in catalysis (29). In this context, a number of observations
presented in this study suggest that in choline oxidase His466 contributes to catalysis by
modulating the electrophilicity of the flavin cofactor (by increasing its reduction-oxidation
potential) and the polarity of the active site for efficient proton transfer of the hydroxyl proton
from the alcohol substrate to the active site proton acceptor, and by stabilizing the negative
charge that is formed in the transition state for the oxidation of choline to betaine aldehyde
(Chapter V and VI) (20, 21). An alternative hypothesis arises from the observation of the
recently solved X-ray crystallographic data of choline oxidase, which suggest that His351 may act
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as the catalytic base. In agreement with that hypothesis, the X-ray crystal structure of choline
oxidase with its substrate choline docked in the active site showed that His351 is located at a
distance of ~3.3 Å from the hydroxyl group of choline (Figure 1.27 in Chapter I). However,
further biochemical and mechanistic characterization on the His351 mutant enzymes is required
to draw conclusions1.
His466 is involved in the oxidation of the choline substrate, but not in the following
reduction of molecular oxygen catalyzed by choline oxidase. Evidence supporting this
conclusion comes from the steady-state kinetic data with CHO-H466A as compared to those
with the wild-type enzyme, showing that the kcat/Km value for choline decreases by three orders
of magnitude whereas that for oxygen is not significantly changed in the mutant enzyme. The
lack of involvement of His466 in the oxidative half-reaction agrees well with previous kinetic data
on choline oxidase as a function of pH, showing that no ionizable groups with pKa values
between 6 and 10 are required for oxidation of the enzyme-bound reduced flavin in catalysis
(30).
Recent kinetic and mechanistic studies on the recombinant choline oxidase were carried
out in our laboratory by Fan F. (31-33). These studies showed that the overall turnover with
choline is limited by both chemical steps for alcohol and aldehyde oxidations (31). For alcohol
oxidation, large deuterium isotope effects were observed by both steady state and pre-steady
state kinetic approaches, indicating that the chemical step for choline oxidation is not masked by
other steps (31). For aldehyde oxidation with betaine aldehyde as substrate, the kcat (133 s-1 at pH
1

The H351A mutant was constructed and purified in our laboratory. Preliminary kinetic characterization showed a
~180 fold decrease in kcat/Km value as compared to the wild type enzyme, indicating the important yet not essential
role of His351 in the catalysis by choline oxidase. In addition, pH-dependence studies with this mutant enzyme
revealed a pKa value of ~ 7.8, which may argue against the notion that His351 is the catalytic base. Nonetheless, this
ongoing study needs to be completed to draw more definitive conclusions (Rungsrisuriyachai, K., and Gadda, G.;
unpublished data).
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10) determined by steady state kinetics is similar to kred (135 s-1 at pH 10) determined by presteady state kinetics, suggesting that the chemical step for betaine aldehyde oxidation is also
rate-limiting (31). Both chemical steps of flavin reduction are significantly faster in the forward
direction relative to the reverse direction, as suggested by the stopped-flow analyses of the
reductive half-reactions with choline and betaine aldehyde (31). Unlike glucose oxidase and
cholesterol oxidase, for which the chemical steps has been masked by other steps (34, 35), the
rate-limiting chemical steps in choline oxidase allow an opportunity to unambiguously determine
the chemical mechanism for catalysis. Primary deuterium and solvent kinetic isotope effects
have been used to elucidate the mechanism for substrate oxidation by choline oxidase using both
steady state kinetics and rapid kinetics techniques. The oxidation of choline catalyzed by choline
oxidase occurs through an asynchronous hydride transfer mechanism, in which the substrate
hydroxyl proton is abstracted to form an alkoxide intermediate followed by a hydride transfer to
the flavin (31). An in-depth investigation of the hydride transfer in choline oxidation suggested
the presence of quantum mechanical tunneling occurring within a highly pre-organized active
site, through a process in which environmental vibrations (gating) is minimally involved (32).
Evidence for this conclusion is provided by the temperature dependent studies on the kcat/Km and
D

(kcat/Km) values with choline as substrate (32). The large isotope effect on the preexponential

factors (AH'/AD') determined from the temperature dependence of the kcat/Km values with choline
and 1,2-[-2H4]-choline, with a value of ~14, rules out a classical over-the-barrier behavior for
hydride transfer, for which AH'/AD' values between 0.7 and 1.7 are expected (36). Modeling
choline into the active site of choline oxidase revealed an orientation of the substrate with its αcarbon towards the N5 of flavin isoalloxazine ring, consistent with the proposed hydride transfer
mechanism rather than carbanion mechanism. Although the distance between flavin N5 and α-
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carbon (~3-4 Å), is rather large when compared to the distance of 2.7 Å proposed for tunneling
by computational calculations (37), this distance is similar to the donor/acceptor distance
observed in liver alcohol dehydrogenase (~3.4 Å), for which the quantum mechanical tunneling
is convincingly suggested (38, 39).
Moreover, the recently solved X-ray crystal structure of choline oxidase at 1.86 Å
resolution showed dimeric structure (George Lountos, Fan Fan, Giovanni Gadda, and Allen M.
Orville; unpublished results). The overall structure of monomeric choline oxidase resembles that
of p-hydroxy-benzoate hydroxylase, and folds into substrate- and flavin-binding domains as
other GMC enzymes. Structural comparison of the choline oxidase with other members of the
GMC oxidoreductase superfamily, e.g., cholesterol oxidase (17, 40, 41), glucose oxidase (15, 16,
42), cellobiose dehydrogenase (19, 43), also revealed a highly conserved catalytic site. These

structural similarities suggest a similar activation mechanism for the oxidation of their substrates.
Mechanistic studies on cholesterol oxidase and glucose oxidase had been hampered since the
chemical steps in these enzymes are masked by other kinetic steps (34, 35).
The X-ray crystal structure of choline oxidase also showed that His466 is located at
distance of ~3.3 Å from the N(1) locus of the enzyme-bound flavin, consistent with the proposed
role of this residue in stabilizing the negative charge that develops on the N(1)-C(2)=O locus of
the bound flavin (Chapter V and VI). Interestingly, another active site histidine residue, His310,
was found to be located at a distance of ~2.9 Å from His466 (His466Nδ1-His310Nδ1) (Figure 7.2 in
Chapter VII). These structural data strongly suggest the presence of a proton-transfer network
between the protonated conserved active site residue His466 and His310 (Chapter VII).
In this study, the preliminary results obtained by substituting the active site residue His310
of choline oxidase with alanine show that the resulting enzyme is completely devoid of any
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catalytic activity with choline as substrate. These data suggest that His310 plays an essential role
in the active site of choline oxidase, and consistent with the proposed proton-transfer network
between the protonated conserved active site residue His466 and His310.
Overall, as shown in Scheme 8.1, and based on the results obtained from this study along
with other structural, kinetic, and mechanistic data on wild-type choline oxidase, which have
been determined by other members of our research group, the proposed mechanism of reaction
for the oxidation of choline to glycine betaine catalyzed by choline oxidase can be summarized
as following: 1) during the reductive half-reaction, an unidentified active site base with a pKa of
7.5 activates the alcohol substrate with formation of an alkoxide species (species 1 and 2 in
Scheme 8.1) (Chapter IV) (30, 31); 2) this alkoxide intermediate is transiently stabilized in the
active site through electrostatic interaction with the Nε2 atom of the protonated side chain of
His466 (species 3 in Scheme 8.1) (Chapter V) (21); 3) similarly, the protonated His466 also
stabilizes electrostatically the negative charge that develops at N(1)-C(2)=O locus of the reduced
flavin (anionic species) through its Nε2 atom (species 3 in Scheme 8.1) (Chapter VI) (20); 4) the
hydride transfer from the α-carbon of the substrate to the N(5) locus of the bound occurs
quantum mechanically from the activated choline alkoxide species (species 3 in Scheme 8.1)
(32); 5) His466 is hydrogen bonded to His310 (His466Nδ1-His310Nδ1) and the latter is hydrogen
bonded to the main chain carbonyl oxygen atoms of Thr380 and Val507. The main proposed role of
such proton-transfer network is to prevent the protonated His466 from losing its proton during the
oxidative half-reaction. Thereby, this proton-transfer network serves to transfer this proton from
His466 to His310 before the reaction of molecular oxygen. As a result of such proton transfer, the
negative charge at the N(1)-C(2)=O locus of the anionic hydroquinone turned to be stabilized
through hydrogen bonding with Nε2 atom of the imidazole side chain of His466 (species 4 in
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Scheme 8.1) (Chapter VII); 6) during the oxidative half-reaction, and after the transfer of the
proton from His466 to His310, the electron delocalization form the N(1) locus of the anionic
hydroquinone along with the proton transfer from the unidentified catalytic base result in the
formation of the C(4a)-hydroperoxo-flavin (species 5 in Scheme 8.1); 7) the highly unstable
C(4a)-hydroperoxo-flavin abstracts the second proton from the hydride at N(5) locus of the FAD
with the subsequent release of H2O2 and the formation of oxidized enzyme-bound FAD (species
6 and 7 in Scheme 8.1); 8 ) finally, the oxidation of the hydrated betaine aldehyde occurs through
a base catalyzed transfer of a hydride ion from the organic substrate to the enzyme-bound FAD,
with a mechanism that is similar to that proposed for the oxidation of choline as proposed
recently in a study by our group on the mechanism of aldehyde oxidation (33).
In summary, the results obtained herein from the biochemical, biophysical, and
mechanistic characterization of a choline oxidase variants in which the protein charge near the
flavin N(1) locus was removed or reversed by site-directed mutagenesis suggest that in wild-type
choline oxidase His466 plays important role in: 1) the transient stabilization of choline alkoxide
intermediate during the oxidation of choline to betaine aldehyde; 2) stabilization of the negative
charge that develops on the N(1)-C(2)=O locus of the bound flavin; 3) modulation of the
electrophilicity of the bound FAD for efficient catalysis by increasing its reduction-oxidation
potential; 4) the covalent attachment of the FAD cofactor to the protein moiety for efficient
catalysis; 5) modulation of the polarity of the active site for efficient proton transfer of the
hydroxyl proton from the alcohol substrate to the active site proton acceptor. In addition the
results obtained in this study also suggest that His310 plays an essential role in the active site of
choline oxidase and point out the possibility of its involvement in a proton-transfer network with
His466. Interestingly, the present study on the biochemical and the mechanistic properties of wild-
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type choline oxidase along with its active site mutants can shed light on other functionally and
structurally related flavoprotein oxidases. In addition, this study will also provide a foundation
for future rational design of efficient transition state analogs and inhibitors that could be used for
the development of therapeutic agents that inhibit the formation of glycine betaine, and in turn
render pathogenic bacteria susceptible to conventional treatments.
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